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ABSTRACT

Tumor  hypoxia  strongly  correlates  with  metastasis  and  poor  survival.  However,  the  molecular 
mechanism by which hypoxia drives metastasis formation is not clear yet. EFNA3, a member of the 
ephrin type A ligands, was identified as a potential novel HIF target gene in an  in silico search 
performed by our group (Ortiz-Barahona, Villar, Pescador, Amigo, & Del Peso, 2010). Although the 
involvement of EFNA3 in cancer has not been studied in detail,  the expression of other ephrin 
members and their receptors are increased in human tumors and correlate with increased metastatic 
potential.   Here,  we  show  that  hypoxia  regulates  Ephrin-A3  expression  through  a  non-direct 
mechanism that involves the HIF-mediated transcriptional induction of a novel family of long-non-
coding  RNAs  (lncRNAs)  from  the  EFNA3  locus.  In  turn,  these  lncRNAs  favor  Ephrin-A3 
accumulation acting at the postranscriptional level. As a consequence of this mechanism, EFNA3 
transcript  expression  is  significantly  augmented  in  human  renal  carcinoma,  where  HIF  is 
constitutively  active,  as  compared  with  normal  kidney  tissue.   Importantly,  we found a  strong 
correlation between high EFNA3 expression and shorter metastasis-free survival in breast cancer 
patients, suggesting a role for Ephrin-A3 in the promotion of metastatic behavior. In support of this 
hypothesis, Ephrin-A3 expression increased the metastatic potential of human breast cancer cells in 
an  orthotopic  xenotransplantation  model.  Importantly,  by  a  combination  of  in  vitro  an  in  vivo 
experiments,  we  also  found  that  Ephrin-A3  expression  increases  the  ability  of  tumor  cells  to 
extravasate from the blood vessels into surrounding tissue. This function is in agreement with the 
role of ephrins as key mediators intercellular adhesion-repulsion and suggest a mechanisms for the 
promotion  of  metastasis.  Altogether,  our  results  suggest  that  hypoxia  contributes  to  metastatic 
spread of cancer cells  via  HIF-mediated induction of EFNA3 lncRNAs and subsequent protein 
accumulation.
La presencia de hipoxia tumoral correlaciona fuertemente con la aparición de metástasis y baja 
supervivencia. Sin embargo, el mecanismo molecular por el cual la hipoxia da lugar a la formación 
de metástasis no está aun claro. EFNA3, miembro de las efrinas de tipo A, fue identificado como un 
nuevo gen potencial diana de HIF en un estudio in silico llevado a cabo por nuestro grupo (Ortiz-
Barahona, A., 2010). Aunque la implicación de EFNA3 en cáncer no se ha estudiado en detalle, la  
expresión de otros miembros de esta familia así como sus receptores está aumentada en tumores 
humanos y correlaciona con un mayor potencial metastásico. En este trabajo, mostramos que la 
hipoxia  regula  la  expresión  de  Efrina-A3 a  través  de  un  mecanismo indirecto  que   implica  la 
inducción transcripcional, mediada por HIF, de una familia nueva de RNAs no codificantes largos 
(lncRNAs) desde el locus EFNA3. A su vez, estos lncRNAs favorecen la acumulación de Efrina-A3 
a nivel postranscripcional. Como consecuencia de este mecanismo, la expresión de tránscritos de 
EFNA3 está incrementada significativamente en carcinoma renal humano, donde HIF se encuentra 
constitutivamente  activo,  en  comparación  con  tejido  renal  normal.  Cabe  destacar,  que  hemos 
encontrado una fuerte correlación entre altos niveles de expresión de EFNA3 y una supervivencia 
libre de metástasis más corta en pacientes con cáncer de mama, sugiriendo que la efrina-A3 pudiera 
tener un papel en la promoción del comportamiento metastásico. En apoyo de esta hipótesis, la 
expresión de Efrina-A3 en células de cáncer de mama, aumentó su potencial metastásico en un 
modelo de  xenotransplante ortotrópico. Además, por combinación de experimentos tanto  in vitro 
como  in vivo, también encontramos que la expresión de Efrina-A3 aumenta la capacidad de las 
células tumorales de extravasar de los vasos sanguíneos a los tejidos circundantes. Este función está 
de acuerdo con el papel de las efrinas como mediadores clave en la adhesión-repulsión intercelular 
y  sugiere  un  mecanismo para  la  promoción  de  la  metástasis.  En  conjunto,  nuestros  resultados 
sugieren que la hipoxia contribuye a la diseminación metastásica de las células cancerosas mediante 
la  inducción  mediada  por  HIF  de  los  lncRNAs  del  locus  EFNA3 y  su  acumulación  proteica 
posterior.  
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Introduction
1. OXYGEN HOMEOSTASIS 
Oxygen is one of the most abundant molecules in our planet and its accumulation in the atmosphere 
2000 million years ago was a determining factor  for the evolution of life.  The passage from a 
reducing atmosphere to the current oxidant atmosphere (21% oxygen), allowed the development of 
highly efficient metabolism which led to an explosion and diversification of aerobic life forms 
(Webster, K. A., 2007). 
As complex organisms became dependent on this molecule to sustain their large energy demands, 
they had to develope mechanisms to ensure oxygen homeostasis by maintaining a fine balance 
between its supply and consumption (Semenza G. L., 2004). In simple organisms oxygen supply is 
ensured just by simple diffusion, but in more complex organisms its delivery to all tissues requires 
the development of sophisticated transport structures such as the tracheal or circulatory systems. 
The evolution of these transport systems in animals imposed the need for specialized structures, 
such as the carotid body, pulmonary arteries and the neuroepithelial bodies in the respiratory tract, 
to monitor oxygen levels and ensure its systemic homeostasis. In vertebrates, a small decrease in the 
blood pO2 (below 60 mmHg) is sensed, almost instantaneously, by the carotid body. Its Glomus 
cells,   release the neurotransmitters,  including dopamine,  in  a  Ca²  dependent  manner,  thereby⁺  
stimulating respiration and cardiac beating (Lopez-Barneo, J., Ortega-Saenz, P., et al. 2009). On the 
other  hand,  muscles  cells  of  the  pulmonary  arteries  constrict  in  response to  low oxygen level, 
resulting in  blood flow distribution  from poorly to well oxygenated areas, enabling optimum gas 
exchange between lungs and  blood cells (Seta, K., et al. 2002).
In addition to the acute systemic responses described above, virtually all animal cells are able to 
adapt to more sustained restrictions in oxygen supply through a local chronic response that involves 
changes in gene expression. Specifically, this ubiquitous response is activated whenever oxygen 
supply  does  not  meet  oxygen consumption,  a  condition  termed  hypoxia.  The  induction  of  the 
hypoxia-induced transcriptional program aims to restore oxygen homeostasis by increasing oxygen 
supply to hypoxic regions through the induction of erythropoiesis (reviewed in Haase, V. H., 2010) 
and  angiogenesis  (Rey,  S.,  &  Semenza,  G.  L.,  2010) and  to  reduce  oxygen  consumption  by 
reprogramming cellular metabolism (reviewed in Wheaton, W. W.,  & Chandel, N. S., 2011)).
The first gene implicated in the cellular response to hypoxia was the erythropoietin gen (EPO), that 
encodes for a hormone responsible for the proliferation and survival of progenitor's red blood cells. 
Investigation on the Epo transcriptional regulation led to the identification of a cis-regulatory 
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element, known as hypoxia response element (HRE), in the 3'enhancer of the Epo gene (Semenza, 
G. L. and Wang, G. L., 1992). Subsequent investigation identified a transcription factor,  Hypoxia-
Inducible Factor (HIF), that bound led to the HRE and mediated in the response of Epo to hypoxia 
(Wang G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L., 1995).  Although the expression of EPO is 
restricted to liver tissue, HIF is ubiquitously expressed in all tissues, acting as the key regulator in  
response to hypoxia. 
The transcriptional response to hypoxia, under the control of HIF, ensures oxygen homeostasis at 
tissue and cellular level, so only in exceptional situations such as embryonic development, tumors 
or inflammatory processes,  an imbalance between supply and consumption of oxygen might occur.
2. HYPOXIA INDUCIBLE FACTOR (HIF)
HIF-1 has been identified in all metazoan species that have been analyzed from the simplest animal, 
Trichoplax adherents (Loenarz, C., 2011 and Rytkönen, K. T., 2011) to Homo sapiens, suggesting 
that the appearance of HIF-1 represented an adaptation that was essential to metazoan evolution 
(Semenza, G. L.,2004).
2.1 HIF STRUCTURE
HIF is a heterodimeric transcription factor composed by an oxygen-regulated alpha (HIFα) and an 
oxygen-insensitive beta subunit (HIFβ, also known as Aryl receptor nuclear translocator, ARNT). 
Both  proteins  belong  to  the  basic  helix-loop-helix  (bHLH)-Per,  ARNT and  Sim domain  (PAS) 
transcription factor family. The bHLH domain mediate DNA binding, whereas both, bHLH and 
PAS, domains are involved in the heterodimerization with other members of the family (Jiang, B. 
H., 1997). In contrast to HIFα,  HIFβ shows a promiscuous behavior and forms dimers with other  
members of the bHLH-PAS superfamily in addition to HIFα. 
There are three genes encoding for HIFα subunits: HIF1α, HIF2α (also known as EPAS) and HIF3α 
(figure 1). Functional studies have revealed that, in addition to the bHLH and PAS domains, all 
three HIFα proteins contain an oxygen dependent degradation domain (ODD) with critical proline 
residues  (Pro  402/Pro  564  in  HIF1α,  Pro  405/Pro  531  in  HIF2α  and  Pro  490  in  HIF3α)  that  
determine their accumulation in response to a decrease in oxygen availability (Huang L. E.,  et al, 
1996) .
All  HIFα subunits  also contain transactivation  domains,  two in  HIF1α and HIF2α (NTAD and 
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CTAD) and one in HIF3α (NTAD). The NTAD (amino acids 531–575 in Human HIF1α) and CTAD 
(amino acids 786 – 826) are separated by an inhibitory domain, ID (amino acids 576 –785) that 
represses CTAD under non-hypoxic conditionswith its repressive activity being prevented during 
hypoxia (Jiang, B. H., et al, 1997)
Figure 1: HIF family showing functional domains
Several mechanisms have been proposed to explain the detection pO2 cellular variations by HIF 
(Wang G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L., 1995). However, the prevailing mode, 
summarized in figure 2, involves the activity of  hydroxylases family, that are highly sensitive to 
pO2 variations.  In normoxic conditions, HIFα is efficiently hydroxylated at two specific  proline 
residues  within  the  ODD.  This  reaction  is  catalyzed  by  a  three-member  family  of  prolyl-
hydroxylases termed Prolyl-Hydroxylase Domain (PHD) EGL-nine homologues (EGLN), (Epstein, 
A. C., et al., 2001).
The hydroxylation in at least one of these prolines allows its recognition by an E3-ubiquitin ligase 
complex that targets HIFα for degradation via proteasome (Maxwell, P., H., et al. 1999; Ivan, M., et  
al. 2001; Jaakkola, P., Mole, D., et al. 2001). The product of the Von Hippel Lindau (VHL) tumor 
suppressor gene is the substrate recognition subunit of the E3-ubiquiting ligase complex (Lisztwan, 
J. 1999, Iwai K., 1999) that targets hydroxylated-HIF for proteasomal degradation. 
In  addition,  under  normoxia,  another  dioxygenase  (Factor  inhibiting  HIF,  FIH)  catalyzes  the 
oxygen-dependent  hydroxylation  of  a  conserved  asparagine  residue,  located  in  the  C-terminal 
transactivation domain. This postranslational modification prevents the interaction of HIFα with the 
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p300 coactivator, blunting its transcriptional activity (Mahon P. C., et al, 2001, Hewitson, K. S., et 
al. 2002; Lando, D., et al. 2002). However, the  functional significance of this modification appears 
to  be  more  subtle  than  the  prolyl-hydroxylation  of  HIFα  subunits,  which  is  likely  the  main 
mechanism behind oxygen-dependent HIF transcription (Dayan F., 2006). 
When  oxygen  becomes  limiting,  all  these  hydroxylation  reactions  are  compromised  and,  as  a 
consequence,  HIFα subunit escapes degradation allowing its translocation to the nucleus and its 
interaction with HIFβ.  Then, the heterodimer HIFα/HIFβ binds to the HRE (consensus sequence 
RCGTG), within regulatory regions of its target genes and recruits p300/CBP coactivator leading to 
their transcription (Min J. H., 2002, Epstein A. C., 2001).
Figure 2: HIF signaling pathway
2.2 IDENTIFICATION OF HIF TARGET GENES:
Since most of the cellular adaptations to hypoxia are mediated by HIF, the identification of the 
complete set of genes regulated by this transcription factor is of key importance to fully understand 
the responses to reduced oxygen availability. This response entails the expression of multiple genes 
involved in different functions, as metabolic reprogramming, angiogenesis, chromatin remodeling, 
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proliferation and cellular differentiation (summarized in figure 3).
A large number of single gene studies have steadily increased the list of HIF-target genes (Wenger 
R. H., 2005). More recently,  the application of high-throughput techniques such as global gene 
expression profiling,  chromatin immunoprecipitation (Xia X.,  2009 and Mole D. R.,  2009) and 
computational prediction (Benita, Y., 2009 , Ortiz-Barahona,  A., 2010), had resulted in a impressive 
increase in the number of known HIF target genes. 
 
Figure 3 : The HIF transcriptome
With the aim of identifying novel HIF targets, our group developed a  computational strategy based 
on  the  combination  of  phylogenetic  footprinting  and  meta-analysis  of  publicly  available  gene 
expression profiles  of  cells  exposed to hypoxia (Ortiz-Barahona,  A.,  2010).  Comparison of  the 
resulting candidates with experimentally validated HIF1α targets, indicated that this approach had a 
high sensitivity (78%) and specificity (97,8%). 
Importantly,  the  implementation  of  this  strategy  led  to  the  identification  of  215  potential  HIF 
targets, of which 152 were not previously involved in the response to hypoxia. Among the novel 
potential  targets  genes  was EFNA3 gene,  in  which  this  project  focuses,  ranking in  the  top  51 
position of the 215 candidates (Ortiz-Barahona, A., 2010)
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2.3  THE ROLE OF HIF IN CANCER
In  addition  to  orchestrating  physiological  responses  to  hypoxia,  HIF has  been  involved  in  the 
ethiology and progression of multiple pathologies including cardiovascular and respiratory diseases, 
diabetes and cancer. In particular, the role of HIF in cancer has been extensively investigated. On 
one hand, hypoxia is frequently observed in solid tumors as a consequence of the rapid expansion of 
the cell mass compounded by aberrant and incomplete vascularization  (Vaupel, P. & Mayer, A., 
2007). On the other hand, the VHL tumor suppressor, whose protein product plays a key role in the 
control of HIFα stability (Maxwell, P., H., et al. 1999; Ivan, M., et al. 2001; Jaakkola, P., Mole, D., 
et al. 2001), is frequently lost in the progression of certain tumor types. Moreover, several lines of 
evidence point to HIFs, in particular EPAS, as key promoters of tumor progression upon VHL loss 
(Kaelin, W. G., 2007). Other oncogenes and tumor suppressor genes including PTEN, mTORC1, 
Ras, Akt and p53 also regulate  HIFs activity (Semenza, G. L., 2012). Importantly, the correlation 
between tumor  hypoxia  and/or  HIFα expression  leads  to  poor  prognosis  and increased  risk  of 
metastasis which has been repeatedly demonstrated in diverse tumor types (Vaupel, P. & Mayer, A., 
2007).  Non-surprisingly, many of the HIF target genes are involved in biological processes that 
impact  the  metastatic  spread  of  cancer  cells,  such  as  angiogenesis,  epithelial-mesenchimal 
transition, cell motility, intra/extravasation and control of the pre-metastatic niche (Lu, X. & Kang, 
Y., 2010). 
3. EPHRIN FAMILY
Ephrins are a large family of cell surface ligands that mediate intercellular adhesion and repulsion 
through interaction with the largest  subfamily of receptor protein-tyrosine kinases (RTKs), the Eph 
receptors (Nievergall, E., Lackmann, M., & Janes, P. W., 2012; Pasquale E. B, 2010).
Ephrins  are  divided in two subclasses,  A and B, according to  their  structure.  Ephrin-A ligands 
(ephrin-A1  to  -A5)  are  glycosylphosphatidyl-inositol  (GPI)-linked  membrane  bound  ligands, 
whereas ephrin-B ligands (ephrin-B1 to -B3) contain a single transmembrane domain and a short 
cytoplasmic tail.
Accordingly, Eph receptors are classified into two classes, A and B, based on the type of ephrin they 
bind to.There are nine EphA receptors (EphA1–8 and 10), and five EphB receptors (EphB1–4 and 
EphB6). In general, the binding between ephrin ligands and receptors is promiscuous within each A 
or B class although with different binding affinities (Gale N. W., et al., 1996). Still,  EphB4 only 
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binds ephrin-B2 (Blits-Huizinga, C. T., et al., 2004). There is some inter-class cross-talk for exaple 
on how EphA4 binds to ephrin-B ligands  (ephrin-B2–ephrin-B3) (Blits-Huizinga,  C. T.,  et  al., 
2004) and EphB2 binds to ephrin-A5 (Himanen, J. P., et al., 2004).
Consistent  with  other  types  of  RTKs,  both  A  and  B  Eph  class  receptors  contain  a  single 
transmembrane domain. The extracellular region of the Eph receptor is glycosylated, and consists of 
a ligand binding domain containing immunoglobulin-like motifs, followed by a cysteine-rich  and 
two repeated fibronectin III-like domains.  The intracellular  region consists  of a juxtamembrane 
region, a single tyrosine kinase domain,  and PDZ binding motif  (PSD-95 post synaptic density 
protein, Disc large, Zona occludens tight junction protein) within the non-catalytic region of the 
COOH-terminus.  The  kinase  domain  and  juxtamembrane  region  contain  tyrosine  residues,  and 
phosphorylation  of  these  tyrosine  residues  creates  docking  sites  for  interactions  with  signaling 
proteins containing SH2/SH3 domains. The PDZ binding motif binds to PDZ domain-containing 
proteins,  which  are  meant  to  serve  as  scaffolds  for  the  assembly  of  multi-protein  signaling 
complexes at the membrane (Cheng, N., 2002), (figure 4).
Figure 4. Structure of Eph receptors and ephrin ligands (Modified from Pasquale E., 2010).
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3.1 EPHRIN CELLULAR SIGNALING
Eph/ephrin signaling is complex in several aspects. As indicated above, receptor-ligand binding is 
promiscuous, one ligand is able to bind multiple receptors. Another unique aspect of the ligand-
receptor interaction in the Eph family is that the extent of receptor activation is dependent on the 
oligomerization  state  of  the  ligands  (Cheng  N.,  2002).  To facilitate  the  construction  of 
macromolecular  signaling  complexes  they  are  anchored  to  the  plasma  membrane  at  precise 
locations  through  protein-lipid  interactions  into  lipid  raft  microdomains,  which  results  in  the 
association of downstream signaling proteins in exact positions for efficient interactions (Gauthier 
and Robbins, 2003; Simons and Toomre, 2000). Other complex aspect is that Eph/ephrin protein 
signaling  results  in  the  activation  of  several  cytoplasmic  downstream  pathways  (figure  6). 
Moreover, both A and B class ephrins complexes emanate bidirectional signaling. Forward signals 
that depend on Eph kinase activity propagate in the receptor-expressing cell, and reverse signals that 
depend on Src family kinases propagate in the ephrin-expressing cell (Pasquale E. B., 2010), but 
also, ephrin-dependent but kinase-independent Eph signals can occur (Gu, C. and Park, S.,  2001, 
Miao, H., et al. 2005).  
Figure 5.  Eph/ephrin signaling pathways (from Coulthard, 2012).
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Finally the attenuation and termination of the signaling involves proteolytic cleavage (Hattori, M., 
et al., 2000; Pascall, J. C., and Brown, K. D., 2004), receptor-mediated endocytosis (Zimmer, M., et 
al.,  2003)  and tyrosine  phosphatase  activity  (Palmer,  A.,  et  al.,  2002).  Altogether,  thiscomplex 
cellular signaling suggests that  Eph/ephrin signaling require networks of interaction rather than 
simple linear pathways (Pawson, T. and Saxton, T. M., 1999).
3.2 EPHRIN FUNCTIONS
Ephrins mediate intercellular adhesion and repulsion through interaction with the Eph receptors 
(Nievergall E,, Lackmann M., & Janes P. W., 2012; Pasquale E. B., 2010), playing essential roles 
during development state where they guide migration and positioning of the cells for proper tissue 
patterning. Their function has been particularly well characterized in the nervous system, where 
Ephrins/Eph function as axon guidance molecules, and in cardiovascular system, where they control 
vasculogenesis (Nievergall, E,, Lackmann, M., & Janes, P. W., 2012).
In addition, recent reports suggest an emerging role of ephrins in the biology of stem cells (Sancho, 
E., et al., 2003) and tissue repair and maintenance (Hafner, C., et al., 2004). immune function (Wu, 
J. and Luo, H., 2005) and hematopoiesis (Okubo, T., et al., 2006). 
3.2.1 THE ROLE OF EPH/EPHRIN IN CANCER 
The protein tyrosine kinases are the largest family of oncogenes because of their central role in 
signal  transduction  pathways which  control  cell  differentiation  and proliferation (Bishop J.  M., 
1991; Blume-Jensen, P., and Hunter, T., 2001; Hunter, T., and Cooper, J. A., 1985). However, the 
Eph subfamily of RTKs are not  classical  oncogenes.  The gene expression patterns  of Eph and 
ephrins has been defined in a variety of benign and malignant human tumors and a number of  
subsequent studies report upregulation or downregulation of Eph/ephrin proteins in tumor cell lines 
and human cancers (Hafner, C., et al., 2004;  Nakamoto, M., and Bergemann, A. D., 2002).   This 
opposing  function  appears  to  be  influenced  by  tissue  type,  oncogenic  context,  and  ligand-
independent versus ligand-dependent signaling (Pasquale E. B., 2010).
The growth of solid tumors is highly dependent on the ability to recruit blood vessels, that supply 
the tumor mass with growth factors, nutrients and oxygen necessary for survival and growth. It has 
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been proposed that Eph/ephrin expressed on the tumor and endothelial cells (Ogawa, K., 2000). 
regulate tumor angiogenesis, but the precise mechanism is unknown.  Ephrins expressed on the 
tumor cells may function as contact-dependent organizing molecules to guide incoming vessels that 
express EphA2 receptor. Alternatively, angiogenic factors such as VEGF or TNF-α in the tumor 
microenvironment may induce expression and/or activation of ephrins in endothelial cells (Cheng, 
N., et al. 2002).
3.3 EPHRIN-A3
In spite of the intense investigation on the Eph/ephrin family, the regulation and function of some 
members remain relatively poorly characterized. Previous works addressed the  role of Ephrin-A3, 
howevermost of them studied it within the context of the nervous system.  Ephrin-A3 induces a 
repulsive interaction that regulates post synaptic morphology through the EphA4 receptor tyrosine 
kinase (Keith K. Murai, 2002). It has also been shown that Ephrin-A3 mediates the restriction of 
entorhinal axon terminals in the outer molecular layer of the dentate gyrus through the EphA5 
(Stein E, 1999) and it is essential for maintaining EphA4 activation and normal spine morphology 
in vivo (Carmona, 2009). In addition to its role in the nervous system, Ephrin A3 has been involved 
in hair follicle development, where accelerates anagen development and increases the density of 
hair follicles (Yamanda, 2008). 
Finally, in regards to its role in cancer mostly is unkown.. Ephrin-A3 mRNA expression has been 
found to be up-regulated 26-fold in squamous cell lung carcinoma (Hafner, 2004). Arecent study 
demonstrates  the  differential  expression  of  Eprin-A3 between the  highly  metastatic  and poorly 
metastatic colon cancer cells (Barderas et al., 2013).
4. NON-CODING RNA
Although genome transcription is pervasive, less than two percent of  human genome codes for 
proteins and thus the majority of the genome gives rise to non-protein-coding RNAs (ncRNAs) 
(Djebali, S,. 2012), which are predicted to play a essential role in a variety of biological processes 
(Wilusz,  J.E.,  2009,  Pauli,  A.,  2011).  A subtype  of  them,  defined  as   long  non-coding  RNAs 
(lncRNAs),  with  lengths  of  over  200  nucleotides,  are  transcribed  by  RNA polymerase  II  and 
processed as protein-coding RNAs. Many of them have small open reading frames but do not code 
for proteins (Yoon, J. H., 2012).  Although the function of most long non-coding RNAs (lncRNAs) 
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is unknown, the number of characterized lncRNAs is growing and many publications suggest they 
play a major role  in regulating gene expression during development,  differentiation and human 
disease (Wilusz, J.E., 2009, Taft, R.J., 2010, Huarte, M. and Rinn, J. L., 2010). 
lncRNAs regulate protein-coding gene expression at both, transcriptional and post-transcriptional 
levels (figure 8). These transcripts affect transcriptional regulation acting either in  cis, when their 
effects are restricted to the chromosome/locus from which they are transcribed, or in  trans, when 
they affect genes in other chromosomes/loci (Kornienko, A. E., 2013). As for the mechanism by 
which they regulate transcription, several possibilities have been proposed. Transcription silencing 
may involve  epigenetic  changes  like  promoter  nucleosome repositioning (Martens,  J.A.,  2004), 
promoter  histone  modifications  (Van  Werven,  F.  J.,  2012)  and  promoter  DNA  methylation 
(Tufarelli, C., 2003), but also there are transcriptional interference cases in the absence of chromatin 
changes  at  the  silenced promoter  (Latos,  P.A.,  2012).   On the  other  hand,   activation  of  gene 
expression by lncRNA may be mediated by blocking access of repressor complexes to chromatin 
(Cumberledge, S., 1990) or creating a permissive chromatin environment that supports enhancer 
function (Kornienko, A. E., 2013). This second model has not  been experimentally tested yet 
At postranscriptional level, lncRNAs act as competing endogenous RNAs to regulate microRNA 
levels as well as modulating pre-mRNA splicing, mRNA stability and translation by homologous 
base pairing (Kornienko, A. E., 2013, Yoon, Y. H., 2012).
17
Introduction
Figure 6: Levels of postranscriptional gene regulation by lncRNAs (from Yoon, J. H., 2012)
In addition to lncRNAs, another group of non-coding RNA, microRNAs (miRNAs), play a key role 
in  the  regulation  of  gene  expression.  miRNAs  constitute  a  family  of  short  non-coding  RNA 
molecules with lenghts varying from 20 to 25 nucleotides that regulate gene expression (Ambros, 
V., 2004; Bartel, D. P.,  2004). In animals, miRNAs typically target sequences in the transcript 3'-
UTRs that are only partially complementary to the miRNA, hereby causing messenger degradation 
and/or  repression in translation of the mRNA  (McCormick, R., 2010). 
A pioneerstudy in  2008 showed that  ephrin-A3 gene (EFNA3) was a  direct  target  of  miR-210 
(Fasanaro,  P.,  et  al.  2008).   The  authors  concluded  that  EFNA3 modulation  by  miR-210  had 
significant functional consequences for endothelial cell response to hypoxia, affecting cell survival, 
migration and differentiation. In addition, a recent report has shown that miR210 modulation of 
EFNA3 underlies  the  molecular  mechanisms  in  preeclampsia  (Zhang,  Y.,  et  al.  2012),  further 
underscoring the role of miR210 in EFNA3 regulation.
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Objectives
Is important to know the genes induced under hypoxic conditions in the tumor environment 
to  the  correct  understanding of  the  tumorigenic  response.  Therefore  we set  the  following 
objectives to be developed in our project:
1. Validate EFNA as a HIF-target gene.
2. Identify the mechanism of EFNA3 regulation by hypoxia.
3. Study the functional role of EFNA3 regulation by hypoxia/HIF in the context of cancer.
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Materials & Methods
1. CELL CULTURE
Cell lines used in this project are detailed in Table 1, along with  their growth medium and origin. 
All cell lines were cultured at 37ºC and 5% CO2 in a humidified incubator.
Cell line Origin Culture medium
HeLa Human cervical-carcinoma cell line DMEM 10% FBS
HEK-293T Human  embryonic  kidney  epithelial  cells  immortalized  with  the  T 
antigen of SV40 
DMEM 10% FBS
MDA-MB-231 Human breast adenocarcinoma  DMEM 10% FBS
MCF7 Human breast adenocarcinoma DMEM 10% FBS
HUVEC Human Umbilical Vein Endothelial cells EGM-2
Table 1. Cell lines
2. HYPOXIC CONDITIONS
For  hypoxia  treatments,  cells  were  grown at  37ºC in  a  1% O2,  5% CO2 94% N2 gas  mixture 
environmennt by use of a Whitley hypoxystation (don Whitley Scientific, UK). In addition, hypoxic 
conditions were mimicked by adding the  Dimethyloxalylglycine (DMOG, Sigma), an inhibitor of 
HIF-prolyl-hydroxylases that prevents HIF degradation,  to the  cultures media at a 500 μM final 
concentration. 
3. RNA EXTRACTION AND QUANTITATIVE RT-PCR
Total RNA was extracted and purified with the RNeasy Mini Kit (Qiagen) and treated with RNase 
free Dnase set (Qiagen, 79254). 1µg of total RNA of each sample was reverse-transcribed to cDNA 
(Transcriptor First Strand cDNA Synthesis kit, Roche) and 2µl of this reaction were diluted 1:4 as 
template for amplification reactions, carried out with the Power SYBR green PCR Master Mix 
(Applied Biosystems, 4367659) or Taqman Universal Master Mix II, no UNG (Applied Biosystems, 
4440040), following the manufacturer’s instructions. 
PCR amplifications were carried out in a StepOne Realtime PCR System (Applied Biosystems), and 
data were analyzed with StepOne software. Expression levels were calculated using ΔΔCt method 
using β-actin as a reference.
For hnRNA quantification, total RNA was extracted, purified and treated with RNase free DNase 
(Qiagen).  Total  RNA (1μg/sample)  was  reverse  transcribed to  cDNA (Transcriptor  First  Strand 
cDNA Synthesis kit, Roche) and 1μl of cDNA was used as template in PCR amplification reactions 
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(see  above).  hnRNA was  amplified  by  qPCR,  with  primers  designed  to  amplify  exon-intron 
boundary regions.
For chormatine immunoprecipitation (ChiP) qPCR, the threshold cycle (Ct) values for each sample 
were interpolated in a standard curve of input DNA dilutions to obtain % of input absolute values. 
The enrichment of HIF1α binding or Polymerase II binding at the target loci was calculated as the 
ratio of the target sequence precipitated (measured as % of input) in hypoxic over normoxic ChIP 
samples (% of input hypoxia / % of input normoxia). 
For microRNA quantification, a specific retrotranscription protocol is required. We used Megaplex 
RT Primers Pools AV2.1 (Applied Biosistem, 4399966) together with the Multiscribe enzime and 
1μl of the product was used as template in PCR amplification reactions (see above).
Name Assay Forward sequence 5'-3' Reverse sequence 3'-5'
1 HRE ChiP HIF1α CTTCTCCTTCCCCTCATTCC CAGGCTGAATTTCCCAGAAG
2 HRE ChiP HIF1α CGAGCACCTCCCTAGAAGGA CTCACCCTAGCCGGGCTTAT
3 HRE ChiP HIF1α TCCCCCCACCAAACCTATTC TTGGAGCACCTCAGCGTTCT
4-8 HRE ChiP HIF1α GAGGGTCTCTGCCCCTTG CCCCAGGTCTGTCAAAGGAG
9-10 HRE ChiP HIF1α GATGGCGAGGATTTGACAAGTT AAGACCAGGGAGTAGGGAAAGG
11-12 HRE ChiP HIF1α GGAAGCTCGGAGGAAAAGTC GAAGCGGCTCAGAGAGAAGA
EGLN3 (+ control) ChiP HIF1α GGTGTGCTCGGGTGTG CGTGGAGGACTGGCTCTAAG
EGLN3 (- control) ChiP HIF1α ACGGGAGGCACTCGGAG CCCTTAACGTTGACTTTCGCTC
Prom1 ChiP Pol II CATGCGGTGTACTGGAACAG  GGATCCCCCAGGACTTCTC
Prom2 ChiP Pol II GGAAGCTCGGAGGAAAAGTC GAAGCGGCTCAGAGAGAAGA
P4HA (+ control) ChiP Pol II GAGCCCGTTAGCCCTTTTAT GGTGTGATCGAGCTCACGTA
STT3 (- control) ChiP Pol II GAGCGCGGAAAGAACGTG FGCAAGGGCCTATTTCAGCGTA
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Name Assay Forward sequence 5'-3' Reverse sequence 3'-5'
Exon 1+2 EFNA3 expression AACCGGCATGCGGTGTA ATCCAGATAGTCGTTCACGTTCA
Exon 4+5 EFNA3 expression CACTCTCCCCCAGTTCACCAT CGCTGATGCTCTTCTCAAGCT
Ms_Coding  EFNA3 
Isoform
EFNA3 expression TGGAACAGCTCCAATCAGCA GAGCTGTTGTAGTGCGGACA
Ms_Non-Coding 
EFNA3 Isoform
EFNA3 expression CACTCTCCCCCAGTTCACCAT CGCTGATGCTCTTCTCAAGCT
hnRNA  coding 
EFNA3
hnRNA ACTGGAACAGCTCCAACCAG GCTCTGGTCTCCCAGGACTC
hnRNA lncEFNA3 hnRNA GGCACTGATACTTCCTACCCTG GGCACCTGAGGGTTCTCTCC
hnRNA Actin hnRNA CCCAGCACAATGAAGATCAA GTGAGGACCCTGGATGTGAC
hnRNA EGLN3 hnRNA TGGGAAGTCGACATACAACG ATCGACAGGCTGGTCCTCTA
Exon 1 Sequencial PCR AGCTGGGAAGCGGAGAAG CTGGTTGGAGCTGTTCCAGT
Exon 2.1 Sequencial PCR CTGCGGCGAGAGGGCTA TGTAGTGCGGGCAGTAAATATCC
Exon 2.2 Sequencial PCR AAGCGCTGGGAGTGCAAC GTGGAACTCGTAGCCCAGAG
Intron 2 Sequencial PCR AGCTCAGACGAGGTCGTGGGG GTGGGCGTGGAGAAACAGCGA
Exon 4 Sequencial PCR CATCGCACTCCGGGGAGAAG CACGTTGATCTTCACATTGGGG
Exon 5 Sequencial PCR GCTTGAGAAGAGCATCAGCG CTAGGAGGCCAAGAACGTCA
3' UTR 1 Sequencial PCR TCCTCCCATGGCTAGAAGTG GTCCACTACAGTGCCCTACG
3' UTR 2 Sequencial PCR GCAATAAGCACGTCCTCCTC CAGGGGGTTAAAGAGGGAAG
Table 2. Primers
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Taqman Reference
Taqman 1+2 codingEFNA3 Hs00191913_m1
Taqman 4+5 lncEFNA3 Hs00900213_g1
EPAS1 Hs01026149_m1
HIF1α Hs00936368_m1
β  Actin 4326315E
Table 3. Taqman probes, all were supplied for Applied Biosistems
4. RNA INTERFERENCE
The cells were transfected with the indicated siRNAs using Lipofectamine RNAiMax (Invitrogen 
13778) according to the manufacturer's instructions. Knockdown efficiency was determined by real 
time  quantitative  PCR analysis  and Western  blot.  We used the  following commercial  siRNAs: 
HIF1α siRNA (Santa Cruz, sc-44225), EPAS-1 siRNA (Santa Cruz sc-35316), Ephrin-A3 (Santa 
Cruz sc-39430) and siRNA-B (Santa Cruz sc-44230) as a negative control. In all cases, siRNAs 
were used at 100nM concentration. 
5. WESTERN BLOT
Whole-cell lysates were extracted in RIPA buffer (50mM Tris-HCl pH 8, 0,1% SDS, 150mM NaCl, 
0,02% NaN3,  1% NP40,  1gr  Sodium Deoxycholate)  containing  protease   inhibitors  (Complete 
ULTRA tablet,  Roche 06538304001).  Lysates were passed through a 27-gauge needle to shear 
genomic DNA.Cellular debries were removed by centrifugation at 4°C for 10 minutes at 14,000×g. 
Proteins  were  then resolved  in  10% SDS-polyacrylamide  gels  and  subsequently  transferred  to 
polyvinyl  pirrolydone (PVDF) membranes.  Membranes,  were  blocked with 5% BSA in TBS-T 
(50mM Tris, pH 7.6, 150mM NaCl, 0.1% Tween 20) for 1 hour and incubated overnight at 4°C with 
the requisite antibodies (Table 3). Next day, the membrane was washed 3 times with TBS-T for a 
total of 45 minutes and incubated with the secondary antibody in TBS-T with 5% BSA for 1 hour at 
room temperature. Then, membrane was washed again three times with TBS-T for 45 minutes and 
developed with ECL (GE Healthcare, Buckinghamshire, UK) and exposed to  medical X-ray film 
(Agfa, ENKMV).
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Antibodies Species Company Dilution
Ephrin A3 Mouse Santa cruz (sc-73954) 1:1000
HIF 1α Mouse BD Bioscience (610958) 1:1000
actin Goat Santa Cruz (sc-1616) 1:1000
anti-mouse Promega (W402B) 1:5000
anti-goat Santa cruz (sc-2020) 1:5000
Table 4. Antibodies
6. DEGLYCOSILATION 
25μg lysates were mixed with 1μl 10X deglycosylation buffer (5%SDS, 0.4M DTT) and H20 up to a 
total  reaction  volume  of  10μl.  The  glycoprotein  was  denatured  at  100ºC  for  10  minutes  and 
incubated  for  additional  hour  at  37ºC with  1μl  PNGaseF (Biolabs,  P0705S),  in  a  total  volume 
adjusted to 20μl with 2μl of 10X G7 Reaction buffer (0.5M Sodium Phosphate pH 7.5), 2μl of 
10%NP40.   
7. RAPID AMPLIFICATION OF of cDNA ENDS (RACE)
Rapid  Amplification  of  cDNA Ends  (RACE)  is  a  procedure  for  amplification  of  nucleic  acid 
sequences from a messenger RNA template between a defined internal site and unknown sequences 
at either the 3' or the 5' ends of the mRNA.
RACE was performed with the FirstChoice RLM-RACE Kit (Ambion) following manufacturer's 
instructions and using the indicated specific primers. All PCR fragments of interest were cloned into 
pCR2.1 vector (Invitrogen) and sequenced.
8. HIGH RESOLUTION GEN EXPRESSION PROFILING
A high resolution  gene  expression  profiling  was performed as  described before  (Dolken,  L.  et 
all.,2008). This assay is based on metabolic labeling of newly transcribed RNA using 4-thiouridine 
(4sU-tagging), a naturally occurring uridine derivative, and thus provides a means to detect newly 
transcribed transcripts  with minimal  interference in  cell  growth and gene expression.  For these 
experiments we exposed HeLa cells to 400mM 4sU in normoxic or hypoxic conditions for 2 hours 
to allow 4sU-triphosphate incorporation into the newly transcribed RNA. Following isolation of 
total  cellular  RNA,  the  4sU-labeled  RNA fraction  is  specifically  biotinylated  by  generating  a 
disulfide bond between biotin and the thiol group in the 4sU-moiety, then “total cellular RNA” can 
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be quantitatively separated into labeled (‘newly transcribed’) and unlabeled (‘pre-existing’) RNA 
with high purity using streptavidin-coated magnetic beads. Finally, labeled RNA is recovered from 
the beads by simply adding a reducing agent cleaving the disulfide bond and releasing the newly 
transcribed RNA from the beads. 
Figure 7. High resolution gene expression profiling squeme
9. HALF LIFE ASSAY
HeLa cells were seeded in a 6cm² plates (1,12x10  cells/well) and 8 hours later are incubated in⁶  
normoxia, hypoxia or in presence of 500 μM of DMOG for 12 hours. Then cells were treated with 
5μg/ml of Actinomycin D and processed for RNA insolation at different time points.
10. ChIP (CHROMATIN IMMUNOPRECIPITATION)
For  ChIP,  EZ  ChIP-Chromatin  Inmunoprecipitation  Kit  (Millipore)  was  used  following  the 
manufacturer's instructions. Briefly, HeLa cells were grown to 85% confluence on 10 cm plates 
before  they  were  exposed  to  hypoxia  or  left  in  normoxic  conditions  for  8  hours.  Following 
treatments,  cells  were  crosslinked  with  1% formaldehyde for 12 min at 4ºC. Cell lysis was 
achieved by scraping in 1 ml of lysis buffer (1% SDS,  10  mM  EDTA,  50  mM  Tris/HCl,  pH 
8.1,  and  a  protease  inhibitor  cocktail,  Roche).  Cell lysates were sonicated to shear the DNA to 
fragments between 200 and 1500 bp. Sonication is a  critical   step  for  successful  chromatin 
immunoprecipitation.  Therefore,  quality  and homogeneous size distribution of sonicated samples 
was assayed by DNA electrophoresis  for  every  experiment,  and only  experiments  that  showed 
homogeneous  results  across  all  samples   (from   normoxia   and   hypoxia   treatments)   were 
continued. Lysates were then immunoprecipitated  overnight  at  4ºC  with  antibodies against RNA 
Polymerase II (Abcam 5408) or polyclonal serum for HIF1α (Abcam, ab2185) and normal Mouse 
IgG (Sigma M8695) or  whole rabbit serum, respectively, as  negative controls.
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The  DNA was  finally  purified  by  phenol–chloroform extraction  and  ethanol  precipitation.  The 
bound regions were identified by qPCR amplification of the immunoprecipitated material using the 
indicated primer pairs in Table 1, and represented as percentage of input material (see qPCR).
11. PLASMID CONSTRUCTION
Lentiviral  shuttle  vector  pLOC-Ephrin-A3  (OHS5897-101186331),  encoding  for  the  canonical 
EFNA3 mRNA and pLOC control (OHS5832) were obtained from Open Biosystems. Alternative 
EFNA3 isoforms were PCR-amplified using the primers  indicated in  Table 5 and subcloned in 
pLOC into SpeI/AscI restriction sites.
For in vitro translation Ephrin-A3 and the non-coding isoforms were cloned  into BamHI/XHoI 
restriction sites of pCDNA3 plasmid.
For reporter assays, regions containing the putative promoters were PCR-amplified (see table 5) 
from  genomic DNA extracted from HeLa cells and cloned into pGL4 reporter vector.
Name Assay Forward sequence 5'-3' Reverse sequence 3'-5'
1 HRE Reporter Assays CCTTGGTACCCCCGAGGGGGCAGT
ACGG
CCTTCTCGAGCCCCGGAGCCGCCG
CCGCCG
2-8 HRE Reporter Assays AAGGATCCCAGAGAGATGTCGGT
GTGTCA
AAGGATCCACAGTCCCCAGGTCTG
TCAA
4-8 HRE Reporter Assays AAGGATCCCACCCTTGGAGCACCT
CA
AAGGATCCGGCATATATTTGGCCAT
CG
4-10 HRE Reporter Assays AAGGATCCGGCCCCATAAATCGTG
AGAG
AAGGATCCCGGGCTGCAGAGTTAC
AGG
11 HRE Reporter Assays GAGAAGCGATGGAGGGTGT CACTCAGACTCTCGCGTTCA
Non Coding 1 Cloning isoforms CGGACTAGTATGGTGAGCCGCAA
CGGCTAC
CGGGGCGCGCCGACTAAGAGCAG
AGTATGAAAGTC
Non Coding 1 
short
Cloning isoforms CGGACTAGTATGGTGAGCCGCAA
CGGCTAC
Non Coding 2 Cloning isoforms CGGACTAGTGAGACCAGGGAGGA
GGCGTG
CGGGGCGCGCCGACTAAGAGCAG
AGTATGAAAGTC
Non Coding 2 
short
Cloning isoforms CGGACTAGTGAGACCAGGGAGGA
GGCGTG
11 HRE_mut Mutagenesis ACACCGTGCAGGTGAAACGACTA
TCTGGAT
ATCCAGATAGTCGTTTCACCTGCA
CGGTGT
12 HRE_mut Mutagenesis GCGGGGCAGAGCAGTCTGTACAT
GGTGAGC
GCTCACCATGTACAGACTGCTCTG
CCCCGC
Table 5. Primers for plasmid construct
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12. IN VITRO TRANSLATION
For  in  vitro  translation  we  used  the  TNT T7  Quick  Coupled  Transcription/Translation  system 
(Promega,  L1170) that is optimized for expression of the most standard T7 promoter driven gene 
constructs. The reaction mix contained 1μg of plasmid and 2μl (20,5 mCi) of EasyTag methionine, 
L-(³ S).The reaction  mix  was  incubated  at  30ºC for  90 minutes  and subsequently  12μl  of  this⁵  
reaction were mixed with 12μl of RIPA buffer with proteases inhibitor and laemmli sample buffer. 
Then the mix was denatured at 72ºC for 10 minutes and resolved a 12% polyacrilamide gel.
13. REPORTER ASSAYS
HeLa cells were seeded in six-well plates (3x10  cells/well) and after 6 hours, transfected with 1⁵ µg 
DNA mixture (0,9µg of the indicated reporter or control vector and 0.1µg of plasmid encoding for 
Renilla), using 2µl of lipofectamine 2000 (Invitrogene). After 16 hours, the cells where re-plated in 
24-well plates, and incubated under normoxia, hypoxia (1% oxygen)  or in the presence of 500µM 
DMOG for an additional 16 hours. After treatments, the cells were lysed and the firefly and Renilla 
luciferase  activities  were  determined  using  Dual-Luciferase  System  (Promega,  Madison,  WI, 
U.S.A.). The firefly luciferase activity was normalized to that of  Renilla luciferase to correct for 
differences in transfection efficiency between samples.
14. MUTAGENESIS
Mutant reporter constructs were generated with the QuikChange® II XL Site-Directed Mutagenesis 
Kit (Agilent, 200521-5) using primers designed to delete the HRE motif (Table 5). This kit is used 
to replace amino acids using Pfu ultra high-fidelity (HF) DNA polymerase, the basic procedure is 
represented in figure 8.
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Figure 8. Mutagenesis squeme
15. EPHRIN-A3 OVEREXPRESSION  
HeLa cells  were  seeded  into  10  cm2 plates  at  90% of  confluence  and 16 hours  after  plating, 
transfected by adding a mixture of 24μg of the corresponding plasmids and 72μl of Lipofectamine 
2000 (Invitrogene). Cells were exposed to the transfection reagents for 4 hours and then we let them 
recover for 24 hours in fresh media before exposing them to  hypoxic or normoxic conditions for 12 
additional hours prior analysis of mRNA and protein expression.
16. LENTIVIRAL PRODUCTION
16.1 Particles generation
Replication-deficient  lentiviral  particles  with  tropism  for  human  cells  were  produced  using 
constructs from Open Biosistem. Precision LentiORF have fully-sequenced human open reading 
frames  (ORFs)  derived  from  cDNA coding  sequences  that  have  been  cloned  into  a  lentiviral 
backbone, enabling gene and protein expression experiments in mammalian cell type.
Features  of  the  Precision  LentiORF  backbone  include  a  CMV  promoter  for  robust  protein 
expression,  a  GFP reporter  to  visually  track  protein  expression,  and  blasticidin  resistance  for 
selection of stable cell lines. 
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Figure 9. LentiORF backbone
The Precision LentiORF control, contains a RFP (red fluorescent protein) sequence in the Multi Tag 
cloning site instead of the canonical Ephrin-A3 sequence.
For Lentivirus production, 7x10  HEK-293T cells were seeded per 10cm² plate.  After 24 hours⁶  
medium was changed for 9ml of fresh DMEM with cloroquine 30μM per plate.
Calcium phosphate transfection was performed under this conditions:
1. Lentiviral plasmid: 14,2μg
2. Packaging plasmids: 12,45μg of psPAX2
3. Envelop plasmid: 4,5μg
After 8 hours of transfection, cells were washed andfresh media added to the plates. Transfection 
efficiency was determined, as the percentage of GFP (green fluorescent protein) positive cells under 
fluorescent microscopy 48 hours after transfection (typically around 90-100%).  
To collect  virus,  culture  supernatant  was centrifuged,  filtered (0,45μm pore size)  and stored  at 
-80ºC.
Lentivirus titration was performed in HEK-293T cell line by flow cytometry quantification of GFP 
positive cells after 72 hours of infection. The titer was calculated by this formula:
TU/ml=(%GFP positive cells/number of cells the day of infection)/virus volume (ml)
16.2 Cells transduction by lentiviral infection:
MDA-MB-231 cells were infected at a MOI of 4 with pLOC-EFNA3-GFP or pLOC-GFP control 
lentivirus in the presence of 8μg/ml polibrene (Sigma) for 8 hours. This protocol resulted in  more 
than 95% of GFP positive cells  72 hours after  infection.  Cells were re-infected with  Lenti-Fire 
Luc2-pGL4 at a MOI of 4 to allow for tracking cells in in vivo assays by means of bioluminescence 
imaging.
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Figure 10. Lenti-Fire Luciferase Luc2 pGL4 vector
17. IN VITRO STUDIES
17.1 Transwell migration
To test the migratory cell capacity, we used a modified Boyden chamber with 6,5mm diameter and 
8μm pore size polycarbonate filters (Costar) pre-coated with 0,5% gelatin in PBS. HUVECs were 
pre-incubated  in  serum-free  media  for  16  hours  and  then  1,25x10⁵ cells  seeded  in  serum-free 
medium  on  the  top  side  of  the  filter  and  insets  placed  on  culture  media  containing  different 
combinations of NIH3T3 conditioned media (30μg total protein), 10 % FBS, 500μM DMOG or 0,2-
5μg of recombinant Fc-Ephrin-A3 fusion protein (Sigma).  Cells  were allowed to migrate for 6 
hours and then cells remaining on the top of the membrane were removed with a cotton swab and 
the filters fixed and stained with Diff Quik (Dade Behring). A minimum of ten 40X fields were 
evaluated for quantitative analysis of cell migration and expressed as the average values ± standard 
deviation.
17.2 Repulsion assay
For repulsion assays HUVEC cells were stained with 10μM PKH26 per million cells and seeded it 
in a 24 multiwell plate (1x10  cells/well).  24 hours later HUVEC-PKH26 had grown to form a⁵  
confluent monolayer and HEK-293T (3000 cells/well), transfected cells with GFP or EFNA3-GFP, 
were plated on top of them. Cultures were evaluated 24 hour latter to asses the number of HEK 
cells attached to the plates.
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18. IN VIVO STUDIES
To study the effect of Ephrin-A3 on tumor growth and metastasis formation we injected MDA-MB-
231 cells luciferase alone or in combination with Ephrin-A3 into 5-7 weeks old female nude mice 
(Harlan). Animals were treated according to the protocols approved by Instituto de Investigaciones 
Biomédicas and Northwertern University Care and Use Committee in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals.
18.1 Orthotopic tumor implantation
Cells were harvested by trypsinization, resuspended in PBS and injected into the mammary fat pad 
(2x10  ⁶  per site, one site per mouse) in a 1:1 mix  with Matrigel (BD Biosciences). The animals 
were subjected to weekly bioluminescence imaging in IVIS Spectrum System (Caliper, Xenogen) to 
monitor tumor progression and metastasis. Mice were anesthetized by isofluorane/oxygen mix  and 
given intraperitoneal injections of D-luciferin (15 mg/ml in PBS) 5 minutes prior to imaging. Mice 
were examined for 5 weeks after inoculation of tumor cells and then sacrificed.Lungs, bones and 
livers were harvested and processed for tissue analysis.
18.2 Spontaneous metastases assay
Cells were harvested by trypsinization, resuspended in 100μl PBS and injected intravenously into 
nude mice (10  cells⁶  per mice).  The animals were subjected to weekly bioluminescence imaging in 
IVIS Spectrum System (Caliper, Xenogen) to monitor tumor progression and metastasis. The mice 
were anesthetized by isofluorane/oxigen mix  and given intraperitoneal injections of D-luciferin (15 
mg/ml in PBS), 5 minutes prior to imaging. Lungs were harvested after 10 weeks and processed for 
tissue analysis.
18.3 Lung extravasation assay 
Cells, were injected intravenously into nude mice (1,5x10  cells). After 2 hours or 8 days, lungs⁶  
were isolated and images were acquired by confocal  microscopy of the surface of fresh lungs. 
GFP-positive cells were counted and analysed by ImageJ software.
18.4 EFNA3 measurements in VHL-defficient mice
cDNA from liver and lung of Vhlfl-UBC-Cre-ERT2 mice were kindly donated by Julian Aragones 
(Elorza. A et al., 2012). Briefly,  C;129S-Vhlhtm1Jae/J mice (Jackson Laboratories, stock no. 4081) 
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were used to generate the Vhlfloxed-UBC-Cre-ERT2 mice. These mice harbor two loxP sites flanking 
the promoter and exon 1 of the murine Vhl locus so that VHL-inactivation can be easily achieved by 
feeding them  ad libitum with Teckland CRD TAM400/CreER tamoxifen pellets (Harlan Teklad), 
which contain 400 mg tamoxifen citrate/kg, for 10 days(Miró-Murillo et al., 2011).
18.5 OCT samples preparation:
Isolated organs were  fixed in Tissue Teck Cryomold (Dako) with OCT in cold condition with dry 
ice. These blocks were stoared at -80ºC and sections of 4μm were cutted by Reichert-Jung Cryocut 
1900 (Leica). These sections were mounted over slides for posterior analyses.
18.6 In situ Immunofluorescence:
For immunodetection of CD31, 10μm cryosections sections were fixed in acetone, blocked with 3% 
BSA in PBS and incubated at 4 C overnight with anti-CD31 antibody (BD Biosciences Pharmingen,̊  
San  Deigo,  CA),  followed  by  the anti-mouse  secondary  antibodies  tagged  with  Alexa-546 
(Invitrogen). DAPI was used to countestain nuclei. Quantification of the CD31-positive area was 
performed using the NIH ImageJ software. Mean values of at least 10 fields of 3 sections were 
calculated for each sample .
18.7 Hematosin & Eosin Stained (H&E):
The  slides  were  stained  with  hematoxilina  (DC Panreac)  for  5  minutes  at  room  temperature, 
washed  3  times  with  dH2O  for  5  minutes  and  then  eosina  stained  for  1  minute   at  room 
temperature  .  Samples where rehydrated with ethanol increased concentration washed (50%, 70%, 
95%, 100%) and cleaned with xilol for 20 minutes . Final samples were mounted with Depex (BDH 
Prolabo).
19. GENE EXPRESSION ANALYSIS
Gene expression data and relevant sample information were downloaded from the Gene Expression 
Omnibus  (GEO,  http://www.ncbi.nlm.nih.gov/geo/)  and  ROCK  (http://www.rock.icr.ac.uk/) 
databases (free public  access) and analyzed using custom R scripts  for  statistical  programming 
(http://www.r-project.org/).
The breast cancer datasets Loi2008 (Loi S., et al., 2008), Pawitan2005 (Pawitan Y., et al., 2005) and 
Ur_Rheman, (Sims D., et al., 2010) and the RCC series GDS505 (Lenburg M. E., et al., 2003) and 
GDS2880, (Tun H. W.,  et  al.,  2010)) were generated using Affimetrix Human Genome U133A 
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Array  platform.  Thus,  in  these  datasets  EFNA3  expression  was  determined  with  the  probe 
210132_at, which recognizes the 3'UTR region. The breast cancer study VandeVijve (Van de Vijver 
M. J., et al., 2002) was performed using custom ~60 mer oligonucleotides specific for NM_004952 
refseq gene. Finally, the RCC series GSE16441 utilized Agilent-014850 Whole Human Genome 
Microarray 4x44K G4112F.
20. STATISTICAL ANALYSES
Statistical analysis and graphic representations were performed in R, a language and environment 
for statistical computation and graphics (R Core Team, 2010).
38
RESULTS

Results
1. EPHRIN-A3 IS INDUCED UNDER HYPOXIA CONDITIONS
We first identified EFNA3, a member of the ephrin type A ligands, as potential novel HIF target 
gene using an in silico search (Ortiz-Barahona A., 2010) . As a first step to validate this prediction, 
we determined the level of Ephrin-A3 protein and found that it was induced by hypoxia in several 
cell lines (figure 11). 
Figure 11. Hypoxia induces the expression of Ephrin-A3. EFNA3 protein was determined in HeLa, HUVEC, MCF-7 
and MDA-MB23, cells were exposed to normoxia (21% oxygen) or hypoxia (1% oxygen) for the indicated periods of  
time.
The Ephrin-A3 species  we detected had an apparent  molecular  weight  of  approximately 72kD, 
much higher  than the 26.3kD  predicted from its  amino acid sequence.  In orderto confirm the 
identity of the protein recognized by the antibody, we treated cells with a siRNA directed against 
EFNA3 and found that it decreased the intensity of the high molecular band specifically (figure 12A 
and 12B). 
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Figure 12. Ephrin-A3 migrate with a molecular weight of 72kD  (A) HeLa cells were transfected with a plasmid 
encoding EFNA3 (pEFNA3) or siRNA directed against EFNA3 and 48h postransfection EFNA3 proteins levels were  
determined by immunoblot. (A) To allow comparison in the same membrane, different amounts of cell lysate were used 
to detect the endogenous and exogenous proteins. (B) HeLa cells were transfected with scramble siRNA (-) or siRNA 
directed against EFNA3 and then grown at 21% (Nx) or 1% oxygen (Hyp) for 12 hours.  Duplicated samples were 
processed to determine EFNA3 mRNA (upper graph) or protein (lower panels) levels. 
Type A Ephrins undergo several postranslational modifications, including the addition of a GPI 
moiety and glycans, that could account for its high apparent mass. In agreement, treatment of cell 
lysates  with  N-glycosidase,  resulted  in  the  depletion  of  the  endogenous  ~72kD  bands  and 
generation of  a faster  migrating band (figure 13A).  Note that  the intensity  of the ~50kD band 
generated by the enzymatic treatment is much higher than that of the corresponding 72kD bands, 
probably due to the exposure of the antigenic determinants after the removal of the oligosaccharide 
chains, as has been shown for other postranslational modifications (Bütikofer, Malherbe, Boschung, 
& Roditi, 2001). An additional test to confirm the identity of the ~72kD bands was performed. We 
used  a  recombinant  form  of  EphA5  (a  high  affinity  receptor  for  Ephrin-A3)  fused  to  the 
immunoglobulin Fc fragment to pull down endogenous Ephrin-A3 from cell lysates. As shown in 
panel figure 13B, the Ephrin-A3 forms that co-precipitated with the EphA5-Fc migrate as a ~72Kd 
bands. Altogether these results indicate that Ephrin-3A is detected as ~72Kd bands in SDS-PAGE 
gels due to postranslational modifications. 
Figure 13 (A)  HeLa cell  lysates  were  incubated  at  37ºC (+) or  0ºC (-)  in  the presence (+) or  absence (-)  of  N-
glycosidase and then resolved by SDS-PAGE and probed with anti-EFNA3 antibodies. (B) HeLa cells lysates were 
incubated with recombinant Fc-EphA5 receptor or Ig Fc fragments. Recombinant constructs were pulled down with 
protein A-sepharose and coimmunoprecipitating material was resolved by SDS-PAGE and probed with anti-EFNA3 
antibodies. 
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2.  EFNA3  LOCUS  ENCODES  LONG  NON-CODING  RNAs  (lncRNAs)  THAT  ARE 
REGULATED BY HYPOXIA
Next we decided to study the effect of hypoxia on EFNA3 mRNA. According to curated databases 
(RefSeq)  the  EFNA3 locus  encodes  for  a  single  mRNA isoform (NM_004952).  However,  our 
analysis of the open access databases, including ESTs and experimentally identified transcription 
start  sites  (TSS) (http://dbtss.hgc.jp/),  suggested the existence of additional  mRNAs transcribed 
from this locus. To identify hypothetical isoforms encoded by the EFNA3 locus, we performed 5'-
RACE experiments in HeLa and LoVo cell lines (“HeLa 5-RACE” ) and found two transcription 
start sites (TSS) in addition to that of the NM_004952 mRNA (Figure 14). 
Figure 14. Diagram of the EFNA3 locus. Canonical EFNA3, NM_004952 RefSeq, gene (upper track,) and the novel 
isoforms (second track from the top, N1-NC2s).
The existence and location of these additional  transcription start  sites  was supported by 5'  cap 
analysis gene expression (CAGE) tags from multiple cell lines produced as part of the ENCODE 
transcriptome Project (Figure 15,  “RNA Subcellular CAGE”). Interestingly, none of these novel 
RNAs seemed to encode for functional proteins and, accordingly, we termed them non-coding-1 
(NC1) and NC2, based on their different TSS (Figure15 ). Specifically, NC1 isoform contains an 
ATG codon within its first 10 nucleotides that is in frame with the open reading frames (ORF) of 
NM_004952, suggesting that  NC1 could encode a truncated form of Ephrin A3. However,  this 
potential product would have an interrupted structural domain (the ephrin domain),  that makes up 
the bulk of the protein, which would likely undermine its stability. On the other hand, the NC2 
sequence does not contain any ORFs of significant length.
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Figure 15. EFNA3 locus encodes for several transcripts expressed from two different promoter regions.
The  5'-ends  of  the  EFNA3  transcripts  was  determined  by  rapid  amplification  of  cDNA ends  (RACE)  using  the  
FirstChoice RLM-RACE kit (Applied Biosystems) according to manufacturer's instructions. Total RNA from HeLa and 
LoVo cells  was  used  as  template for  5'-  RACE reactions,  the products  cloned into pCR2.1 (Invitrogen) and  their  
sequence determined by Sanger sequencing. The figure shows the position of the RACE products (“HeLa 5-RACE”) 
relative to the canonical NM_004952 RefSeq gene (EFNA3 track). The names indicate the location of EFNA3-specific 
primers  used for  the PCR amplification of  RACE products:  AGAAGGCGCTGTAGCGCTGGAA (Exon1 and 2) ;  
TTCCAGTGCAGGTTGTGAGT (Exon 3). The “RNA Subcellular CAGE” track shows 5' cap analysis gene expression 
(CAGE) tags from the ENCODE project and thus points to Transcription Start Sites (TSS) within this locus. Note the 
tight correlation between our 5'-RACE results and those reported by ENCODE. To keep image size to a minimum, in  
this and following tracks we only included information from cell lines used in our work (HeLa, HUVEC and MCF7).  
The  “Transcription”  track  shows  transcription  levels  for  HeLa  (green)  and  HUVEC  (blue)  as  assayed  by  high-
throughput sequencing of polyadenylated RNA (RNA-seq).The prediction of Poly(A) sites using a supported vector 
machine-based algorithm indicates the existence of two different 3-end for this locus (“predicted poly(A) sites” track). 
The next track shows the result of Gene Identification Signature (GIS) paired-end ditag (PET) sequencing experiments 
in HeLa cells. This technique provide signatures of the 5' start and the 3' end of individual mRNA transcripts (Ng et al.,  
2005). The “Transcription Factor ChIP-Seq” track shows the CTCF binding sites in HeLa, HUVEC and MCF7 cells.  
Finally, the “TargetScan miRNA” track shows the predicted binding sites (TargetScan) for several miRNAs one of them 
being miR210. The figure was generated by the UCSC genome browser upon loading the indicated custom tracks
In  agreement,  in  vitro  transcription-coupled  translation  of  EFNA3 and  NC1 cDNAs,  produced 
proteins  of  expected sizes,  whereas  NC2 cDNA generated  no apparent  protein product  (Figure 
16A). To test the coding potential of NC1 and NC2 in intact cells, we transfected HeLa cells with 
the respective plasmids along with the canonical EFNA3 cDNA (EFNA3) (Figure 16B). Neither 
NC1  nor  NC2  caused  the  expression  of  exogenous  protein  that  could  be  recognized  by  the 
monoclonal or polyclonal antibody against EFNA3. Thus NC1 and NC2 can be considered novel 
long non-coding RNAs (lncRNAs).
Figure 16. EFNA3 isoforms are long-non coding RNA. (A) cDNAs corresponding to EFNA3, NC1 or NC2 isoforms 
were transcribed and translated in vitro in the presence of 35S-methionine and proteins resolved by SDS-PAGE. Image 
shows the autoradiogram of a representative experiment. (B) HeLa cells were transfected with plasmids encoding for 
the indicated EFNA3 isoforms and cell lysates probed with monoclonal (MAb) or polyclonal (PAb) antibodies against 
the C-terminal region of human Ephrin-A3 
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In addition to the novel TSS, a method using support vector machine for poly(A) site prediction 
(Cheng Y., 2006) identifies two potential 3'-ends for this locus (figure 15  “Poly(A) Sites” track). In 
agreement,  analysis of Paired-end diTag (PET) Sequencing data from ENCODE (Ng P.,  et  al.,  
2005) indicates that all combinations of the TSSs and 3’-ends are present in cells (figure 15, “GIS-
PET” track). Thus, both NC1 and NC2, can be expressed as shorter forms with a truncated 3'UTR, 
which we termed NC1s and NC2s respectively (figure 14). 
We next investigated the regulation by hypoxia of the different transcripts encoded by the EFNA3 
locus. First, we used commercially available TaqMan probes to amplify the regions of the EFNA3 
gene specific to the canonical EFNA3 mRNA (Exon1+2, Figure ) and a region common to all the 
RNA isoforms encoded by this locus (Exonn4+5, Figure ). qPCR results indicate that the absolute 
expression levels and relative induction in response to hypoxia varied widely between RNA species 
(figure 17). The expression of the canonical coding isoform was low, compared to the combined 
expression level for all isoforms, suggesting that under normoxic conditions the transcription of the 
long non-coding RNAs predominates. This result was confirmed by the ENCODE genome-wide 
transcription analysis (figure 15, “Transcription” track). Strikingly, the canonical EFNA3 isoform 
was barely induced in response to hypoxia, in stark contrast with the robust upregulation of the bulk 
of EFNA3 RNAs (figure 17). 
Figure 17. mRNA absolutes levels of the  lncRNA and canonical isoform of the EFNA3. HeLa cells were exposed 
to 1% oxygen (Hyp) or left at normoxic conditions (Nx) for 12h and EFNA3 RNA levels were determined using the  
indicated TaqMan probes (see Table3). The graph shows the ratio of the number of EFNA3 to ACTB (beta-Actin) copy  
number. Bars represent the mean of three independent biological replicates and the error bars the standard deviation.  
The differences between groups were statistically significant  (ANOVA F3,8=34.21,  p<0.001).The asterisks indicate 
mean pairs that were  statistically significant (adjusted p <0.001) in a posteriori Tukey test.
46
Results
This result suggested that the lncRNAs, but not the canonical mRNA, were regulated by hypoxia. 
To confirm this possibility, we designed primer pairs for all the exons in the gene to determine the 
response to hypoxia of every potential  RNA isoform. Indeed,  hypoxia strongly upregulated the 
novel  lncRNA isoforms,  while  the regulation of  the  canonical  protein-coding mRNA was only 
marginal (figure 18).
Figure 18. Fold induction quantification of each exon in the EFNA3 locus. HeLa cells exposed to 1% oxygen (Hyp) 
or at normoxic conditions (Nx) for 12 hours and EFNA3 RNA levels were determined using the indicated primer pairs 
(See Figure 21). The graph shows the ratio of hypoxic  EFNA3 RNA to the expression in normoxia. Symbols represent 
the mean of three independent biological replicates and the error bars the standard deviation.
Importantly, the induction of EFNA3 transcripts in response to hypoxia was mediated by HIF as it 
was blocked by siRNA directed against HIF1α (figure 19). 
Figure 19. siRNAs treatments HeLa cells were treated with the indicated siRNAs and then grown at normoxic (21% 
oxygen, Nx) or hypoxic (1% oxygen, Hyp) conditions for 12 hours and the levels of EFNA3 (A), HIF1A (B) and  
EPAS1 (C) mRNA were determined by qPCR. The graph represents the normalized levels of mRNA as fold over  
control conditions (normoxic cells treated with scramble siRNA). Bars represents average values in four independent 
biological replicates and error bars the standard deviation. The differences between groups were statistically significant:
(A)  ANOVA F7,48=23.52,  p<0.001;  (B)  ANOVA F7,24=16.9,  p<0.001;  (C)  ANOVA F7,20=17.58,  p<0.001.  The 
asterisks indicate mean pairs that were  statistically significant (***, adjusted p <0.001) in a posteriori Tukey test. 
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To investigate the regulation of EFNA3 by HIF in vivo, we employed conditional VHL knockout 
mouse lines (Miró-Murillo M., et al., 2011) . VHL deletion results in constitutive HIF activity and, 
consistently  with the in  vitro results,  this  led to  increased EFNA3 lncRNA expression  without 
significantly altering the level of the coding EFNA3 mRNA. Importantly, the induction of EFNA3 
upon VHL loss was partially prevented in animals lacking both VHL and EPAS (HIF2α) alleles 
(figure 20), suggesting that the in vivo HIF2α mediates the effect of VHL, at least in the liver and  
the lung. 
Figure 20. EFNA3 is regulated by HIF in vivo. Vhlfl/fl-UBC-Cre-ERT2 (n = 5), Vhlfl/flHIF2αfl/fl-UBC-Cre-ERT2 
(n=3) and control ( n=11) mice were placed on a tamoxifen diet for ten days followed by ten additional days on a 
normal diet. The box-and-whisker plot represents the distribution of the normalized EFNA3 mRNA expression in the  
liver of animals with the indicated genotypes. The box contains the values comprised between the second and third 
quartiles, and the horizontal black line the median. The “whiskers” extent to 1.5 times the interquartile range. The  
differences between groups were statistically significant (ANOVA F2,18=20.49, p<0.001) and the asterisks indicate 
means pairs that were the statistically significant (adjusted p <0.001) in a posteriori Tukey test. 
Regardless  the  specific  HIF  isoform  involved,  that  could  just  reflect  their  differential  tissue 
expression, it is clear from these set of results that EFNA3 expression is induced, both in vitro and 
in vivo, in response to hypoxia, in a HIF-dependent manner. 
3. LncRNAs ENCODED BY THE EFNA3 LOCUS CAUSE EPHRIN-A3 ACCUMULATION
Mounting evidence indicates that lncRNAs are key regulators of gene expression that affect the 
mRNA transcription rate, stability and translation (Nie L., et al., 2012; Yoon J. H., 2012). Thus, in 
an attempt to reconcile the induction of Ephrin-A3 protein with the regulation of coding and non-
coding transcripts by hypoxia,  we tested whether NC1 and NC2 lncRNAs could affect EFNA3 
mRNA or  protein  levels.  As  shown in  figure  21  ,  the  overexpression  of  the  lncRNAs had  no 
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significant effect on EFNA3 mRNA levels (figure 21A). However, exogenous expression of the 
different isoforms, particularly the short ones (NC1s and NC2s) in HeLa (figure 21B and 21C) and 
MDA-MB-231  (figure  21D),  caused  EFNA3  protein  accumulation.  These  results  provide  an 
explanation for the induction of EFNA3 protein under hypoxia in spite of its  modest effect on 
EFNA3 mRNA level. 
Figure  21.  lncRNA expression  results  in  increased  EFNA3  protein  levels.  HeLa  cells  were  transfected  with 
constructs encoding for the indicated lncRNAs or empty plasmid (pLOC) and the level of the canonical EFNA3 mRNA 
(A) and protein (B and C) were determined by qPCR and immunoblot respectively. The graph in A represents the level  
of the NM_004952 mRNA, determined with primers Exon1+2, as a fold over the level found in untreated cells. Bars 
represent the mean of five independent biological replicates and the error bars the standard deviation. The differences 
between groups were not statistically significant (ANOVA F4,20=1.452, p=0.254). The graph in C represents the level  
of Ephrin-A3 as the ratio of the Ephrin-A3 band intensity corrected by the Actin band intensity in three independent 
experiments. The differences between groups was statistically significant (ANOVA F5,11=8.635, p<0.01).The asterisks 
indicate sample means that were significantly different from controls (pLOC samples) in a posteriori Tukey test (*,  
adjusted p < 0.05; **, adjusted p < 0.01). The image in B is representative of at least three independent experiments. (D) 
Immunoblot in MDA-MB-231 cells infected at different MOI with lentivirus encoding for the indicated lncRNA.
4.  EFNA3  ISOFORMS  ARISE  FROM  ALTERNATIVE  PROMOTERS  WITH 
DIFFERENTIAL RESPONSIVENESS TO HYPOXIA
The different transcription start sites of the EFNA3 isoforms suggested the existence of alternative 
promoters.  In  agreement,  histone  modifications  landscape,  location  of  the  open chromatin  and 
transcription factor binding site (TFBS) regions in the EFNA3 locus (figure 22) were consistent 
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with the existence of two promoter regions (figure 22, Prm1 and Prm2). 
Figure  22 LncRNAs  encoded  by  the  EFNA locus  are  transcribed  from  an  alternative  hypoxia-responsive 
promoter. Diagram depicting the EFNA3 locus and showing the NM_004952 RefSeq gene (“EFNA3” track) along 
with  accessible  chromatine  regions  (“DNase  clusters  track”),  histone  marks  associated  to  promoters  (“Layered 
H3K4Me3” track) and active regulatory elements (“H3K27Ac Track”). The colors in the histone tracks correspond to 
the signal obtained in different cell lines (see UCSC for details).  The figure was generated by the UCSC genome 
browser upon loading custom tracks to indicate the location of primer and amplicons used in the RNA pol II (P1 and  
P2)  and  Hif1a  (H1-H6)  ChIP-qPCR  experiments  as  well  as  the  regions  cloned  to  assay  their  promoter  activity  
(“promoters” track). 
To further investigate the regulation of the different EFNA3 transcripts, we analyzed the binding of 
RNA polymerase II (Pol II) to these putative promoter regions. As controls, we also included the 
promoter regions of a bona fide hypoxia inducible gene (P4HA) and a non-responsive gene STT3A. 
ChIP-qPCR analysis showed that Pol II bound to both regions of the EFNA3 gene locus under 
normoxia (figure 23). 
Figure 23 .  Binding of  RNA polymerase II  by ChiP-qPCR. HeLa cells  were  exposed  to  21% or  1%  oxygen 
environment for 8 hours and RNA pol II binding to the indicated regions of the EFNA3 locus. Binding of P4hA and  
STT3S promoters were used as positive and negative controls respectively. The graph shows the amount of precipitated  
material as a percentage of the input (% enrichment). Bars represent the mean of three independent biological replicates 
and the error bars the standard deviation. The differences between groups were statistically significant (ANOVA F 15,69 
=15.6, p< 0.001) and the asterisks indicate mean pairs that were  statistically significant in a posteriori Turkey test.
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Consistent with the relatively low EFNA3 expression in HeLa cells, the binding of Pol II to the 
EFNA3  promoter  regions  was  lower  than  its  binding  to  the  P4HA and  STT3A promoters. 
Importantly, Pol II binding to the P2 region was strongly induced by hypoxia (figure 23 ), to a level 
comparable to the HIF-responsive promoter of P4HA. In contrast, the Pol II binding to the Prm1 
region and to the STT3A promoter remained unaffected by hypoxia (figure 23). 
Next, we investigated direct binding of HIF1α to the EFNA3 locus by ChIP-qPCR. We designed six 
primer sets (figure 22, H1-H6) to sample most of the RCGTG motifs (figure 22 , “RCGTG motifs” 
track) within EFNA3 locus and found that the only fragment that showed, significant HIF binding 
under hypoxic conditions was H6 (figure 24). Interestingly, H6 region is close proximity to Prm2, 
which could explain the differential response of promoter regions 1 and 2 to hypoxia. 
Figure 24  .  Binding of HIF1α by ChiP-qPCR. HeLa cells were exposed to 21% or 1% of oxygen for 8 hours and 
HIF1α binding to the indicated regions of the EFNA3 locus. Binding of EGLN3 enhancer region (E3_E) and EGLN3 
promoter  region (E3_P) were used as  positive and negative controls respectively.  The graph shows the amount of 
precipitated  material  as  a  percentage  of  the  input  (% enrichment).  Bars  represent  the  mean  of  three  independent 
biological  replicates  and  the  error  bars  the  standard  deviation.  The  differences  between  groups  were  statistically  
significant (ANOVA F31,32  =39.99, p< 0.001) and the asterisks indicate mean pairs that were  statistically significant in 
a posteriori Turkey test.
Finally, we cloned both EFNA3 promoter regions and studied their response to hypoxia and to the 
chemical inhibitor of HIF prolyl hydroxylase, DMOG, which causes acute HIF activation. Although 
both regions showed similar basal promoter activity (data not shown), Prm2 was strongly induced 
by  hypoxia  and  DMOG,  whereas  Prm1  remained  unaffected  (figure  25).  Importantly,  Prm2 
response  to  hypoxia  was  critically  dependent  on  one  of  its  RCGTG  motifs  whose  mutation 
completely abrogated hypoxic induction (figure 25). 
51
Results
Figure 25. Reporter assay The effect of hypoxia (white bars) and DMOG (grey bars) on the transcriptional activity of 
the promoter region 1 and 2 was assessed by reporter assays upon transfection of the indicated constructs into HeLa  
cells.   White boxes within the promoter  2  (Prm2) diagram represent  RCGTG motifs  and crossed boxes represent  
mutated  RCGTG motifs.  The graph shows the  normalized  luciferase  activity  in  hypoxic  (Hyp)  or  DMOG-treated 
(DMOG) samples expressed as fold over the activity obtained in normoxic conditions. Bars represent the mean of three 
independent  biological  replicates  and  the  error  bars  the  standard  deviation.  The differences  between groups  were 
statistically significant  (ANOVA F4,10 =21.9,  p<0.01) and the asterisks indicate mean pairs  that  were statistically 
significant (*, adjusted p<0.05;  **, adjusted p<0.01) in a posteriori Turkey test.
5. HIF ACTIVATION CORRELATES WITH EFNA3 EXPRESSION IN HUMAN TUMORS
Over  80% of  human  clear  cell  renal  cell  carcinomas  (ccRCC)  samples  are  deficient  for  VHL 
function and, as a consequence, present constitutive HIF activity even in the presence of oxygen 
(Kaelin W.G., 2007) . Thus, ccRCC is highly suitable to study a putative link between HIF and 
EFNA3 in human tumors.  In  agreement,  the expression of  EGLN3, a  well-characterized  direct 
target  of  HIF,  was  clearly  increased  in  the  three  independent  ccRCC tumor  series  (figure  26). 
Similarly, EFNA3 was significantly increased in ccRCC tumor cells as compared with the normal 
kidney tissue in the same series, regardless of the microarray platform used to assay tumor samples 
(figure 26).  The probes used to determine EFNA3 expression in  these datasets  bind to  regions 
common to all transcripts from this locus and thus they detect the cumulative signal by the mRNA 
and lncRNA transcripts. However, since the expression of lncRNAs was much higher than that of 
canonical EFNA3 mRNA (figure 17), we assume that the microarray signal is largely generated by 
the lncRNA. We also examined the expression of two other EFNA family members, EFNA1 and 
EFNA4,  whose  coding  genes  flank  the  EFNA3  locus  in  mammalian  genomes.  Interestingly, 
EFNA1, but not EFNA4, is induced by hypoxia (YamashitaT.,   et al.,  2008). Concordantly,  the 
expression of EFNA1, but not that of EFNA4, is clearly increased in ccRCC (figure 26). These 
results rule out that the increased EFNA3 expression observed in these tumors could be caused by a 
gross  structural  alteration  or  transcriptional  deregulation  of  the  genomic  region  containing  the 
EFNA3 gene and suggest  it  is  due  to  increased  HIF activity  as  it  correlates  with  the  changes  
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observed for other hypoxia regulated genes. 
Figure 26.  EFNA3 expression is induced in human renal clear cell carcinomas (RCC). The expression of EGLN3, 
EFNA3,  EFNA1 and EFNA4 (columns)  was  determined  in publicly  available  gene  expression  profiles  of  ccRCC 
samples from three independent studies (ID shown on the left margin of each row). Graphs represent the expression of  
the indicated genes in arbitrary units (normalized microarray intensity values). The individual samples are shown and 
pairs of tumoral and normal kidney tissue are joined by segments. . The statistical significance of mean differences in  
indicated on top of each graph (paired student's t test). 
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6. EFNA3 PROMOTES METASTATIC BEHAVIOR BY ENHANCING EXTRAVASATION 
OF TUMOR CELLS 
Since  hypoxia  is  a  common condition  in  solid  tumors  that  correlates  with  metastatic  potential 
(Vaupel & Mayer, 2007) and some ephrin family members have been implicated in the promotion 
of metastatic behavior  (Surawska et al., 2004), we next studied the metastatic potential of MDA-
MB-231 cells  engineered to express luciferase and  EFNA3 in an orthotopic xenotransplantation 
model. Figure 27A, show luminescence signal five weeks after tumor inoculation and Figure 27B 
the progression of luciferate activity during the course of the experiment. At five weeks after tumor 
inoculation, the total photon flux was significantly higher in most animals bearing EFNA3-positive 
tumors, compared to controls (Figure 27A and 27B). Moreover, the necropsies performed at the end 
of the experiment confirmed that 7 out of 8 of the animals injected with EFNA3-positive cells 
presented metastasis as opposed to 1 out of 7 in the control group. Metastasis were located mostly,  
in the peritoneal cavity, attached to the surface of internal organs (Figure 28B and 28C)
Figure 27. EFNA3 overexpression increases metastasis formation in an animal model. (A,B) MDA-MB-231 cells 
engineered to stably express luciferase alone (ploc-luc) or in combination with EFNA3 (pefna3-luc) were orthotopically 
injected  into  the  mammary  fat  pad  of  nude  mice  and  tumor  growth  followed  by  non-invasive  whole  body  
bioluminescence imaging. (A) Bioluminescence images of mice at end time point (5 weeks). (B) Luminescence signal 
during the course of the experiment. The graph represents the luciferase signal (total flux) in photons/seconds X10⁸
Importantly, there were no significant differences in the volume of the primary tumor (Figure 28A) 
nor tumor vascularization (Figure 28D and 28E) between both animal groups, suggesting that the 
increased metastatic potential observed in the EFNA3 group was not due to increased tumor growth 
nor vascularization. 
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Figure 28. The increased metastatic potential observed in the EFNA3 group was not due to increased tumor 
growth  nor  vascularization (A)  Tumor  volume  was  determined  after  five  weeks.  The  boxplot  represents  the 
distribution  of  volume  in  each  group.  The  differences  between  controls  and  EFNA3-expressing  tumors  was  not  
significant (independent samples t test: t12=-1.5373, P=0.1499). Animals were euthanised and tissues processed for  
H&E staining (B and C) or immunostaining. (E) Representative H&E staining from liver at 10X (left) and 40X (right)  
magnification. Blood vessels were stained with an antibody against human CD31 and cell nuclei with DAPI. (D) The 
CD31 signal was normalized to cellularity (DAPI staining).Te graph represents the distribution of normalized values. 
Differences  between  groups  weere  not  significant  (independent  samples  t-test  t10  =1.0522,  p=  0.3182).  (E) 
Representative images of CD31 and DAPI staining.
Finally, the increased metastatic potential of the EFNA3 cells was confirmed in an independent 
experiment where  cells were injected via the tail vein to generate experimental lung metastasis. As 
shown in figure 29, Lung weight measurement at ten weeks showed significant differences between 
mice control and mice overexpressing Ephrin-A3, that correlated with the differences observed in 
bioluminescence signal.
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Figure  29.  EFNA3  overexpression  increases  metastasis  formation  in  an  animal  model.  MDA-MB-231  cells 
engineered to stably express luciferase alone (pLOC) or in combination with EFNA3 (EFNA3). The cells injected via 
the tail vein of nude mice and tumor growth followed by non-invasive whole body bioluminescence imaging (BLI) (A) 
BLI image of mice at 9 weeks time point.  (B) Luminescence signal during the course of the experiment.  The graph  
represents the luciferase signal (total flux) in photons/seconds at end time point (10 weeks). ( C) The weight of the 
lungs was determined at the end of the experiment, the boxplot represents the distribution of volume in each group. The 
differences between controls and EFNA3-expressing tumors were significant (independent samples t-test: t12=-2.696, 
p<0.05). 
7.  EFNA3  INDUCES  ENDOTHELIAL  CELL  REPULSION  AND  PROMOTES 
EXTRAVASATION OF TUMOR CELLS
The  experiments  above  demonstrate  that  Ephrin-A3  expression  results  in  increased  metastatic 
potential without affecting the microvascular density nor primary tumor growth. Ephrins, through 
their receptors, mediate attraction and repulsion signals between cells (Nievergall et al., 2012). This 
function could enable tumor cells entry and exit from blood vessels and in this way increase their 
metastatic potential.  To test this possibility, we plated HEK293T cells transiently transfected with 
plasmids  encoding  for  EFNA3  or  the  empty  vector,  on  top  of  the  HUVEC  cells  grown  in 
monolayer. We measured the ability of HEK-EFNA3 cells to pass through HUVEC monolayer and 
attach to the plastic below. The number of GFP-positive cells attached and spread on plastic was 
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significantly higher when EFNA3 was expressed compared to control (figure 30). This result is 
consistent with EFNA3 transducing the repulsive signal to HUVECs that allowed HEK293 cells to 
infiltrate through the monolayer.
Figure  30. EFNA3  expression  results  in  repulsion  of  HUVEC  cells  and  promotes  extravasation.  EFNA3 
expression results in repulsion of HUVEC cells and promotes  extravasation. (A,B) HEK293 cells were transiently 
transfected with a plasmids encoding for GFP and EFNA3 (“EFNA3”) or GFP alone (“Vector”) and then plated on top 
of a monolayer of HUVEC cells previously labeled with a red fluorochrome. (A) Representative images of cells 2h and 
24h after plating HEK293 cells on top of the HUVEC monolayer. (B) The graph represents the proportion of GFP-
positive cells attached to the plastic surface and spreading at 24h. The differences between cells expressing EFNA3 and 
cells transfected with GFP alone was statistically significant (2x2 contingency table: χ21=67.52, p<0.001). 
In  agreement,  recombinant  Ephrin-A3-Fc  blocked  the  directional  migration  of  HUVEC  cells 
induced by the conditioned media from NIH 3T3 cells (Figure 31). 
Figure 31. Recombinant Ephrin-A3-Fc block migration of HUVEC cells. HUVEC migration was determined using 
NIH  conditioned  media  (NIH_CM)  as  chemoattractant  in  the  absence  or  presence  of  0.2,  1  or  5  microgr/ml  of 
recombinant Ephrin-A3 fused to the Fc region of immunoglobulins (EphrA3). The graph represents the average number  
of migrated cells per field in a single experiment and error bars the standard deviation. The experiment was repeated 
three independent times with similar results. The differences among treatments werestatistically significant (ANOVA 
F7,178=47.17, p<0.001) and the asterisks indicate means that were the statistically significant to the NIH-conditioned 
media treatment (***, adjusted p < 0.001) in a posteriori Tukey test.
57
Results
These data suggests a mechanism for the increased metastatic potential of the tumors with EFNA3 
expression whereby they can efficiently intravasate and extravasate through the vascular wall. To 
investigate this possibility  in vivo,  we injected MDA-MB-231 cells via the tail vein of immune 
deficient mice and assessed the appearance of the individual tumoral cells in the lungs in a short-
term assay.  Although the  numbers  of  circulating  tumor  cells  immediately  after  injection,  were 
similar in the groups injected with EFNA3 and control cells, 8 days later the GFP signal was much 
higher  than  for  the  animals  injected  with  EFNA3-expressing  cells  (Figures  32A and  32B). 
Therefore, EFNA3 facilitates metastasis, at least in part,  by allowing extravasation of the tumor 
cells from the vasculature. 
Figure 32.   Lung extravasation assay.  MDA-MB-231 cells stably expressing GFP alone or  in combination with 
EFNA3 were injected in the tail of nude mice. After the indicated periods of time, mice were euthanized and lungs were 
examined by confocal microscopy for the presence of GFP-positive cells. The boxplot represents the distribution of  
total  GFP signal normalized to lung area in each group of mice.  Results from two independent experiments were 
pooled. The differences between the two groups were statistically significant (Student's t-test t(3) = -4.44, p<0.05). 
8.   EFNA3  EXPRESSION  CORRELATES  WITH  METASTATIC  RISK  IN  BREAST 
CANCER PATIENTS
In knowledge ofthese results, we next analyzed the correlation between EFNA3 expression and the 
risk of  metastasis in breast cancer patients. We made use of the public access datasets of human 
breast  cancer  gene expression from the ROCK website  (Online Breast  Cancer  Knowledgebase, 
http://www.rock.icr.ac.uk/). In addition to gene expression profiles, this website provides detailed 
clinical data allowing for correlation analyses between genes and phenotypes  (Sims D.,   et  al., 
2010). We categorized patient samples according to EFNA3 expression level (high vs. low) and 
analyzed the incidence of metastasis over time in both groups (figure 33). In agreement with the 
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results  of  the animal  studies,  the risk of metastatic  disease was significantly higher  in  patients 
whose primary tumors expressed higher levels of EFNA3 (figure 33). Noteworthy, the probes used 
to determine EFNA3 mRNA in these sets of human tumors were directed against regions common 
to  all  RNA products  of  the  EFNA3 locus  (see  materials  and  methods).  Thus  they  detect  the 
cumulative  signal  by  the  mRNA and lncRNA, whereby  the  signal  is  largely  generated  by  the 
lncRNA.
Figure 33 High levels of EFNA3 correlate with metastasis in human tumors.  High levels of EFNA3 correlate with 
metastasis in human tumors. Gene expression profiles from the indicated series of breast cancer tumors (Loi2008, (Loi  
et al., 2008) ; Pawitan2005, (Pawitan et al., 2005) ; Ur-Rehman, www.rock.icr.ac.uk/; vandeVijve, (van de Vijver et al., 
2002) ) were downloaded from the ROCK database (www.rock.icr.ac.uk/).  Samples  were categorized according to 
EFNA3 expression into high (samples with EFNA3 expression in the top quartile of the series, labeled in red) and low 
expression (rest of samples in the serie, labeled in blue) and the Kaplan−Meier estimate of the distant metastasis free  
survival (DMFS) over time calculated (graphs). The survival of the two groups was compared using a Cox proportional  
hazards model, the p-values are indicated in the graphs. The probes used in the gene profiling assays are indicated in  
brackets in the graph title. 
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Discussion
HIF-mediated transcriptional response plays a central role in the adaptation of tissues to hypoxia. 
For  this  reason,  the identification of HIF-regulated genes is  essential  to  draw a comprehensive 
picture of these adaptive mechanisms. In the past few years, many HIF-target genes have been 
characterized and, in the majority of cases,  HIF activation results in induction of transcription of 
the coding mRNA. In this study, we not only identified a novel HIF target gene, but also found a 
completely novel way of hypoxic regulation of gene expression whereby the changes in the coding 
mRNA are only marginal. Instead, HIF directly regulates the levels of long non-coding (lnc) RNAs, 
which, in turn, increase protein levels. This discovery leads to the question of how do lncRNA 
regulate Ephrin-A3 protein levels. 
LncRNAs have been shown to regulate virtually every step of the gene expression cascade from 
transcription to translation (Nie, L., et al., 2012; Yoon, J. H., et al., 2012). In particular, one recent 
report describes lncRNA that affects Uchl1 protein levels by enhancing mRNA translation of the 
coding mRNA (Carrieri, C., et al, 2012), suggesting that EFNA3 lncRNA could act using a similar 
mechanism. Although our results show a clear effect of EFNA3 lncRNA on Ephrin-A3 expression 
at the postranscriptional level, further work is needed to determine whether this effect is caused by 
increased translation or reduced protein turnover. 
Interestingly,  some  non-coding  transcripts  act  in  concert  to  regulate  the  expression  of  coding 
mRNAs. For example, some lncRNAs act as decoys for the miRNA that target a particular mRNA 
(Yoon, J. H., et al., 2012). It is known that miR-210, which is induced by hypoxia (Huang, X., et al., 
2009; Kulshreshtha, R., et al., 2007), prevents the translation of several mRNA including ISCU and 
EFNA3 (Chan, S. Y., et al., 2009; Fasanaro, P., et al., 2008; Favaro, E., et al., 2010; Huang, X., Le,  
Q. B. & Giaccia, A. J., 2010). Since miR-210 binds the 3'-UTR of the EFNA3 mRNA (Fasanaro, P., 
et al., 2008), it is feasible that EFNA3 lncRNAs increase EFNA3 mRNA translation by depleting 
miR-210.  However,  the  fact  that  shorter  isoforms,  NC1s  and  NC2s  are  more  efficient  in  the 
induction of Ephrin-A3 than the long ones (NC1 and NC2), argues to the contrary because the 
predicted miR-210 binding sites are not represented on the shorter lncRNAs isoforms, NC1s and 
NC2s (figure 14). Nonetheless, it is still possible that miR-210 could bind to sites other  than those 
predicted.  
It could also be argued that lncRNA might promote Ephrin-A3 accumulation by acting at the level 
of  EFNA3 mRNA stability  rather  than  translation.  We explored  this  possibility  and found that 
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EFNA3 mRNA half-life, as determined by inhibition of transcripion by Actinomycin D treatment, 
was indeed increased during hypoxia compared with EFNA3 lncRNA (figure 34). 
Figure 34.  Hypoxia effect  on  the  half-life  of  the  different  EFNA transcripts.  HeLa cells  were  cultured  under 
normoxic or hypoxic conditions for 12 h prior the inhibition of transcription with Actynomycin D (ACTD) and then 
kept at normoxia or hypoxia for the indicated periods of time (minutes) until processing. Non-coding isoform or coding 
EFNA3 mRNA levels were determined by qPCR at the indicated periods of time after the addition of ACTD.
However, when we analyzed the half life by means of 4-thio-Uridine labelling (Rädle, B., et al, 
2013), we were unable to detect any increment in the half life of coding EFNA3 under hypoxic 
conditions (table 6). Thus, we can not draw any consistent conclusion in regards to the effect of 
hypoxia  on EFNA3 coding mRNA stability.
Table 6. Half life of the indicated transcripts as determined by 4-thio-Uridine labelling (Rädle, B., et al, 2013).
Although our data suggets that the major effect of lncRNA occurs at the postranscriptional level, it 
is possible that they act at multiple levels. Thus, another plausible mechanism by which lncRNA 
could contribute to Ephrin-A3 expression is that HIF-induced lncRNA transcription can act creating 
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a permissive chromatin environment  that facilitates the  expression of nearby mRNAs (Kornienko, 
A. E.,  2013).  In our case,  transcription from Prom2 could facilitate  transcription of the coding 
EFNA3 from Prom1 (figure 35). This could explain the small, but reproducible, increase in EFNA3 
mRNA  observed under hypoxia. 
Figure 35. LncRNA transcription allows enhancer activity: 1: An inactive enhancer with closed chromatin cannot 
activate protein coding gene. 2 y 3 transcription of the enhancer open chromatin 4. HIF1A can bind to the enhancer and 
interact  with coding isoform promoter allowing its expression.
In fact, this hypothesis might explain why hypoxia has a minor, but consistent, effect on the level of 
the  coding  mRNA as  well.  Moreover,  this  possibility  is  supported  by  the  analysis  of  newly 
synthesized heterogeneous nuclear RNA (hnRNA) in cells grown in the presence of 4-thio-Uridine 
(Rädle, B., et al, 2013). As shown in figure 36, hypoxia induces newly transcribed coding EFNA3 
hnRNA, but the kinetic of this induction is retarded compared with that of the hnRNA precursor of 
the  EFNA3  lncRNA or  EGLN3  hnRNA.  Thus,  in  this  model,  hypoxia  would  result  in  the 
recruitment of HIF and RNA pol II to Prom2 (as supported by our data in figure 23) leading to 
increased transcription of the lncRNA. The increased transcription from Prom2, could indirectly 
enhance transcription from Prom1 by, for example, creating a permissive chromatin environment 
within the EFNA3 locus. The increased activity of Prom1 would be secondary and consequence of 
the  transcription from Prom1 and does  not  involve recruitment  of  RNA-pol  II   or  HIF to  this 
promoter (figure 23 and figure 24). 
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Figure  36.  hnRNA levels  under 4-thio-Uridine  treatment.  400mM of  4-thio-Uridine  was  added  to  HeLa  cells 
medium the last 2 hours of hypoxia treatment. hnRNA levels were quantified with the specific set of primers.
From our  data,  it  is  quite  evident  that  hypoxia  preferentially  regulates  the  transcription  of  the 
EFNA3 lncRNA from Prom2 and yet Prom1 is not far away from the HIF binding site. Hence the 
question on how hypoxia affects differentially these promoters arises. Interestingly, the presence of 
CTCF binding sites flanking EFNA3 Prom2 region (figure 15) offers a plausible explanation for the 
preferential transcriptional activation of the lncRNA by HIF and the lack of the regulation of the 
canonical coding isoform. Other studies also demonstrate the role of insulators in determination of 
HIF specificity for promoters located in the close proximity (Tiana, M., et al., 2011).  Of note, in 
agreement with the model proposed above, the presence of CTCF binding sites would block the 
activity  of  cis-regulators  such  as  HIF,  but  will  probably  not  have  an  effect  on  trans-acting 
regulators, such as lncRNA.
Also regarding the molecular mechanism, we found that in vitro EFNA3 induction was dependent 
on HIF-1α and not affected by HIF-2α knockdown whereas in animal models, EPAS1 was required 
for EFNA3 induction upon VHL loss. Thus, HIF isoforms responsible for EFNA3 may be context-
dependent and could be dictated by availability of a specific HIF isoform, or another, HIF cell-type 
specific transcription factor(s), that favor interaction with a specific HIF isoform. Nonetheless, this 
has  been  observed  for  other  hypoxia-regulated  genes.  For  instance,  the  hypoxic  regulation  of 
another ephrin, Ephrin-A1, also requires HIF1α  (Vihanto, M. M., et al., 2005) in cell cultures, but 
not in vivo, where it is dependent on HIF2α (Yamashita, T., et al., 2008).
Taken together, our results and those published elsewhere point to a complex regulation mediated 
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by non coding RNAs of different types and strongly suggest that Ephrin-A3 levels need to be tightly 
controlled in the response to hypoxia. This fact leads to the question of what is the role of Ephrin-
A3 in the physiological response to hypoxia.  Since the induction of angiogenesis  is  one of the 
paradigmatic  responses  to  hypoxia  and  other  ephrins  have  key  roles  in  angiogenesis  and 
vasculogenesis  (Mosch,  B.,  Reissenweber,  B.,  Neuber,  C.  & Pietzsch,  J.,  2010),  we decided to 
investigate the role of EFNA3 in angiogenesis. 
To address this question we decided study the effect of forced Ephrin-A3 expression in an in vivo 
model of tumoral vascularization. Using this approach, we did not found evidence of a role for 
Ephrin-A3 on the control of angiogenesis. In fact, the vascular density of tumors expressing this 
protein was similar to that of controls (figures 28D and 28E).  This is consistent with the fact that 
Ephrin-A3 KO mice (Pfeiffenberger, C., et al., 2005) have no vascular phenotype described so far. 
Earlier  studies  showed that  Ephrin-A3 overexpression prevented the  formation of  capillary-like 
structures by HUVEC cells in vitro (Fasanaro, P., et al., 2008; Xiao, F., et al., 2013). We similarly 
found that  recombinant  Ephrin-A3-Fc prevents  the  migration  of  HUVECs in  vitro (figure  31), 
however,  we interpret this result as an evidence of the repulsive activity of EFNA3  than explains 
the enhanced ability of Ephrin-A3 expressing cells to enter/exit blood vessels. 
A further biological process in which ephrins play a key role is axon pathfinding (Flanagan, J. G.,  
2006). Interestingly,  recent works in C. elegans (Pocock, R. & Hobert,  O., 2008) and zebrafish 
(Stevenson, T. J., et al., 2012) have shown that hypoxia disrupts normal CNS pathfinding through 
the induction of Eph/ephrins in a HIF-dependent manner. Moreover, Ephrin-A3 protein is induced 
at very high levels in post-ischemic mouse hippocampus in vivo (Pulkkinen, K., Malm, T., Turunen, 
M.,  Koistinaho,  J.  &  Ylä-Herttuala,  S.,  2008).  Thus,  it  is  tempting  to  speculate  that  the 
physiological role of Ephrin-A3 induction by hypoxia could be related to axon guidance in the 
CNS. 
Regardless their physiological roles, Eph/ephrins are frequently co-opted by transformed cells to 
modulate  cell-cell  and  cell-matrix  attachment  and  survival  during  invasion,  angiogenesis  and 
metastasis (Chen, J., 2012; Nievergall, E., et al., 2012). Accordingly, we found that the expression 
of Ephrin-A3 in MDA-MB231 breast cancer cells resulted in increased metastatic potential (figure 
27 and 29)  suggesting  that  the activation of  HIF as  a  consequence  of  intratumoral  hypoxia  or 
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oncogenic alterations could promote metastasis through the induction of Ephrin-A3. Supporting this 
possibility we found a strong correlation between high EFNA3 level and development of metastasis 
(figure 26 and 33). 
Also in  agreement  with our  findings,  Ephrin-A3 was recently identified as one of the proteins 
differentially expressed in metastatic colon cancer cells (Barderas, R., et al., 2013) and in squamous 
cell carcinoma in lung associated with poor prognosis  (Li, J. J., 2012). As for the mechanism by 
which Ephrin-A3 promotes metastasis, our results suggests that tumor cells expressing Ephrin-A3 
might have enhanced ability to intra and extravasate and this ability be related to the repulsion of 
endothelial cells by tumor cells expressing Ephrin-A3 (figure 30). Interestingly, this mechanism is 
similar  to  the  one  employed by angiopoietin-like  4 (ANGPTL4),  which  is  also  HIF-dependent 
hypoxia-inducible gene, to promote metastasis (Zhang , H., et al., 2011). 
In summary, we demonstrate a novel mechanism of hypoxic regulation, where EFNA3 expression is 
regulated by previously non-annotated intragenic lncRNAs whose transcription is driven by HIF in 
response to hypoxia. We propose that in hypoxic regions of solid tumors or in tumors harboring 
mutations  leading to HIF stabilization,  this  mechanism allows Ephrin-A3 accumulation and the 
promotion of metastasis by augmenting the ability of tumoral cell to pass through the endothelium 
of blood vessels (figure 37). 
Figure  37:  EphrinA3  metastasis 
induction  scheme
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Conclusions
➢ Ephrin-A3 protein and EFNA3 transcripts are induced by hypoxia.
➢ EFNA3 locus encodes for a coding mRNA and several lncRNAs that are transcribed 
from alternative promoters.
➢ Hypoxia induces the transcription of the lncRNA through the binding of HIF to an 
HRE element located within the second exon of the gene.
➢ Hypoxia promotes Ephrin-A3 protein accumulation by a mechanism that is likely to be 
controlled by EFNA3 lncRNAs acting at multiple levels including the postrancriptional 
one.
➢ EFNA3 expression correlates with HIF activity in human renal carcinomas
➢ The  overexpression  of  Ephrin-A3  results  in  increased  metastatic  potential  without 
altering tumor growth nor vascularization.
➢ The increased metastatic potential associated to Ephrin-A3 expression is probably due 
to enhanced extravasation of tumor cells as a consequence of their repulsive effect on 
endothelial cells.
➢ EFNA3 expression correlates with higher metastatic potential and poor prognosis in 
human breast cancer samples
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Conclusions
➢ La proteína Efrina-A3 y los tránscritos de EFNA3 son inducido por hipoxia
➢ El locus EFNA3 codifica para un mRNA codificante y varios  RNAs no codificantes 
largos (lncRNAs) desde el locus EFNA3  transcritos desde un promotor alternativo
➢ La hipoxia induce la transcripción de RNAs no codificantes largos (lncRNAs) desde el 
locus EFNA3 mediante la unión de HIF a un HRE localizado en el segundo exón del  
gen
➢ La  hipoxia  promueve  la  acumulción  de  Efrina-A3  por  un  mecanismo  que  parece 
controlado  por  RNAs  no  codificantes  largos  (lncRNAs)  desde  el  locus  EFNA3, 
actuando a múltiples niveles de regulación.
➢ La expresión de  EFNA3 correlaciona  con  actividad de  HIF en  carcinomas  renales 
humanos
➢ La sobreexpresión de Efrina-A3 se traduce en mayor potencial metastásico sin alterar 
el crecimiento del tumor ni su vascularización
➢ El  mayor  potencial  metastásico  asociado  a  la  expresión  de  Efrina-A3,  es 
probablemente debido al aumento de la extravasación de las células tumorales como 
consecuencia de su efecto de repulsión sobre las células endoteliales. 
➢ La  expresión  de  EFNA3  correlaciona  con  un  mayor  potencial  metastásico  y  peor 
prognosis en muestras de cáncer de mama humano
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ABSTRACT 
The presence of hypoxic regions in solid tumors is an adverse prognostic factor for patient outcome. 
Here, we show that hypoxia induces the expression of Ephrin-A3 through a novel Hypoxia Inducible 
Factor (HIF)-mediated mechanism.  In response to hypoxia, the coding EFNA3 mRNA levels remained 
relatively stable, but HIFs drove the expression of previously unknown long non-coding (lnc) RNAs 
from EFNA3 locus and these lncRNA caused Ephrin-A3 protein accumulation. Ephrins are cell surface 
proteins that regulate diverse biological processes by modulating cellular adhesion and repulsion. 
Mounting evidence implicates deregulated ephrin function in multiple aspects of tumor biology. We 
demonstrate that Ephrin-A3 expression increased the metastatic potential of human breast cancer cells 
in an xenotransplantation model, likely by increasing the ability of tumor cells to extravasate from the 
blood vessels into surrounding tissue. In agreement, we found a strong correlation between high 
EFNA3 expression and shorter metastasis-free survival in breast cancer patients. Together, our results 
suggest that hypoxia could contribute to metastatic spread of breast cancer via HIF-mediated induction 
of EFNA3 lncRNAs and subsequent Ephrin-A3 protein accumulation. 
 
Keywords: Ephrin, HIF, hypoxia, lncRNA, metastases,  
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INTRODUCTION 
In a variety of pathological situations, oxygen demand exceeds it supply to affected tissues leading to a 
condition known as hypoxia. In particular, hypoxia is a frequently observed in solid tumors and, 
importantly, it has been suggested to be an adverse prognostic factor for patient outcome (Bertout, 
Patel, & Simon, 2008; Vaupel & Mayer, 2007).  
At the cellular level, oxygen homeostasis is largely dependent on the induction of a specific gene 
expression program under the control of the Hypoxia Inducible Factors (HIFs). HIFs are heterodimers 
composed of alpha and beta subunits that belong to the basic helix-loop-helix (bHLH) Per-ARNT-Sim 
(PAS) family (Wang, Jiang, Rue, & Semenza, 1995). In mammals, three genes encode HIFα subunits, 
HIF1A, EPAS1/HIF2A and HIF3A, of which HIF-1α and EPAS1 are the best characterized (Kaelin & 
Ratcliffe, 2008). Oxygen regulates the stability (Epstein et al., 2001; Salceda & Caro, 1997) and 
transcriptional activity (Hewitson et al., 2002; Jiang, Zheng, Leung, Roe, & Semenza, 1997; Lando, 
Peet, Whelan, Gorman, & Whitelaw, 2002) of HIFα  without affecting HIFβ function. The induction 
of the HIF transcriptional program results in cellular adaptation to hypoxia, a response that aims to 
restore oxygen supply to hypoxic regions through the induction of erythropoiesis and angiogenesis and 
to reduce oxygen consumption by reprogramming cellular metabolism. 
HIF’s role in cancer has been extensively investigated. On one hand, as hypoxia develops in tumors as 
a consequence of the rapid expansion of the transformed cells, HIF is activated contributing to critical 
aspects of tumor progression (Bertout et al., 2008; Semenza, 2003). On the other hand, VHL tumor 
suppressor, which plays a key role in the control of HIFα stability (Ivan et al., 2001; Jaakkola et al., 
2001; Maxwell et al., 1999), is frequently lost in clear cell renal cell carcinomas (ccRCC). Moreover, 
several lines of evidence point to HIFs, in particular EPAS1, as a ethiological factor in this kind of 
cancer (Kaelin, 2007). Other oncogenes and tumor suppressor genes including PTEN, mTORC1, 
Ras, Akt and p53 also regulate of HIF activity (Semenza, 2012). Importantly, the correlation between 
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tumor hypoxia and/or HIFα expression with poor prognosis and increased risk of metastasis has been 
repeatedly demonstrated in diverse tumor types (Vaupel & Mayer, 2007). Non-surprisingly, many of 
the HIF target genes are involved in biological processes that impact the metastatic spread of cancer 
cells, such as angiogenesis, epithelial-mesenchymal transition, cell motility, intra/extravasation and 
control of the pre-metastatic niche (Lu & Kang, 2010).  
Ephrins are a large family of cell surface ligands that mediate intercellular adhesion and repulsion 
through interaction with a large group of receptor tyrosine kinases, the Eph receptors (Nievergall, 
Lackmann, & Janes, 2012; Pasquale, 2010).  Ephrins play essential roles during development where 
they guide migration and positioning of the cells for proper tissue patterning. Their function has been 
particularly well characterized in the nervous system, where Ephrins/Eph function as axon guidance 
molecules, and in cardiovascular system, where they control vasculogenesis and angiogenesis 
(Nievergall et al., 2012). Ephrins are separated in two families according to their structure. Type A 
Ephrins (ephrin-A1 to -A5) are glycosylphosphatidyl-inositol (GPI)-linked membrane bound ligands, 
whereas type B ephrins (ephrin-B1 to -B3) contain a single transmembrane domain and a short 
cytoplasmic tail (Pasquale, 2008). Interestingly, many of the biological functions of ephrins and Ephs 
are co-opted by transformed cells and contribute to tumor progression (Chen, 2012a). Accordingly, 
many ephrin family members are altered in human cancers and their expression often correlates with a 
more aggressive phenotype, invasion, metastasis and poor prognosis (Surawska, Ma, & Salgia, 2004). 
In addition to their role in adhesion and repulsion, Eph/Ephrins may contribute tumor progression and 
metastasis by altering angiogenesis (Surawska et al., 2004). Intriguingly, HIF-dependent regulation of 
Ephrin-A1, Ephrin-B2, EphA2 and Eph4 has been described in a mouse model of skin hypoxia 
(Vihanto et al., 2005), suggesting a potential link between intratumoral hypoxia, ephrin/Eph 
expression and tumor progression.  In agreement, Ephrin-A1 is upregulated at transcription level, via 
EPAS1, in hypoxic tumors and this upregulation contributes to increased tumor vascularization (Ogawa 
5 
et al., 2000; Yamashita et al., 2008). Altogether, these works suggest a link between tumoral hypoxia 
and progression to aggressive phenotype via HIF-mediated regulation of Ephrin expression. 
 
In this study we show that hypoxia leads to Ephrin-A3 protein accumulation via a previously unknown 
mechanism that involves HIF-mediated transcriptional upregulation of a novel group of lncRNAs 
encoded by the EFNA3 locus. Using animal models and in vitro assays, we demonstrate that Ephrin-A3 
expression leads to metastatic spread. In contrast with previous studies we observed no effect on 
vascularization, but a strong repulsive action, which leads to increased intra- and extravasation that 
underlies the promotion of metastatic spread by EFNA3. Finally, the analysis of public gene expression 
profiling datasets revealed that EFNA3 is induced by HIF in human tumors and this induction is 
predictive of poor prognosis and increased risk of metastasis.  
 
  
 
6 
RESULTS 
 
EFNA3 locus encodes long non-coding RNAs (lncRNAs) that are regulated by hypoxia 
We first identified EFNA3, a member of the ephrin type A ligands, as potential novel HIF target gene 
using an in silico search (Ortiz-Barahona, Villar, Pescador, Amigo, & del Peso, 2010). As a first step 
to validate this prediction, we determined the level of Ephrin-A3 protein and found that it was induced 
by hypoxia in several cell lines (Figure 1A). The Ephrin-A3 species we detected had an apparent 
molecular weight of approximately 72kD, much higher than the 26.3kD molecular weight predicted 
from its amino acid sequence, due to postranslational modifications (supplementary Figure 1). Next we 
decided to study the effect of hypoxia on EFNA3 mRNA. According to curated databases (RefSeq) the 
EFNA3 locus encodes for a single mRNA isoform (NM_004952). However, inspection of the publicly 
available information, including ESTs and experimentally identified transcription start sites 
(http://dbtss.hgc.jp/), suggested the existence of additional mRNAs transcribed from this locus. To 
identify the hypothetical RNAs isoforms encoded by the EFNA3 locus, we performed 5'-RACE 
experiments in HeLa and LoVo cell lines (Supplementary Figure 2) and found two transcription start 
sites (TSS) in addition to that of the NM_004952 mRNA (Figure 1B). The existence and location of 
these additional transcription start sites was supported by 5' cap analysis gene expression (CAGE) tags 
from multiple cell lines produced as part of the ENCODE transcriptome Project (Supplementary figure 
2). Interestingly, none of these novel RNAs seemed to encode for functional proteins and, accordingly, 
we termed them non-coding-1 (NC1) and NC2, based on their different TSS (Figure 1B). Specifically, 
NC1 isoform contains an ATG codon within its first 10 nucleotides that is in frame with the open 
reading frames (ORF) of NM_004952, suggesting that NC1 could encode a truncated form of Ephrin 
A3. However, this potential product would have an interrupted structural domain (the ephrin domain), 
that makes up the bulk of the protein, which would likely undermine its stability. On the other hand, the 
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NC2 sequence does not contain any ORFs of significant length. In agreement, in vitro transcription-
coupled translation of EFNA3 and NC1 cDNAs, produced the proteins of expected sizes, whereas NC2 
cDNA generated no apparent protein product (Figure 1C). To test the coding potential of NC1 and NC2 
in intact cells, we transfected HeLa cells with the respective plasmids along with the canonical EFNA3 
cDNA (EFNA3) (Figure 1D). Neither NC1 nor NC2 caused the expression of exogenous protein that 
could be recognized by the monoclonal or polyclonal antibody against EFNA3. Thus NC1 and NC2 can 
be considered novel long non-coding RNAs (lncRNAs). In addition to the novel TSS, a method using 
support vector machine for poly(A) site prediction (Cheng, Miura, & Tian, 2006) identifies two 
potential 3'-ends for this locus (Supplementary Figure 2, “Poly(A) Sites” track). In agreement, analysis 
of Paired-end diTag (PET) Sequencing data from ENCODE (Ng et al., 2005) indicates that all 
combinations of the TSSs and 3’-ends are present in cells (Supplementary figure 2, “GIS-PET” track). 
Thus, both NC1 and NC2, can be expressed as shorter forms with a truncated 3'UTR, which we termed 
NC1s and NC2s respectively (Figure 1B).  
We next investigated the regulation by hypoxia of the different transcripts encoded by the EFNA3 
locus. First, we used commercially available TaqMan probes to amplify the regions of the EFNA3 gene 
specific to the canonical EFNA3 mRNA (TaqMan1+2, Figure 1E) and a region common to all the RNA 
isoforms encoded by this locus (TaqMan4+5, Figure 1E). qPCR results indicate that the absolute 
expression levels and relative induction in response to hypoxia varied widely between RNA species 
(Figure 1E). The expression of the canonical coding isoform was low, compared to the combined 
expression level for all isoforms, suggesting that under normoxic conditions the transcription of the 
long non-coding RNAs predominates. This result was confirmed by the ENCODE genome-wide 
transcription analysis (Supplementary Figure 2, “Transcription” track). Strikingly, the canonical 
EFNA3 isoform was barely induced in response to hypoxia, in stark contrast with the robust 
upregulation of the bulk of EFNA3 RNAs (Figure 1E). This result suggested that the lncRNAs, but not 
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the canonical mRNA, were regulated by hypoxia. To confirm this possibility, we designed primer pairs 
for all the exons in the gene to determine the response to hypoxia of every potential RNA isoform. 
Indeed, hypoxia strongly upregulated the novel lncRNA isoforms, while the regulation of the canonical 
protein-coding mRNA was only marginal (figure 1F). Importantly, the induction of EFNA3 transcripts 
in response to hypoxia was mediated by HIF as it was blocked by siRNA directed against HIF1α 
(Figure 1G, Supplemntary Figure 3). To investigate the regulation of  EFNA3 by HIF in vivo, we 
employed conditional VHL knockout mouse lines (Miró-Murillo et al., 2011). VHL deletion results in 
constitutive HIF activity and, consistently with the in vitro results, this led to increased EFNA3 lncRNA 
expression without significantly altering the level of the coding EFNA3 mRNA (Figure 1H). 
Importantly, the induction of EFNA3 upon VHL loss was partially prevented in animals lacking both 
VHL and EPAS (HIF2α) alleles (Figure 1H), suggesting that the in vivo HIF2α mediates the effect of 
VHL, at least in the liver and the lung. Regardless the specific HIF isoform involved, that could just 
reflect their differential tissue expression, it is clear from these set of results that EFNA3 expression is 
induced, both in vitro and in vivo, in response to hypoxia, in a HIF-dependent manner. 
Mounting evidence indicates that lncRNAs are key regulators of gene expression that affect the mRNA 
transcription rate, stability and translation (Nie et al., 2012; Yoon, Abdelmohsen, & Gorospe, 2012). 
Thus, in an attempt to reconcile the induction of Ephrin-A3 protein with the regulation of coding and 
non-coding transcripts by hypoxia, we tested whether NC1 and NC2 lncRNAs could affect EFNA3 
mRNA or protein levels. As shown in Figure 2A, the overexpression of the lncRNAs had no significant 
effect on EFNA3 mRNA levels. However, exogenous expression of NC1/2, particularly the short 
isoforms (NC1s and NC2s), caused EFNA3 protein accumulation (Figure 2B, 2C and data not shown). 
These results provide an explanation for the induction of EFNA3 protein under hypoxia in spite of its 
modest effect on EFNA3 mRNA level. 
 
9 
HIF binding to an intragenic regulatory region induces the transcription of EFNA3 lncRNAs 
and, indirectly, regulates Ephrin-A3 expression postranscriptionally 
The different transcription start sites of the EFNA3 isoforms suggested the existence of alternative 
promoters. In agreement, histone modifications landscape, location of the open chromatin and 
transcription factor binding site (TFBS) regions in the EFNA3 locus (Figure 3A) were consistent with 
the existence of two promoter regions (Figure 3A, Prm1and Prm2). To further investigate the regulation 
of the different EFNA3 transcripts, we analyzed the binding of RNA polymerase II (Pol II) to these 
putative promoter regions. As controls, we also included the promoter regions of a bona fide hypoxia 
inducible gene (P4HA) and a non-responsive gene STT3A. ChIP-qPCR analysis showed that Pol II 
bound to both regions of the EFNA3 gene locus under normoxia (Figure 2B). Consistent with the 
relatively low EFNA3 expression in HeLa cells, the binding of Pol II to the EFNA3 promoter regions 
was lower than its binding to the P4HA and STT3A promoters. Importantly, Pol II binding to the Prm2 
region was strongly induced by hypoxia (Figure 3B), to a level comparable to the HIF-responsive 
promoter of P4HA. In contrast, the Pol II binding to the Prm1 region and to the STT3A promoter 
remained unaffected by hypoxia (Figure 3B).  
Next, we investigated direct binding of HIF1α to the EFNA3 locus by ChIP-qPCR. We designed six 
primer sets  (Figure 3A, H1-H6) to sample most of the RCGTG motifs (Figure 3A, “RCGTG motifs” 
track) within EFNA3 locus and found that the only fragment that showed, significant HIF binding 
under hypoxic conditions was H6 (Figure 3C). Interestingly, H6 region is close proximity to Prm2, 
which could explain the differential response of promoter regions 1 and 2 to hypoxia. 
Finally, we cloned both EFNA3 promoter regions and studied their response to hypoxia and to the 
chemical inhibitor of HIF prolyl hydroxylase, DMOG, which causes acute HIF activation. Although 
both regions showed similar basal promoter activity (data not shown), Prm2 was strongly induced by 
hypoxia and DMOG, whereas Prm1 remained unaffected (Figure 3D). Importantly, Prm2 response to 
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hypoxia was critically dependent on one of its RCGTG motifs whose mutation completely abrogated 
hypoxic induction (figure 3D). 
 
HIF activation correlates with EFNA3 expression in human tumors 
Over 80% of human clear cell renal cell carcinomas (ccRCC) samples are deficient for VHL function 
and, as a consequence, present constitutive HIF activity even in the presence of oxygen (Kaelin, 
2007). Thus, ccRCC is highly suitable to study a putative link between HIF and EFNA3 in human 
tumors. In agreement, the expression of EGLN3, a well-characterized direct target of HIF, was clearly 
increased in the three independent ccRCC tumor series (Figure 4A). Similarly, EFNA3 was 
significantly increased in ccRCC tumor cells as compared with the normal kidney tissue in the same 
series, regardless of the microarray platform used to assay tumor samples (Figure 4B). The probes used 
to determine EFNA3 expression in these datasets bind to regions common to all transcripts from this 
locus (see materials and methods) and thus they detect the cumulative signal by the mRNA and 
lncRNA transcripts. However, since the expression of lncRNAs was much higher than that of EFNA3 
mRNA in all cell types and tissues  tested so far (Figure1, Supplementary Figure 2 and data not shown), 
we assume that the microarray signal is largely generated by the lncRNA. We also examined the 
expression of two other EFNA family members, EFNA1 and EFNA4, whose coding genes flank the 
EFNA3 locus in mammalian genomes. Interestingly, EFNA1, but not EFNA4, is induced by hypoxia 
((Yamashita et al., 2008), and data not shown). Concordantly, the expression of EFNA1, but not that 
of EFNA4, is clearly increased in ccRCC (Figure 4). These results rule out that the increased EFNA3 
expression observed in these tumors could be caused by a gross structural alteration or transcriptional 
deregulation of the genomic region containing the EFNA3 gene and suggest it is due to increased HIF 
activity as it correlates with the changes observed for other hypoxia regulated genes.  
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EFNA3 promotes metastatic behavior by enhancing extravasation of tumor cells 
Since hypoxia is a common condition in solid tumors that correlates with metastatic potential (Vaupel 
& Mayer, 2007) and some ephrin family members have been implicated in the promotion of 
metastatic behavior (Surawska et al., 2004), we next studied the metastatic potential of MDA-MB-
231 cells engineered to express luciferase and EFNA3 in an orthotopic xenotransplantation model. At 
five weeks after tumor inoculation, the total photon flux was significantly higher in most animals 
bearing EFNA3-positive tumors, compared to controls (Figure 5A and 5B). Importantly, the 
luminiscence signal in EFNA3 animals was not restricted to the original injection site but diffused 
throughout the abdominal area, suggesting metastatic spread rather than increased primary tumor 
growth. In agreement, the volumes of the primary tumors did not differ significantly between groups at 
the end of the experiment (Figure 5C) and necropsies confirmed that 7 out of 8 of the animals injected 
with EFNA3-positive cells presented with metastases as opposed to 1 out of 7 in control group (Figure 
5D). Most metastases were located in the peritoneal cavity, attached to the surface of internal organs 
(Figure 5E). The increased metastatic potential of the expressing cells was confirmed in another model 
where the same cells were injected via the tail vein to generate experimental lung metastases 
(Supplementary figure 4). 
Importantly, the microvascular density, as determined by analysis of CD31 staining, was similar 
between the EFNA3-positive and negative tumors (Figure 5F). Thus, the increased metastatic potential 
of EFNA3-expressing cells was not due to increased vascular density. Ephrins, through their receptors, 
mediate attraction and repulsion signals between cells (Nievergall et al., 2012). This function could 
enable tumor cells entry and exit from blood vessels and in this way increase their metastatic potential. 
To test this possibility, we plated HEK293T cells, transiently transfected with plasmids encoding 
EFNA3, on top of the HUVEC cells grown as a cell monolayer and measured the ability of HEK-
EFNA3 cells to pass through HUVEC monolayer and attach to the plastic surface below. As shown in 
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Figures 6A and 6B, the number of GFP-positive cells attached and spread on the plate was significantly 
higher when EFNA3 was expressed. This result is consistent with EFNA3 transducing a repulsive 
signal to HUVECs that allowed HEK293 cells to transmigrate through the monolayer. In agreement, 
recombinant Ephrin-A3-Fc blocked the directional migration of HUVEC cells induced by the 
conditioned media from NIH 3T3 cells (Figure 6C).  
These data suggest a mechanism for the increased metastatic potential of the tumors cells expressing 
EFNA3 whereby they can efficiently intravasate and extravasate through the vascular wall. To 
investigate this possibility in vivo, we injected MDA-MB-231 cells in the tail vein of immune defficient 
mice and assessed the appearance of the individual tumoral cells in the lungs in a short-term assay. 
Although the numbers of circulating tumor cells two hours after injection, were similar in the control 
and experimental groups, seven days later the GFP signal was much higher in the animals injected with 
EFNA3-expressing cells (Figures 6D and 6E). Therefore, EFNA3 facilitates metastasis, at least in part, 
by allowing the extravasation of the tumor cells from the vasculature. 
In view of these results, we next analyzed the correlation between EFNA3 expression and the risk of 
metastases in breast cancer patients. To this end, we made use of the public access datasets of human 
breast cancer gene expression and associated clinical data from the ROCK website (Online Breast 
Cancer Knowledgebase, http://www.rock.icr.ac.uk/) (Sims et al., 2010). We categorized patient 
samples according to EFNA3 expression level (high vs. low) and analyzed the incidence of metastasis 
over time in both groups (Figure 7). In agreement with the results of the animal studies, the risk of 
metastatic disease was significantly higher in patients whose primary tumors expressed higher levels of 
EFNA3 (Figure 7).  
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DISCUSSION 
The majority of known HIF targets are regulated by direct induction of coding mRNA. In this study, 
using Ephrin A3 as an example, we demonstrate a completely novel way of hypoxic regulation of gene 
expression whereby the changes in the coding mRNA are only marginal. Instead, HIF directly regulates 
the levels of long non-coding (lnc) RNAs, which, in turn, increase protein levels. Further work is 
needed to determine whether this effect is caused by increased translation or reduced protein turnover, 
however one recent report describes lncRNA that affects Uchl1 protein levels by enhancing mRNA 
translation of the coding mRNA (Carrieri et al., 2012). In fact, lncRNAs have been shown to regulate 
virtually every step of the gene expression cascade from transcription to translation (Nie et al., 2012; 
Yoon et al., 2012). Interestingly, some non-coding transcripts act in concert to regulate the expression 
of coding mRNAs. For example some lncRNAs act as decoys for the miRNA that target a particular 
mRNA (Yoon et al., 2012). It is known that miR-210, which is induced by hypoxia (Huang et al., 
2009; Kulshreshtha et al., 2007), prevents the translation of several mRNA including ISCU and 
EFNA3 (Chan et al., 2009; Fasanaro et al., 2008; Favaro et al., 2010; Huang, Le, & Giaccia, 2010). 
Since miR-210 binds the 3'-UTR of the EFNA3 mRNA (Fasanaro et al., 2008), it is feasible that 
EFNA3 lncRNAs increase EFNA3 mRNA translation by depleting miR-210. However, the fact that 
shorter isoforms, NC1s and NC2s are more efficient in the induction of Ephrin-A3 than the long ones 
(NC1 and NC2), argues to the contrary because the miR-210 binding sites are not represented on the 
shorter lncRNAs isoforms, NC1s and NC2s Supplementary Figure 2). In agreement, we found that 
expression of truncated forms of NC1 and NC2, lacking all the sequences corresponding to the 3'-UTR, 
were also able to increase Ephrin-A3 protein levels (data not shown). Our study and reports by other 
groups (Fasanaro et al., 2008; Larsen, Muz, Khong, Feldmann, & Paleolog, 2012) suggest that 
EFNA3 response to hypoxia is tightly controlled. 
Regarding the mechanism responsible for the selective transcription of specific EFNA3 isoforms, we 
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found that it is mediated by discriminatory recruitment of HIF and RNA pol II to the Prm2 promoter 
region. Interestingly, the presence of CTCF binding sites flanking EFNA3 Prm2 region (Supplementary 
Figure 2) offers a plausible explanation for the preferential transcriptional activation of the lncRNA by 
HIF and the lack of the regulation of the canonical coding isoform. Other studies also demonstrate the 
role of insulators in determination of HIF specificity for promoters located in the close proximity 
(Tiana et al., 2011).  Also regarding the molecular mechanism, we found that in vitro EFNA3 
induction was dependent on HIF-1α and not affected by HIF-2α knockdown whereas in animal models, 
EPAS1 was required for EFNA3A induction upon VHL loss. Thus, HIF isoforms responsible for 
EFNA3 may be context-dependent and could be dictated by availability of a specific HIF isoform, or 
another, HIF cell-type specific transcription factor(s), that favor interaction with a specific HIF 
isoform. Nonetheless, this has been observed for other hypoxia-regulated genes. For instance, the 
hypoxic regulation of another ephrin, Ephrin-A1, also requires HIF1 α  (Vihanto et al., 2005) in cell 
cultures, but not in vivo, where it is dependent on HIF-2α (Yamashita et al., 2008). 
An important question arising from our results relates to the role of Ephrin-A3 in the physiological 
response to hypoxia. The induction of angiogenesis is one of the classical responses to hypoxia and 
other ephrins play key roles in angio- and vasculogenesis. However, we did not find a significant effect 
of Ephrin-A3 expression on tumor vascular density as determined by CD31 staining. Although we 
cannot rule out effects on other vascular parameters like maturation or normalization of tumor 
vasculature, our results demonstrate a direct role of Ephrin-A3 on tumor cell intra-/extravasation that 
could underlie the pro-metastatic action of this ephrin. Earlier studies showed that Ephrin-A3 
overexpression prevents the in vitro formation of capillary-like structures by HUVE cells  (Fasanaro et 
al., 2008; Xiao et al., 2013). We similarly found that recombinant Ephrin-A3-Fc prevents the 
migration of HUVECs in vitro, however these in vitro effects did not manifest in the in vivo models.  
Regardless of their physiological role, ephrins are frequently co-opted by the transformed cells 
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whereby they contribute to the changes in cell-cell and cell-matrix attachment and survival during 
invasion, angiogenesis and metastasis (Chen, 2012b; Nievergall et al., 2012). In agreement, we found 
that the expression of Ephrin-A3 in MDA-MB-231 breast cancer cells increased their metastatic 
potential. The significant correlation that we found between high EFNA3 levels and metastasis in 
clinical samples strongly supports this conclusion. Also in agreement with our findings, a recent study 
demonstrate the differential expression of Eprin-A3 between the highly metastatic and poorly 
metastatic colon cancer cells (Barderas et al., 2013). Although we have not formally demonstrated it, 
it is tempting to speculate that the correlation of hypoxia with metastasis risk observed in human 
tumors is, at least in part, explained by the induction of Ephrin-A3 downstream of HIF activation due 
to the tumor hypoxia or oncogenic alterations. As for the mechanism, our results suggest that Ephrin-
A3 promotes metastasis by repelling vascular endothelium and therefore creating points of intra- and 
extravasation for the tumor cells. Similar events are caused by angiopoietin-like 4 (ANGPTL4), 
another hypoxia-inducible gene, to promote metastasis (Zhang et al., 2011). 
In summary, we demonstrate a novel mechanism of hypoxic regulation, where EFNA3 expression is 
driven by previously non-annotated intragenic lncRNAs whose transcription is controlled by HIF. We 
propose that in hypoxic regions of solid tumors or in tumors harboring genetic alterations leading to 
constitutively active HIF, this novel mechanism leads to Ephrin-A3 accumulation and the promotion of 
metastasis.  
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MATERIALS AND METHODS 
Cell culture 
Cells were grown in standard culture conditions. For hypoxia treatments, cells were placed in a 1% O2, 
5% CO2, 94% N2 gas mixture in a Whitley hypoxystation (don Whitley Scientific, UK). 
Dimethyloxalylglycine (DMOG, Frontier Scientific, CA, USA) was added where indicated at a 500 μM 
final concentration. MDA-MB231-EphrinA3-Luc and MDA-MB231-Luc cells were generated by 
infection with pLOC-EFNA3 or pLOC lentivirus respectively and then reinfected with Lenti-Fire 
Luciferase Luc2 (CellCyto) lentivirus. 
 
ChIP (chromatin immunoprecipitation) 
ChIP was performed as previously described (Villar et al., 2012) with minor modifications. Briefly, 
EZ Chromatin Inmunoprecipitation Kit (Millipore) was used following the manufacturer's instructions. 
HeLa cells were grown to 85% confluence on 10 cm plates before they were exposed to hypoxia or left 
in normoxic conditions. Chromatin was immunoprecipitated with antibodies against RNA Polymerase 
II (Abcam 5408) or Hif1a (Abcam, ab2185). Mouse IgG (Sigma M8695) or whole rabbit serum were 
used as negative controls. DNA was purified by phenol–chloroform extraction and ethanol precipitation 
and bound regions were identified by qPCR with indicated primer pairs (supplementary Table I). 
 
Repulsion assay 
HUVE cells were stained with 10μmoles/106 cells of a membrane labelling reagent PKH26 (Sigma), 
seeded into a 24 multi-well plate (1X10 cells/well) and allowed spread to form a cell monolayer 
overnight. Then HEK-293T cells, expressing GFP alone or in combination with Eprhrin-A3, were 
plated on top of the HUVEC (3000 cells/well) and mixed cell culture followed over time.  
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Orthotopic tumor implantation and extravasation assays. 
Tumor studies were performed on 5–7 week-old female nude mice (Harlan) according to the protocols 
in accordance with the NIH Guide for the Care and Use of Laboratory Animals. MDA-MB-231-Luc 
and  MDA-MB-231-EphrinA3-Luc cells were harvested by trypsinization, resuspended in PBS and 
injected into the mammary fat pad (10 per site, one site per mouse) of immune deficient mice in a 1:1 
mix  with Matrigel (BD Biosciences). The animals were subjected to weekly bioluminescence imaging 
in an IVIS Spectrum System (Caliper, Xenogen) to monitor tumor progression and metastasis. The 
mice were given intraperitoneal injections of D-luciferin (15 mg/ml in PBS), 5 min prior to imaging. 
Tumors, lungs, bones and livers were harvested after 9 weeks and processed for tissue analysis. 
Primary tumor volumes were calculated as length x width2 x 0.52. For the extravasation assays cells 
were injected into the tail vein. Extravasation of cells was monitored by confocal images of whole fresh 
lungs.  
 
Gene expression profile analysis 
Gene expression data and relevant sample information were downloaded from the Gene Expression 
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and ROCK (http://www.rock.icr.ac.uk/) databases 
(free public access) and analyzed using custom scripts written in R language. 
 
Statistical Analysis 
Statistical analysis and graphic representations were performed in R, a language and environment for 
statistical computation and graphics (R Core Team, 2010). 
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FIGURE LEGENDS 
Figure 1. Hypoxia regulates EFNA3 expression. (A) Ephrin-A3 protein level was determined in 
HeLa, HUVEC, MCF-7 and MDA-MB231 cells were exposed to normoxia (21% oxygen) or hypoxia 
(1% oxygen) for the indicated periods of time. (B) Diagram of the EFNA3 locus showing the canonical, 
NM_004952 RefSeq, gene (upper track, EFNA3) and the novel isoforms (second track from the top, 
N1-NC2s). The bottom tracks show the position of the qPCR oligonucleotides employed in figures 2D-
2G (black boxes) and target regions (thin lines). The figure was generated by the UCSC genome 
browser upon loading the indicated custom tracks. (C) cDNAs corresponding to EFNA3, NC1 or NC2 
isoforms were transcribed and translated in vitro in the  presence of 35S-methionine and proteins 
resolved by SDS-PAGE. Image shows the autoradiogram of a representative experiment. (D) HeLa 
cells were transfected with plasmids encoding for the indicated EFNA3 isforms and cell lysates probed 
with monoclonal (MAb) or polyclonal (PAb) antibodies against the C-terminal region of human 
Ephrin-A3. (E) HeLa cells were exposed to 1% oxygen (Hyp) or left at normoxic conditions (Nx) for 
12h and EFNA3 RNA levels were determined using the indicated TaqMan probes (see panel B). The 
graph shows the ratio of EFNA3 to ACTB (beta-Actin) copy number. Bars represent the mean of three 
independent biological replicates and the error bars the standard deviation. The differences between 
groups were statistically significant (ANOVA F3,8=34.21, p<0.001) and the asterisks indicate means 
pairs that were the statistically significant (adjusted p <0.001) in a posteriori Tukey test. (F) Cells were 
treated as in E and EFNA3 RNA levels were determined using the indicated primer pairs (see panel B). 
The graph shows the ratio of hypoxic EFNA3 RNA to the expression in normoxia. Symbols represent 
the mean of three independent biological replicates and the error bars the standard deviation. (G) HeLa 
cells were treated with the indicated siRNAs and then grown at normoxic (21% oxygen, Nx) or 
hypoxic (1% oxygen, Hyp) conditions for 12 hours. The graph represent the normalized levels of 
EFNA3 mRNA as fold over control conditions (normoxic cells treated with scramble siRNA). Bars 
24 
represent average values in four independent biological replicates and error bars the standard deviation. 
The differences between groups were statistically significant (ANOVA F7,48=23.52, p<0.001) and the 
asterisks indicate means pairs that were the statistically significant (***, adjusted p <0.001) in a 
posteriori Tukey test. (H) Vhlfl/fl-UBC-Cre-ERT2 (n = 5), Vhlfl/flHIF2αfl/fl-UBC-Cre-ERT2 (n=3) 
and control ( n=11) mice were placed on a tamoxifen diet for ten days followed by ten additional days 
on a normal diet. The box-and-whisker plot represents the distribution of the normalized EFNA3 
mRNA expression in the liver of animals with the indicated genotypes. The box contains the values 
comprised between the second and third quartiles, and the horizontal black line the median. The 
“whiskers” extent to 1.5 times the interquartile range. The differences between groups were statistically 
significant (ANOVA F2,18=20.49, p<0.001) and the asterisks indicate means pairs that were the 
statistically significant (adjusted p <0.001) in a posteriori Tukey test. 
 
Figure 2. lncRNA expression results in increased EFNA3 protein levels. HeLa cells were 
transfected with constructs encoding for the indicated lncRNAs or empty plasmid (pLOC) and the level 
of the canonical EFNA3 mRNA (A) and protein (B and C) were determined by qPCR and immunoblot 
respectively. The graph in A represents the level of the NM_004952 mRNA, determined with primers 
Exon1+2 (Figure 3A), as a fold over the level found in untreated cells. Bars represent the mean of five 
independent biological replicates and the error bars the standard deviation. The differences between 
groups were not statistically significant (ANOVA F4,20=1.452, p=0.254). The graph in C represents the 
level of Ephrin-A3 as the ratio of the Ephrin-A3 band intensity corrected by the Actin band intensity in 
three independent experiments. The differences between groups was statistically significant (ANOVA 
F5,11=8.635, p<0.01) and the asterisks indicate sample means that were was significantly different from 
controls (pLOC samples) in a posteriori Tukey test (*, adjusted p < 0.05; **, adjusted p < 0.01). The 
image in B is representative of at least three independent experiments.  
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Figure 3. lncRNAs encoded by the EFNA locus are transcribed from an alternative hypoxia-
responsive promoter. (A) diagram depicting the EFNA3 locus and showing the NM_004952 RefSeq 
gene (“EFNA3” track) along with accessible chromatine regions (“DNase clusters track”), histone 
marks associated to promoters (“Layered H3K4Me3” track) and active regulatory elements 
(“H3K27Ac Track”). The colors in the histone tracks correspond to the signal obtained in different cell 
lines (see UCSC for details). The figure was generated by the UCSC genome browser upon loading  
custom tracks to indicate the location of primer and amplicons used in the RNA pol II (P1 and P2) and 
Hif1a (H1-H6) ChIP-qPCR experiments as well as the regions cloned to assay their promoter activity 
(“promoters” track). (B, C) HeLa cells were exposed to 21% or 1% oxygen for 8 hours and RNApol-II 
(B) or Hif1a (C) binding to the indicated regions of the EFNA3 locus was determined by ChIP-qPCR. 
Binding to the P4HA and STT3S promoters were used in the RNApol II ChIP experiment as positive 
and negative controls respectively. In the case of Hif1a ChIP, the EGLN3 enhancer region (E3_E) and 
EGLN3 promoter region (E3_P) were used as positive and negative controls (Pescador et al., 2005). 
The graphs show the amount of precipitated material as a percentage of the input (%Enrichment). Bars 
represent the mean of three (B) or just one (C) independent biological replicates and the error bars the 
standard deviation. The differences between groups were statistically significant (ANOVA F15,69=15.6, 
p<0.001; ANOVA F31,32=39.99, p<0.001) and the asterisks indicate means pairs that were the 
statistically significant (adjusted p <0.001) in a posteriori Tukey test. (D) The effect of hypoxia (white 
bars) and DMOG (black bars) on the transcriptional activity of the promoter regions 1 and 2 was 
assessed by reporter assays upon transfection of the indicated constructs into HeLa cells. White boxes 
within the promoter 2 (Prom2) diagram represent RCGTG motifs and crossed boxes represent deleted 
RCGTG motifs.  The graph shows the normalized luciferase activity in hypoxic (Hyp) or DMOG-
treated (DMOG) samples expressed as fold over the activity obtained in normoxic conditions. Bars 
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represent the mean of three (B) independent biological replicates and the error bars the standard 
deviation. The differences between groups were statistically significant (ANOVA F4,10=21.9, p<0.001) 
and the asterisks indicate means pairs that were the statistically significant (*, adjusted p < 0.05; **, 
adjusted p < 0.01) in a posteriori Tukey test. 
 
Figure 4. EFNA3 expression is induced in human renal clear cell carcinomas (RCC). The 
expression of EGLN3, EFNA3, EFNA1 and EFNA4 (columns) was determined in publicly available 
gene expression profiles of ccRCC samples from three independent studies (ID shown on the left 
margin of each row). Graphs represent the expression of the indicated genes in arbitrary units 
(normalized microarray intensity values). The individual samples are shown and pairs of tumoral and 
normal kidney tissue are joined by segments. Graphs in each row represent the data from an 
independent study. The statistical significance of mean differences in indicated on top of each graph 
(paired student's t test). 
 
Figure 5. EFNA3 overexpression increases metastasis formation in a spontaneous metastasis 
assay. MDA-MB-231 cells were engineered to stably express luciferase alone (pLOC) or in 
combination with EFNA3 (EFNA3). Then cells were orthotopically injected into the mammary fat pad 
of nude mice and tumor growth followed by non-invasive whole body bioluminescence imaging (BLI). 
(A) BLI image of mice at end time point (5 weeks). (B) Luminiscence signal during the course of the 
experiment. The graph represents the luciferase signal (total flux) in photons/second x108. (C)  Tumor 
volume was determined at five weeks. The boxplot represents the distribution of volume in each group. 
The differences between controls and EFNA3-expressing tumors was not significant (independent 
samples t test: t12=-1.5373, P=0.1499). Animals were euthanized and tissues processed for H&E staining 
(D,E) or immunostaining (F,G). (D) The box-and-whisker plot represents the distribution of the number 
27 
of macroscopic metastasis per mice identified by visual inspection during necropsy. The difference 
between groups was statistically significant (independent samples t test: t7=2.5923, P<0.05). (E) 
Representative H&E staining images at 10x (left) and 40x (right) magnification (F) Blood vessels were 
stained with an antibody against human CD31 and cell nuclei with DAPI. The CD31 signal was 
normalized to cellularity (DAPI staining). The graph represents the distribution of normalized values. 
Differences between groups was not significant (independent samples t test: t10=1.0522, P=0.3182) (G) 
Representative images of CD31 and DAPI staining. 
 
Figure 6. EFNA3 expression results in repulsion of HUVEC cells and promotes extravasation. 
(A,B) HEK293 cells were transiently transfected with a plasmids encoding for GFP and EFNA3 
(“EFNA3”) or GFP alone (“Vector”) and then plated on top of a monolayer of HUVEC cells previously 
labeled with a red fluorochrome. (A) Representative images of cells 2h and 24h after plating HEK293 
cells on top of the HUVEC monolayer. (B) The graph represents the proportion of GFP-positive cells 
attached to the plastic surface and spreading at 24h. The differences between cells expressing EFNA3 
and cells transfected with GFP alone was statistically significant (2x2 contingency table: χ21=67.52, 
p<0.001). (C) HUVEC migration was determined using NIH conditioned media (NIH_CM) as 
chemoattractant in the absence or presence of 0.2, 1 or 5 microgr/ml of recombinant Ephrin-A3 fused 
to the Fc region of immunoglobulins (EphrA3). The graph represents the average number of migrated 
cells per field in a single experiment and error bars the standard deviation. The experiment was 
repeated three independent times with similar results. The differences among treatments was 
statistically significant (ANOVA F7,178=47.17, p<0.001) and the asterisks indicate means that were the 
statistically significant to the NIH-conditioned media treatment (***, adjusted p < 0.001) in a 
posteriori Tukey test. (D,E) MDA-MB-231 cells stably expressing GFP alone or in combination with 
EFNA3 were injected in the tail of nude mice. After the indicated periods of time, mice were 
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euthanized and lungs were examined by confocal microscopy for the presence of GFP-positive cells. 
The boxplot represents the distribution of total GFP signal normalized to lung area in each group of 
mice. Results from two independent experiments were pooled. The differences between the two groups 
was statistically significant (Student's  t-test t(3) = -4.44, p<0.05). 
 
Figure 7. High levels of EFNA3 correlate with metastasis in human tumors. Gene expression 
profiles from the indicated series of breast cancer tumors (Loi2008, (Loi et al., 2008); Pawitan2005, 
(Pawitan et al., 2005); Ur-Rehman, www.rock.icr.ac.uk/; vandeVijve, (van de Vijver et al., 2002)) 
were downloaded from the ROCK database (www.rock.icr.ac.uk/). Samples were categorized 
according to EFNA3 expression into high (samples with EFNA3 expression in the top quartile of the 
series, labeled in red) and low expression (rest of samples in the serie, labeled in blue) and the 
Kaplan−Meier estimate of the distant metastasis free survival (DMFS) over time calculated (graphs). 
The survival of the two groups was compared using a Cox proportional hazards model, the p-values are 
indicated in the graphs. The probes used in the gene profiling assays are indicated in brackets in the 
graph title.  
 







Supplementary Figure 1
EphrinA3 migrates as a ~72kD band in SDS-PAGE due to postranslational modifications.
EFNA3 mRNA levels were low in all cell types tested and, accordingly, the immunoblot detection of
Ephrin-3A proved difficult. However, Ephrin-A3 migrates with an apparent molecular weight of about
72kD (figure 1C and supplementary figure 1A), much higher than the hypothetical size of 26.3kD
predicted from its amino acid sequence. Thus, to confirm the identity of the protein recognized by the
antibody,  we treated  cells  with  a  siRNA directed  against  EFNA3 and  found that  it  decreased  tha
intensity  of  the  high  molecular  band  specifically  (A and  B).  Type  A Ephrins  undergo  several
postranslational modifications, including the addition of a GPI moiety and glycans, that could account
for  its  high  apparent  mass.  In  agreement,  overexpression  of  EFNA3 cDNA also  resulted  in  high
molecular weight bands (A). Moreover, treatment of cell lysates with N-glycosidase, resulted in the
depletion of the endogenous ~72kD bands and generation of a faster migrating band.  Note that the
intensity of the ~50kD band generated by the enzymatic treatment is much higher than that of the
corresponding 72kD bands, probably due the exposure of the antigenic determinants after the removal
of the oligosaccharide chains, as has been shown for other postranslational modifications  (Bütikofer,
Malherbe, Boschung, & Roditi,  2001) (C). Finally, we used a recombinant form of EphA5 (a high
affinity receptor for Ephrin-A3) fused to the immunoglobulin Fc fragment to pull down endogenous
Ephrin-A3 from cell lysates. As shown in panel D, the Ephrin-A3 forms that co-precipitated with the
EphA5-Fc migrate as a ~72Kd bands. Altogether these results indicate that Ephrin-3A is detected as
~72Kd bands in SDS-PAGE gels due to postranslational modifications.
Figure legend
(A) HeLa cells were transfected with a plasmid encoding EFNA3 (pEFNA3) or siRNA directed against
EFNA3 and 48h postransfection EFNA3 proteins levels were determined by inmmunoblot. To allow
comparison in the same membrane, different amounts of cell lysate were used to detect the endogenous
and exogenous proteins. MWM, molecular weight markers, the cross-reactivity band correspond to the
75kD marker.  (B) HeLa cells were transfected with scramble siRNA (-) or siRNA directed against
EFNA3  and then grown at 21% (Nx) or 1% oxygen (Hyp) for 12 hours.  Duplicated samples were
processed to determine EFNA3 mRNA (upper graph) or protein (lower panels) levels. (C) HeLa cell
lysates were incubated at 37ºC (+) or 0ºC (-) in the presence (+) or absence (-) of N-glycosidase and
then resolved by SDS-PAGE and probed with anti-EFNA3 antibodies.   (D) HeLa cells lysates were
incubated with recombinant Fc-EphA5 receptor or Ig Fc fragments. Recombinant contructs were pulled
down with protein A-sepharose and coinmunoprecipitating material was resolved by SDS-PAGE and
probed with anti-EFNA3 antibodies.
Supplementary Figure 2
EFNA3 locus encodes for several transcripts expressed from two different promoter regions. 
The 5'-ends of the EFNA3 transcripts was determined by rapid amplification of cDNA ends (RACE)
using the FirstChoice RLM-RACE kit (Applied Biosystems) according to manufacturer's instructions.
Total  RNA from HeLa and LoVo cells was used as template for 5'- RACE  reactions, the products
cloned into  pCR2.1 (Invitrogen)  and their  sequence  determined by Sanger  sequencing.  The figure
shows the position of the  RACE  products (“HeLa 5-RACE”) relative to the canonical NM_004952
RefSeq gene (EFNA3 track). The names indicate the location of EFNA3-specific primers used for the
PCR  amplification  of  RACE  products: AGAAGGCGCTGTAGCGCTGGAA  (Exon1  and  2)  ;
TTCCAGTGCAGGTTGTGAGT (Exon 3).
Similar results were obtained when RNA form LoVo cells was used as template (data not shown). 
In addition to our RACE results, the figure includes data from other sources as follows (tracks from top
to bottom). The “RNA Subcellular CAGE” track shows 5' cap analysis gene expression (CAGE) tags
from the ENCODE project and thus points to Transcription Start Sites (TSS) within this locus. Note the
tight correlation between our 5'-RACE results and those reported by ENCODE. To keep image size to a
minimum, in this and following tracks we only included information from cell lines used in our work
(HeLa, HUVEC and MCF7).    The “Transcription” track shows transcription levels for HeLa (green)
and HUVEC  (blue)  as assayed by high-throughput sequencing of polyadenylated RNA (RNA-seq).
Note that, in close agreement with our data (figure 2), the expression level of the first exon is below the
rest. This pattern is particularly pronounced in HUVEC were there is no detectable expression of the
first exon. The prediction of Poly(A) sites using a supported vector machine-based algorithm insicates
the existence of two different 3-end for this locus (“predicted poly(A) sites” track).  The next track
shows the result of Gene Identification Signature (GIS) paired-end ditag (PET) sequencing experiments
in HeLa cells. This technique provide signatures of the 5' start and the 3' end of individual mRNA
transcripts (Ng et al., 2005). The “Transcription Factor ChIP-Seq” track shows the CTCF binding sites
in  HeLa,  HUVEC and  MCF7 cells.  Note  that  the  HIF  binding  site  and  prom2 region  (figure  2)
identified in our work are flanked by strong CTCF-binding signal and thus probably isolated from other
regions of this locs and in particular de prom1 region. Finally, the “TargetScan miRBNA” track shows
the predicted binding sites (TargetScan) for several miRNAs one of them being miR210.
The figure was generated by the UCSC genome browser upon loading the indicated custom tracks.

Supplementary Figure 3
Efficiency of HIF1A and EPAS1 knock-down in HeLa cells
HeLa cells were treated with the indicated siRNAs and then grown at normoxic (21% oxygen, Nx) or
hypoxic (1% oxygen, Hyp) conditions for 12 hours and the levels of HIF1A (A) and EPAS1 (B) mRNA
were determined by qPCR. The graph represent the normalized levels of mRNA as fold over control
conditions  (normoxic  cells  treated  with  scramble  siRNA).  Bars  represent  average  values  in  four
independent biological replicates and error bars the standard deviation. The differences between groups
were statistically significant: (A) ANOVA F7,24=16.9, p<0.001; (B) ANOVA F7,20=17.58, p<0.001.
The asterisks indicate means pairs that were the statistically significant (***, adjusted p <0.001) in a
posteriori Tukey test.
Supplementary Figure 4
EFNA3 overexpression increases metastasis formation in an experimental metastasis assay.
MDA-MB-231 cells were engineered to stably express luciferase alone (pLOC) or in combination with
EFNA3 (EFNA3). Then cells were injected into the tail vein of nude mice and tumor growth followed
by non-invasive whole body bioluminescence imaging (BLI). (A) BLI image of mice at 9 weeks time
point. (B) Luminiscence signal during the course of the experiment. The graph represents the luciferase
signal (total flux) in photons/second.  (C)  The weight of the lungs was determined at the end of the
experiment, the boxplot represents the distribution of volume in each group. The differences between
controls and EFNA3-expressing tumors was significant (independent samples t test: t12=-2.696, p<0.05).

Methods
Deglycosylation 
25μg lysates were mixed with 1μl 10X deglycosylation buffer (5%SDS, 0.4M DTT) and H20 to a
10μl total reaction volume. The glycoprotein was denature at 100ºC for 10 minutes and incubated
for additional hour at 37ºC with 1μl PNGaseF (Biolabs, P0705S), in a total volume adjusted to 20μl
with 2μl of 10X G7 Reaction buffer (0.5M Sodium Phosphate pH 7.5), 2μl of 10%NP40.   The
deglycosylation was analyzed by westernblotting.
Rapid Amplification of cDNA Ends (RACE)
RACE was performed  with the  FirstChoice RLM-RACE Kit (Ambion) following manufacturer's
instructions and using the indicated specific primers. All PCR fragments of interest were cloned into
pCR2.1 vector (Invitrogen) and sequenced.
References
Supplementary Table I
TaqMan probes (Applied Biosystems) used in this study
Probe Name Reference
TaqMan 1+2 Hs00191913_m1
TaqMan4+5 Hs00900213_g1
EPAS1 Hs01026149_m1
HIF1α Hs00936368_m1
Actin 4326315E
Supplementary Table II
Oligonucleotides used in this study
Primer Name Assay Forward sequence 5'-3' Reverse sequence 3'-5'
H1 ChiP HIF1α CTTCTCCTTCCCCTCATTCC CAGGCTGAATTTCCCAGAAG
H2 ChiP HIF1α CGAGCACCTCCCTAGAAGGA CTCACCCTAGCCGGGCTTAT
H3 ChiP HIF1α TCCCCCCACCAAACCTATTC TTGGAGCACCTCAGCGTTCT
H4 ChiP HIF1α GAGGGTCTCTGCCCCTTG CCCCAGGTCTGTCAAAGGAG
H5 ChiP HIF1α GATGGCGAGGATTTGACAAGTT AAGACCAGGGAGTAGGGAAAGG
H6 ChiP HIF1α GGAAGCTCGGAGGAAAAGTC GAAGCGGCTCAGAGAGAAGA
EGLN3_E ChiP HIF1α GGTGTGCTCGGGTGTG CGTGGAGGACTGGCTCTAAG
EGLN3_P ChiP HIF1α ACGGGAGGCACTCGGAG CCCTTAACGTTGACTTTCGCTC
Prm1 ChiP Pol II CATGCGGTGTACTGGAACAG  GGATCCCCCAGGACTTCTC
Prm2 ChiP Pol II GGAAGCTCGGAGGAAAAGTC GAAGCGGCTCAGAGAGAAGA
P4HA ChiP Pol II GAGCCCGTTAGCCCTTTTAT GGTGTGATCGAGCTCACGTA
STT3 ChiP Pol II GAGCGCGGAAAGAACGTG FGCAAGGGCCTATTTCAGCGTA
Exon 1+2 qPCR CACTCTCCCCCAGTTCACCAT CGCTGATGCTCTTCTCAAGCT
Exon 4+5 qPCR AACCGGCATGCGGTGTA ATCCAGATAGTCGTTCACGTTCA
Coding EFNA3
(mouse)
qPCR TGGAACAGCTCCAATCAGCA GAGCTGTTGTAGTGCGGACA
Non-coding
(mouse)
qPCR AACCGGCATGCGGTGTA ATCCAGATAGTCGTTCACGTTCA
hnRNA1 qPCR ACTGGAACAGCTCCAACCAG GCTCTGGTCTCCCAGGACTC
hnRNA5 qPCR GGCACTGATACTTCCTACCCTG GGCACCTGAGGGTTCTCTCC
bACTIN
hnRNA
qPCR CCCAGCACAATGAAGATCAA GTGAGGACCCTGGATGTGAC
Exon 1 qPCR AGCTGGGAAGCGGAGAAG CTGGTTGGAGCTGTTCCAGT
Exon 2.1 qPCR CTGCGGCGAGAGGGCTA TGTAGTGCGGGCAGTAAATATCC
Exon 2.2 qPCR AAGCGCTGGGAGTGCAAC GTGGAACTCGTAGCCCAGAG
Exon 4 qPCR CATCGCACTCCGGGGAGAAG CACGTTGATCTTCACATTGGGG
Exon 5 qPCR GCTTGAGAAGAGCATCAGCG CTAGGAGGCCAAGAACGTCA
3UTR1 qPCR TCCTCCCATGGCTAGAAGTG GTCCACTACAGTGCCCTACG
3UTR2 qPCR GCAATAAGCACGTCCTCCTC CAGGGGGTTAAAGAGGGAAG
Prm1 Cloning CCTTGGTACCCCCGAGGGGGCAGTACGG CCTTCTCGAGCCCCGGAGCCGCC
GCCGCCG
Prm2 Cloning GAGAAGCGATGGAGGGTGT CACTCAGACTCTCGCGTTCA
NC 1 Cloning CGGACTAGTATGGTGAGCCGCAACGGCT
AC
CGGGGCGCGCCGACTAAGAGCAG
AGTATGAAAGTC
NC 2 Cloning CGGACTAGTGAGACCAGGGAGGAGGCGT
G
CGGGGCGCGCCGACTAAGAGCAG
AGTATGAAAGTC
11 HRE_mut Mutagenesis ACACCGTGCAGGTGAAACGACTATCTGG
AT
ATCCAGATAGTCGTTTCACCTGCA
CGGTGT
12 HRE_mut Mutagenesis GCGGGGCAGAGCAGTCTGTACATGGTGA
GC
GCTCACCATGTACAGACTGCTCTG
CCCCGC
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ABSTRACT
Hypoxia inducible factor (HIF) up-regulates the tran-
scription of a few hundred genes required for the
adaptation to hypoxia. This restricted set of
targets is in sharp contrast with the widespread dis-
tribution of the HIF binding motif throughout the
genome. Here, we investigated the transcriptional
response of GYS1 and RUVBL2 genes to hypoxia
to understand the mechanisms that restrict HIF
activity toward specific genes. GYS1 and RUVBL2
genes are encoded by opposite DNA strands and
separated by a short intergenic region (1 kb) that
contains a functional hypoxia response element
equidistant to both genes. However, hypoxia
induced the expression of GYS1 gene only.
Analysis of the transcriptional response of
chimeric constructs derived from the intergenic
region revealed an inhibitory sequence whose
deletion allowed RUVBL2 induction by HIF.
Enhancer blocking assays, performed in cell
culture and transgenic zebrafish, confirmed the
existence of an insulator element within this
inhibitory region that could explain the differential
regulation of GYS1 and RUVBL2 by hypoxia.
Hence, in this model, the selective response to HIF
is achieved with the aid of insulator elements. This
is the first report suggesting a role for insulators
in the regulation of differential gene expression in
response to environmental signals.
INTRODUCTION
A large number of biochemical reactions require oxygen
as a substrate and metazoa metabolism is largely depend-
ent on oxidative phosphorylation. At the cellular level,
the unbalance between oxygen demand and supply
(hypoxia) results in the activation of a speciﬁc gene
expression program aimed at increasing oxygen delivery
and reducing its consumption through metabolic
reprogramming. This transcriptional response is mostly
mediated by an evolutionarily conserved family of tran-
scription factors termed hypoxia inducible factors (HIFs),
that belong to the basic helix-loop-helix superfamily (1).
HIFs are heterodimers of a constitutive beta subunit
(HIFb also known as ARNT), that partners with several
factors and an alpha subunit (HIFa), whose stability (2)
and transcriptional activity (3) is regulated by oxygen.
Under hypoxia, HIFa subunits avoid degradation, bind
to the constitutively expressed beta subunits and the
heterodimers translocate to the nucleus where they bind
to the RCGTG motif within the regulatory regions of
target genes to promote their transcription (4–6). Several
works have identiﬁed individual HIF targets that, taken
together, account for the metabolic adaptation and induc-
tion of angiogenesis observed under hypoxia (7). To gain
insight into the full range of cellular adaptations to
hypoxia, several groups recently attempted the global
identiﬁcation of HIF-targets (5,6,8–11). Interestingly, all
these works coincide in that only a few hundred, out of all
the genes containing RCGTG motifs, are regulated by
hypoxia. Thus, as it is the case for other transcription
factors (12), HIF binds only to a small proportion of the
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potential binding sites (5,6,8–11). The basis for this select-
ivity is incompletely understood, but several mechanisms
have been proposed. Among them, the cooperation with
other transcription factors, have been well characterized in
some instances (13,14). In the case of HIF, requirement of
functional HNF-4 (15), AP-1 (16), GATA-2 (16) or ETS
(17,18) sites for proper hypoxic induction of selected
targets have been described. In agreement with these
single locus studies, global analysis of HIF binding sites
by means of experimental (5) and computational methods
(11) showed the existence of overrepresented transcription
factor binding sites (TFBS) in close proximity to the
hypoxia response element (HRE) that might account for
factors cooperating with HIF. However, the experimental
characterization of the role of these TFBS in the regula-
tion of HIF targets by hypoxia is yet to be determined.
Thus, the cooperation between HIF and other factors
could contribute to the target selectivity, but it is yet
unclear to what extent this mechanism explains the
observed pattern of targets.
A further mechanism that could dictate the target se-
lectivity is the accessibility to the TFBS. Histone modiﬁ-
cations alter the structure of chromatin and hence the
availability of the underlying nucleotide sequence for the
binding of transcription factors (19). In addition, DNA
methylation can preclude the binding of speciﬁc transcrip-
tion factors (20–22). In this regard, a recent study ad-
dressed the cell-type speciﬁcity in response to hypoxia
and concluded that only those loci that were transcription-
ally active under basal (normoxic) conditions were permis-
sive to HIF-regulation (8). However, although these
results explain most of the intercellular variation in the
hypoxic transcriptome, it is clear that an additional layer
of regulation is required, as only a small fraction of all the
active genes under basal conditions were induced by
hypoxia in any of the cell lines studied.
Finally, insulators are included among the regulatory
mechanisms employed by eukaryotes to ensure speciﬁc
patterns of gene expression and as such, they could be
involved in the selection of genes to be activated by HIF
in response to hypoxia. Insulators are deﬁned as DNA
elements that partition chromatin into independent tran-
scriptional domains, thereby contributing, in combination
with additional epigenetic mechanisms, to the tight
control of gene expression (23) and to the nuclear struc-
ture and dynamic organization (24). These elements have
been functionally described, according to their ability to
block the spread of heterochromatin (barrier function)
into adjacent loci and to prevent the promiscuous inter-
action of distal enhancers with proximal promoters, when
placed in between (enhancer blocking function) (25). The
role of insulators in the determination of linage-speciﬁc
patterns of gene expression is well characterized, as
illustrated in the chicken b-globin locus (26). However,
the participation of these elements in the target discrimin-
ation by acutely activated transcription factors, in
response to environmental factors, has not been reported.
Here, we investigate the mechanism that restricts HIF
activity toward speciﬁc genes by the study of a locus that
we consider paradigmatic, the GYS1/RUVBL2 genomic
region from the human genome. The GYS1 gene was
recently described as a novel hypoxia-inducible gene and
a functional HRE was identiﬁed upstream its promoter
(27). Interestingly, very close to GYS1, but encoded by
the opposite DNA strand, is located the RUVBL2 gene.
In spite of the location of the HRE between both genes,
we found that only GYS1, but not RUVBL2, was induced
in response to hypoxia. The lack of RUVBL2 response to
hypoxia was not due to epigenetic silencing of its promoter
as it showed a substantial transcriptional activity and the
level of RUVBL2 mRNA was comparable with that of
GYS1. Instead, the analysis of different reporter con-
structs derived from the intergenic GYS1/RUVBL2
sequence, revealed an inhibitory region, located between
the HRE and the RUVBL2 minimal promoter, that pre-
vented the induction of RUVBL2 by HIF. Removal of
this region allowed the up-regulation of the RUVBL2
promoter upon HRE activation. This result hinted the
existence of an enhancer blocking element within the in-
hibitory region that prevented the interaction between the
HRE and the RUVBL2 promoter. By means of speciﬁc
enhancer blocking assays (EBA), performed in cell culture
and using heterologous constructs in transgenic zebraﬁsh,
we conﬁrmed the existence of an insulator element within
this locus that could explain the differential regulation of
GYS1 and RUVBL2 by hypoxia. Altogether, our results
suggest that HIF selectivity is achieved, at least in this
locus, by an insulator element that prevents the activity
of the HRE/HIF complex on the RUVBL2 promoter.
MATERIALS AND METHODS
Cell culture and reagents
Human cervical-carcinoma cells (HeLa) and Human em-
bryonic kidney 293 (HEK293) cells were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% (v/v) fetal bovine serum and 100U/ml
penicillin and 100mg/ml streptomycin and cultured at
37C and 5% CO2 in a humidiﬁed incubator.
For hypoxia treatments, cells were grown at 37C in
sealed chambers (Billups–Rothenberg) ﬂushed with a 1%
O2, 5% CO2, 94% N2 gas mixture or in a Whitley
hypoxystation (don Whitley Scientiﬁc, UK) set at 1%
oxygen concentration.
Dimethyloxalylglycine (DMOG, Frontier Scientiﬁc,
CA, USA) was added to the indicated cultures at a
500 mM ﬁnal concentration. For the analysis of
RUVBL2 and GYS1 expression, cDNA obtained from
the following cell lines were also used: HepG2, HepaC1,
NIH/3T3; N2a, HEK293 and A549.
Analysis of gene proﬁling datasets
The expression proﬁles corresponding to the indicated
datasets and series were downloaded from Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih
.gov/geo/) (28) database. In all the cases, untreated
normoxic cells were used as reference. For each data set
we calculated the mean of probe values in the biological
replicates. All probes mapping to the locus of interest,
except those with null values, were included in the
analysis. Then, for each probe, the effect of hypoxia was
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calculated as the logarithm of the ratio of the means of
treated and control samples. Finally, individual log-ratio
values were normalized by subtraction of the mean of all
the log-ratios across the data set and division by their
standard deviation. In the case multiple probes mapping
to a given gene locus, the average of the log ratio was
calculated. Information regarding GEO and probes ID
can be found in the Supplementary Table S1.
RNA extraction and quantitative PCR
Total RNA was extracted and puriﬁed with the RNeasy
Mini Kit (Qiagen). One microgram of RNA from each
sample was reverse-transcribed to cDNA (Improm-II
reverse transcriptase; Promega) and 1ml of cDNA
samples were used as template for ampliﬁcation reactions
carried out with the LC Fast Start DNA master SYBR
Green I kit (Roche Applied Science), following the manu-
facturer’s instructions. PCR ampliﬁcations were carried
out in a Light Cycler System (Roche Applied Science),
and data were analyzed with LightCycler software 3
version 3.5.28 (Idaho Technology Inc.). For each
sample, duplicate determinations were made, and the
gene expression determined by the Ct method using
b-actin as reference gene. The primers used in this study
are shown in the Supplementary Table S2.
Plasmid construction
Human genomic DNA extracted from HeLa cells was
used as template for PCR ampliﬁcation of GYS1 and
RUVBL2 promoter regions. For reporter assays, PCR
products were ﬁrst cloned into pCR2.1-TOPO (invitrogen)
and subsequently subcloned into the KpnI/XhoI restric-
tion sites of pGL3-Basic.
For the in vitro EBA, the putative insulators were
cloned in the plasmid pELuc (29) and assayed their
activity by transfection of the resulting constructs into
HEK293 cells. This vector carries a CMV enhancer and
a minimal promoter controlling the ﬁreﬂy luciferase report
gene cassette with the polyadenylation site from SV40. All
inserts were cloned into the XhoI site, between the
enhancer and the CMV promoter (IN-position), and
into SmaI, upstream of the enhancer (OUT-position).
The insertion in SmaI site is a control for the assay that
tests the potential silencer/repressor effects of our insert.
For the in vivo EBA the putative insulator elements were
cloned in the vector 48RCar (30) and injected resulting
constructs into zebraﬁsh embryos to assess their effect
on transcription. In this plasmid the GFP gene is carried
in the vector under the control of an actin promoter, that
directs expression in heart and muscle. The insulator is
cloned in the KpnI site, between the actin promoter and
the Enhancer 48, which targets the expression to the
central nervous system (31).
The identity of all constructs was veriﬁed by sequencing.
All primer sequences are available in the Supplementary
Table S1.
Reporter assays
Reporter assays were performed using the HeLa. Cells
were seeded on six-well plates (3 105 cells/well) 6 h
prior to transfection. A 9 mg DNA mixture containing
3 mg of the indicated reporter construct or empty
plasmid and 0.6mg of a plasmid encoding for renilla (sea
pansy) luciferase under the control of a null promoter
(Promega, Madison, WI, USA.) was used for transfection
using the calcium phosphate method. On completing 16 h
after transfection, cells where washed, replated in 24-well
plates and incubated in normoxia, in the presence of
DMOG or under hypoxia for additional 16 h. After treat-
ments, the cells were lysed and the ﬁreﬂy and renilla
luciferase activities of the lysate were determined using a
dual-luciferase system (Promega, Madison, WI, USA).
The ﬁreﬂy luciferase activity was normalized to that of
renilla luciferase.
In vitro EBA
Cells were transiently transfected using Lipofectamine
2000 (invitrogen) and OPTI-MEM medium
(Invitrogen) according to the supplier’s instructions.
Brieﬂy, 1.8 105 HEK293 cells were seeded the day
before transfection in 24-well plates. For each well,
0.66mg of the linearized reporter vector was transfected
together with 0.14mg of pCMV-lacZ control plasmid (for
normalization purposes). The pELuc-derived constructs
were linearized prior to transfection, to avoid bidirectional
enhancer activity, using the restiction enzyme Asp-718.
This site is located 30 downstream from the
polyadenylation signal. The pCMV-lacZ plasmid was
also linearized using ScaI. The cells were incubated 24 h
with the transfection mixture and were thereafter lysed
with Reporter Lysis Buffer (Promega).
The luciferase activity was determinad using the
Luciferase Assay Reagent (Promega) according to the
manufacturer’s speciﬁcations in a microplate luminometer
(Orion, Berthold Detection Systems). The sample
luciferase activity was corrected by the b-galactosidase
activity in and the number of molecules (picomol) of the
transfected plasmid construct (according to each plasmid
size). Finally, activities were normalized as a fraction of
the mean luciferase values obtained for the empty (pEluc)
plasmid.
Transgenesis and in vivo EBA
Transgenesis and in vivo EBA were performed as described
(30,31). For zebraﬁsh transgenesis, the Tol2 transposon/
transposase method of transgenesis (32) was used with
minor modiﬁcations. In total, 1 nl was injected in the
cell of one-cell stage embryos containing 50 ng/ml of
transposase mRNA, 40 ng/ml of phenol/chloroform
puriﬁed DNA and 0.05% phenol red.
Statistical analysis of data
Statistical analysis of the experimental data was per-
formed with the R software package [(33), http://www
.R-project.org/]. The statistical tests applied to each data
set are indicated in the ﬁgure legends. We adopted the
following code to indicate the magnitude of P-values
throughout the manuscript ﬁgures as: ***P=[0, 0.001];
**P=[0.001, 0.01] and*P= [0.01, 0.05].
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RESULTS
Differential regulation of GYS1 and RUVBL2 by hypoxia
The muscle glycogen synthase gene, GYS1, is regulated by
HIF as part of the cellular metabolic reprogramming
required for the adaptation to hypoxia (27). The regula-
tion of human GYS1 by hypoxia is mediated by a func-
tional RCGTG element located 255 bp upstream its
transcription start site (TSS) (27). Very close to GYS1,
but encoded by the opposite DNA strand, is located the
RUVBL2 gene (Figure 1A). The relative position,
intergenic distance and orientation of these two genes
are conserved across mammals (data not shown). The
TSS of RUVBL2 is located at 288 bp of the HRE
driving GYS1 expression in response to hypoxia
(location of the HRE is shown by a black box in the
‘blat’ track, Figure 1A), raising the possibility of a
coordinated regulation of these two genes by HIF. In
fact, the intergenic region between GYS1 and RUVBL2
can be considered a bidirectional promoter (Figure 1A,
‘Elnitski bidirectional promoters’ prediction track). To
study this possibility, we analyzed publicly available
gene expression proﬁles of cells exposed to hypoxia and
found that, whereas GYS1 mRNA levels were induced by
hypoxia in most of the proﬁles, the expression of RUVBL2
remained constant or was even repressed under low
oxygen tension (Figure 1B). To conﬁrm these results we
exposed myotubes to hypoxia and determined its effect on
GYS1 and RUVBL2 mRNA levels. As shown in
Figure 1C, GYS1 mRNA level signiﬁcantly increased in
response to hypoxia, in agreement with published results
(27), but the treatment did not induce RUVBL2 mRNA.
In order to rule out a cell-type speciﬁc effect, we
determined the effect of hypoxia on the expression of
GYS1 and RUVBL2 in a variety of cell types
(Figure 1D). These analyses conﬁrmed that, whereas
GYS1 expression was increased by hypoxia in virtually
all cell lines studied, RUVBL2 remained largely unaffect-
ed. In agreement with this conclusion, a meta-analysis of
gene expression proﬁle experiments suggested that, unlike
GYS1, RUVBL2 is not signiﬁcantly modulated by hypoxia
(10). These results indicated that hypoxia speciﬁcally
affects GYS1, but not RUVBL2 transcription. To
conﬁrm this possibility, we investigated the effect of
hypoxia on a set of reporter constructs derived from this
locus. As shown in Figure 1E, a reporter construct con-
taining the region ﬂanking GYS1 gene and including the
HRE (region cG spanning residues+84 to 429 relative to
GYS1 TSS, Figure 1A), was robustly induced by hypoxia
and the hypoxia mimetic DMOG in HeLa cells, as
expected from the presence of the evolutionarily conserved
block containing the HRE within this cG region. In
contrast, the analogous region upstream of RUVBL2
(cR, spanning 396 to +12 relative to RUVBL2 TSS)
did not respond to HIF activation in spite of including
the same HRE-containing region (Figure 1E).
Importantly, this same result was obtained when the
whole intergenic region, maintaining the original
genomic structure, was used to drive luciferase expression
from the GYS1 (cRcG) or the RUVBL2 (cGcR) pro-
moters (Figure 1E).
Collectively, these results indicate that the HRE located
between GYS1 and RUVBL2 genes selectively drives the
transcription of the former in response to hypoxia.
The lack of RUVBL2 induction by hypoxia is not due
to gene silencing
The accessibility of promoter regions is one that the mech-
anisms that restricts the activity of a TF toward speciﬁc
genes. This can be achieved by methylation of promoter
regions and/or by altering chromatin compactness
through histone modiﬁcation. In fact, it has been
recently found that basal promoter activity determines
cell type-speciﬁc HIF transcription (8). Thus, we
investigated whether a lack of RUVBL2 transcriptional
activity could explain the observed selectivity of hypoxia
within this locus. As shown in Figure 2A, the normoxic
levels of RUVBL2 and GYS1 mRNAs were of similar
magnitude, at least for the set of cell lines included in
our study. Moreover, the differential effect of hypoxia
(Figure 1D) was observed even for cell lines, such as
HeLa or A549, in which the relative basal level of
RUVBL2 mRNA was much higher than that of GYS1.
On the other hand, the genomic region adjacent to the
RUVBL2 gene (cR) showed a strong basal promoter
activity when assayed in HeLa cells (Figure 2B). In fact,
the promoter activity of the cR region was signiﬁcantly
higher than that of the cG region (Figure 2B). In agree-
ment with our results, published data of genome-wide
RNA polymerase II binding shows a similar signal in
the GYS1 and RUVBL2 promoter regions in a wide
range of cell types (Supplementary Figure S1).
Altogether, these results indicate that RUVBL2 and
GYS1 are transcribed under normoxia to a similar
extent and thus, we discarded RUVBL2 promoter accessi-
bility as a potential explanation for the differential regu-
lation observed under hypoxia.
An inhibitory region prevents RUVBL2 induction
by the HRE
To gain insight into the molecular mechanism responsible
for the differential regulation of RUVBL2 and GYS1 by
hypoxia, we generated a set of reporter constructs contain-
ing different deletions and rearrangements of the genomic
region between GYS1 and RUVBL2 genes (Figure 3A and
diagrams on the left of Figure 3B). Based on the evolu-
tionary conservation (Phas Cons elements, see Figure 1A),
we differentiated ﬁve blocks within this region (Figures 1A
and 3): proximal GYS1 (pG), upstream GYS1 (uG),
HRE-containing block (HRE), upstream RUVBL2 (uR)
and proximal RUVBL2 (pR). As shown in Figure 3,
analysis of the transcriptional activity of these reporter
constructs in HeLa cells showed that neither pG nor pR
proximal regions responded to HIF activation. However,
combination of these proximal regions with the HRE
block, regardless of the orientation of the latter, resulted
in constructs (HREF_pG, HRER_pG, HREF_pR and
HRER_pR) that were robustly induced by the hypoxia
mimetic DMOG. The induction of these constructs was
of similar magnitude to that observed for the complete
GYS1 construct (cG), suggesting that upstream regions
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Figure 1. Differential regulation of GYS1 and RUVBL2 by hypoxia. (A) Schematic diagram depicting the human (hg18 assembly) genomic region
containing the intergenic region between GYS1 and RUVBL2 and its sequence conservation across mammals [adapted from UCSC genomic browser,
http://genome.ucsc.edu/(53)]. The boxes below the diagram represent the different blocks identiﬁed within this region according to their evolution-
arily conservation and solid lines indicate the regions cloned to generate reporter constructs, cG, cR and cG+cR. (B) Effect of hypoxia or the
hypoxia-mimetic deferoxamine (GSE5579) on GYS1 and RUVBL2 expression extracted from gene expression proﬁles of human breast carcinoma cell
line MCF7 (GSE3188), mouse embryo ﬁbroblast (GSE3196), human B lymphocyte P493-6 cells (GSE4086), human monocyte-derived macrophages
(GDS2036), human lymphatic endothelial cells (GSE5579), human aortic smooth muscle cells (GSE4725), human colon adenocarcinoma cell line
HT29 cells (GSE9234), mouse hepatocytes (GDS1648), human embryonic kidney cell line HEK293 (GSE2020), human astrocytes (GSE3045) and
human epithelial cervical cancer cell line HeLa (GSE3051) exposed to hypoxia. Asterisks indicate that the set of data values was signiﬁcantly different
(one sample t-test, t=3.6988, df=11, P=0.003509) from the value of zero (no induction). (C) c2c12 myoblast were exposed to normoxia or
hypoxia for 12–24 h and GYS1 and RUVBL2 expression was determined by quantitative PCR from total RNA samples. Data were calculated relative
to b-actin and expressed as fold change relative to normoxia. Data shown are the results of three independent experiments and their mean (bar). The
relative induction of both mRNAs was signiﬁcantly different (t-test, t=4.9995, df=2, P=0.03776). (D) A variety of cell lines (HepG2 and
HepaC1, mouse hepatocarcinoma cell lines; primary mouse hepatocytes; NIH3T3, mouse ﬁbroblast cell line; HeLa; N2a, mouse neuroblastoma
cell line; HEK293; A549, human lung adenocarcinoma cell line) were exposed to normoxia or hypoxia and the levels of GYS1 and RUVBL2 mRNA
determined and represented as indicated in C. Asterisks indicate that the set of data values was signiﬁcantly different (one sample t-test, t=4.4522,
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(uG and uR) are not required for the activity of the
HRE-containing block. These data ruled out a collabor-
ation between HIF and other transcription factors binding
to pG or uG as a potential explanation for the differential
induction of GYS1 and RUVBL2 by hypoxia. On the
other hand, comparison of response of the cR and
HREF_pR constructs, hinted the existence of an inhibi-
tory region within the uR region as removal of this region
signiﬁcantly increased the response to HIF activation. In
agreement, the up-regulation of the HREF_pG construct
was blunted by the inclusion of the upstream region of
RUVBL2 between the HRE and proximal GYS1 block
(Figure 3, HREF_pG and HREF_uR_pG).
In summary, these results suggest that the genomic
region from 202 to 30, relative to the RUVBL2 TSS,
(uR) prevents the induction of RUVBL2 by HIF.
The GYS1/RUVBL2 intergenic region contains an
enhancer blocking element
Insulators are DNA elements that can prevent the promis-
cuous effect of enhancers or silencers, restricting their
interactions with promoters. Our results suggested that
the uR region prevents the interaction of the HRE
over the RUVBL2 promoter, a function that is compatible
with the enhancer blocking type activity commonly
associated to insulators. To test this possibility, we
studied the ability of different sequences, derived from
the RUVBL2/GYS1 intergenic region, to interfere with
the activity of a heterologous enhancer/promoter pair in
a standard EBA, in HEK293 cells (29). Each of the
genomic fragments under study was cloned either,
between the enhancer and promoter (IN position) or
upstream and the enhancer (OUT position) (Figure 4A).
As a positive control, we also included the boxes II/III (E
II/III) derived from the classical chicken 50HS4 b-globin
insulator element (34), known to bind the nuclear factor
CTCF and responsible for the enhancer blocking effect of
the 50HS4 element (35). The enhancer blocking activity of
these sequences, represented as fold reduction of the
activity of a vector lacking insert, is represented in
Figure 4B. In agreement with previous reports (35), the
E II/III boxes, but not a mutant form, interfered with the
activity of the CMV enhancer when inserted into the XhoI
site (Figure 4B, white bars). Enhancer blockers work only
in the ‘IN’ conﬁguration as demonstrated by the lack of
activity of the EII/III constructs in the ‘OUT’ conﬁgur-
ation (Figure 4B, black bars). Signiﬁcantly, all the con-
structs containing the uR in the ‘IN’ conﬁguration, except
1R, showed a signiﬁcant reduction in the enhancer activity
(Figure 4B, white bars corresponding to constructs 1F,
2F, 2R, 3F and 3R). Importantly, these same regions
had no signiﬁcant inhibitory effect when cloned in the
‘OUT’ conﬁguration (Figure 4B, black bars corresponding
to constructs 1F, 2F, 2R, 3F and 3R). In contrast to these
results, neither the HRE nor uG regions were able to
suppress the activity of the CMV enhancer (Figure 4B,
constructs 4F, 4R, 5F, 5R, 6F, 6R and Supplementary
Figure S2).
The EBA results strongly support the existence of an
enhancer blocking element within the genomic region
from 202 to 30 relative to the RUVBL2 TSS
(Figure 4B, constructs 3F and 3R). Thus, we decided to
functionally validate the presence of an insulator in this
region in vivo by means of an independent assay using
Figure 1. Continued
df=7, P=0.002964) from the value of one (no induction). (E) HeLa cells were transiently transfected with reporter constructs containing the
indicated region (cG, cR, cGcR or cRcG, see Figure 1A) upstream a ﬁreﬂy luciferase gene and exposed to normoxia, hypoxia or the hypoxia mimetic
DMOG for 12 h. The graphs represent the corrected luciferase activity values of each construct in cells exposed to hypoxia/DMOG and represented
as fold change over the activity obtained in normoxic cells. Bars represent the average of values obtained in three independent experiments and error
bars their standard deviation. Statistically signiﬁcant differences between pairs of constructs are indicated by asterisks (one-way ANOVA,
F9,20=36.704, P=1.6 1010, followed by Tukey’s multiple comparison test).
Figure 2. RUVBL2 is transcribed under normoxia. (A) The basal (normoxic) expression of GYS1 and RUVBL2 was determined by quantitative PCR
for the cell lines indicated in Figure 1D. The graph represents the normalized mRNA levels for each gene across the different cell lines. The difference
between both groups was not statistically signiﬁcant (paired t-test, t=0.9365, df=7, P=0.3802) (B) HeLa cells were transfected with a reporter
construct containing the indicated region upstream a ﬁreﬂy luciferase gene or the corresponding empty plasmid lacking insert (pGL3basic). The
graph represents the corrected luciferase activity values obtained for each plasmid as fold over the activity contained in cells transfected with empty
vector. Bars represent the average of values obtained in three independent experiments and errors bars their standard deviation. The difference
between the means of both groups was statistically signiﬁcant (paired t-test, t=10.2002, df=2, P=0.009475).
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transgenic zebraﬁsh. To this end, we used a reporter con-
struct in which EGFP expression is under the control of
the cardiac actin promoter from Xenopus laevis and the
Z48 enhancer, which drives transgene expression in the
midbrain (Figure 5A) (31). Transgenic zebraﬁsh embryos
injected with this construct showed EGFP expression in
the heart and in the developing somites (due to the cardiac
actin promoter), as well as in the CNS (Figure 5B and C,
control), due to the Z48 enhancer, as reported earlier
(30,31). Micro-injection of a construct containing the uR
region cloned between the enhancer and the promoter,
regardless of its orientation, resulted in a strong attenu-
ation of the CNS signal, whereas retaining the EGFP
signal in the developing somites (Figure 5C, uR_F and
uR_R). Analysis of the somites/CNS EGFP-mediated
ﬂuorescence signal ratio in 62 independent transgenic
zebraﬁsh lines demonstrated an enhancer blocking
activity associated with the uR sequence (Figure 5B,
uR_F and uR_R). Importantly, in agreement with the
in vitro EBA assays (Figure 4), the effect was speciﬁc for
the uR region as cloning of the uG sequence between the
Z48 enhancer and the actin promoter did not interfere
with the EGFP expression in the CNS (Figure 5B and
C, uG_F and uG_R).
Altogether, these results demonstrate the existence of a
powerful enhancer blocking element in the uR region that
could explain the differential regulation of GYS1/
RUVBL2 by HIF. The activity of this insulator element
is observed when assayed in a distant heterologous system
(zebraﬁsh) suggesting that its function and potential trans-
acting factors have been evolutionary conserved in
vertebrates.
DISCUSSION
The recognition of short DNA motifs by transcription
factors is a key step in the regulation of transcription.
However, the low information content of most of the
TFBS predicts a promiscuous binding that is in contrast
with the observed speciﬁcity. This apparent paradox raises
the question of how transcription factor selectivity is
achieved. Although several mechanisms including chro-
matin accessibility and TF cooperation, have been
shown to restrict the target space for a given TF, a
complete explanation is still lacking in most of the cases.
In this scenario, HIF transcription factors are not an ex-
ception. HIF heterodimers bind to the RCGTG motif
Figure 3. Region uR prevents the increase in transcription mediated by the HRE. (A) Schematic diagram of the GYS1/RUVBL2 intergenic showing
the different elements included in the reporter constructs. (B) HeLa cells were transfected with the indicated constructs and treated with the hypoxia
mimetic DMOG or left untreated for 12 h. The graph represents the corrected luciferase activity values of each construct in treated cells represented
as fold change over the activity obtained in control (normoxic) cells. Bars represent the average of values obtained in three independent experiments
and error bars, their standard deviation. The diagrams on the left are a schematic representation of the genomic elements included in the reporter
construct and their orientation relative to the luciferase gene. Statistically signiﬁcant differences between pairs of constructs within the groups
containing pG or pR are indicated by asterisks (one-way ANOVA followed by Tukey’s multiple comparison test. pG-containing constructs
F4,10=13.608, P=0.0004705; pR-containing constructs F4,10=7.518, P=0.004598).
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(4,6,9), which is present in almost every gene in the human
genome, yet hypoxia results in the regulation of a few
hundred genes only and, accordingly, HIF only binds to
a subset of the potential binding sites (5,6,9,10). It has
been recently demonstrated that HIF binds preferentially
to RCGTG motifs present in the promoters of genes
actively transcribed under normoxic conditions (8).
Although this restriction results in a large reduction in
the number of potential targets, it does not fully explain
HIF selectivity as many genes transcribed under normoxia
and containing RCGTG motifs are not induced by
hypoxia. With the aim of gaining insight into the mech-
anisms of HIF target selectivity, we investigated the
GYS1/RUVBL2 genes as a particularly striking example
of differential regulation. Given their close proximity and
the location of the functional HRE between both genes,
we had expected their coordinated regulation by HIF.
However, our results showed that while GYS1 was
induced by hypoxia, RUVBL2 levels remained unchanged
(Figure 1). The basal level of mRNA, RNA polymerase II
binding and promoter activity (Figure 2 and
Supplementary Figure S1) ruled out the accessibility of
chromatin as an explanation for the lack of induction of
RUVBL2 by hypoxia. Detailed analysis of the promoter
activity of different fragments derived from the GYS1/
RUVBL2 intergenic region revealed the existence of an
inhibitory region between the HRE and the RUVBL2
gene (Figure 3). Finally, speciﬁc EBAs performed
in vitro (Figure 4), as well as in vivo (Figure 5)
demonstrated the existence of an insulator element that
could explain the lack of effect of the HRE over the
RUVBL2 promoter and thus, the differential regulation
of GYS1 and RUVBL2 genes by hypoxia.
Insulators have been shown to play a key role in the
differential patterns of gene expression during develop-
ment and cell-lineage speciﬁcation (23). However, to our
Figure 4. The uR region contains an enhancer blocking element. (A) Schematic diagrams of the different elements within the GYS1/RUVBL2
intergenic region (left diagram) and the EBA vector showing the ‘IN’ (middle diagram) and ‘OUT’ (right diagram) cloning sites. (B) Each of the
indicated elements (diagrams on the left under ‘INSERT’) derived from the GYS1/RUVBL2 intergenic region, or from the b-globin gene (E II/III and
a mutated version, E II/III mut), were cloned into the XhoI (‘IN’ position, white bars) or SmaI (‘OUT’ position, black bars) sites of the pELuc
vector to generate the indicated constructs (‘CONST.’). The HEK293 cells were transiently transfected with each one of these constructs, an empty
EBA vector lacking insert (pEluc) or an empty EBA vector lacking the enhancer (pEluc). On completing 24 h after transfection, the cells were
processed to determine the transcriptional activity of the constructs. The ﬁgure represents the corrected luciferase activity in each sample and is
expressed as fold reduction of the activity observed in cells transfected with the empty vector, pEluc (29). Bars represent the average of values
obtained in three independent experiments and errors bars, their standard deviation. Asterisks indicate constructs whose activity was signiﬁcantly
different from that observed for the control, pEluc (one-way ANOVA, F29,237=131.10, P=2.2 1016, followed by Tukey’s multiple comparison
test).
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knowledge, this is the ﬁrst example of an enhancer
blocking element contributing to the selectivity of a
transcription factor acutely induced by environmental
factors, such as HIF. Although further work is required
to determine whether this is a general mechanism
contributing to HIF speciﬁcity, our working hypothesis
is that this mechanism could be particularly relevant in
cases of bidirectional promoters, such as the one described
herein, where chromatin accessibility and DNA methyla-
tion is likely to be similar across the intergenic region. In
support to this possibility, we have found at least one
further example of bidirectional promoters differentially
regulated by hypoxia, BCKDHA and EXOSC5.
Preliminary results indicate that, in spite of similar basal
transcription, BCKDHA, but not EXOSC5, is induced by
hypoxia (Supplementary Figure S3).
Another issue raised by our results relates to the mo-
lecular identity of the insulator element located upstream
of the RUVBL2 gene. In vertebrates, several regulatory
elements including CTCF binding motifs (36–38),
repetitive elements, [such as ALUs (39), SINE B2 (29)
and SINE B1 (30)] and scaffold/matrix-attachment
regions [S/MARs; (40,41)], have been shown to function
as insulators (25,42). Among them, the most widespread
and well characterized are CTCF-binding elements (43).
We have not found obvious CTCF binding motif within
the 202 to 30 region upstream of RUVBL2, and pub-
lished ChIP data shows CTCF binding to the GYS1 TSS
region, but not to the region between the HRE and
RUVBL2 gene (Supplementary Figure S4A, CTCF ChIP
signal track). On the other hand, there are no repetitive
elements within this genomic region (Supplementary
Figure S4A, repeats tracks) arguing against the existence
of a SINE element that could explain the observed
enhancer blocking activity. Finally, although we found
no locally high proportion of A/T nucleotides, typically
associated with S/MARs elements (41) in the region
upstream of RUVBL2 (Supplementary Figure S4A, GC
percent track), computer prediction of S/MAR sites,
found a signiﬁcant signal in the upstream region of
Figure 5. The insulator element derived from RUVBL2 genomic region blocks enhancer activity in vivo. (A) Schematic representation of the ZED
construct. (B and C) zebraﬁsh embryos were micro-injected with an empty ZED vector (control), lacking insert between the enhancer and promoter,
or constructs containing the RUVBL2-derived enhancer blocking element (uR) or the corresponding region upstream the GYS1 gene (uG). Both
elements were cloned in the forward (uR_F, uG_F) or reverse (uR_R, uG_R) orientation. After 36 h after micro-injection, the GFP signal in CNS
and somites was determined by ﬂuorescence microscopy and quantiﬁed with LaserPix (Bio-Rad) image analysis software, as reported before (30).
(B) A representative image of each group of animals is shown. Arrowheads indicate the location of the CNS. (C) The graph represents the ratio
between the GFP signals in somites and CNS for each of the transgenic ﬁsh. Horizontal line represents the median of the ratios for each group of
animals. Asterisks indicate set of values that were signiﬁcantly different from those obtained for the empty construct Kruskal–Wallis,
chi-squared=89.2081, df=5, P< 2.2e-16; P-values for comparisons were calculated by Wilcoxon rank and corrected for multiple comparison
using Bonferoni’s method.
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RUVBL2 (Supplementary Figure S4B). Thus, the insula-
tor activity described herein could be mediated by S/MAR
elements. However, as this evidence has been obtained
through in silico approaches, further work is required to
identify the minimal region required for the enhancer
blocking function, including its molecular identity,
underlying mechanism and the associated potential
trans-acting factors. This is yet another perfect example
demonstrating the diversity of mechanisms, most of them
not known to date, that cells are using to organize func-
tional insulator elements (25).
The mechanism by which enhancer blockers prevent the
activity of upstream enhancers is unclear, although our
current understanding is that insulators will probably
not be using unique mechanisms but, rather, adaptations
of pre-existing ones already in place for the normal regu-
lation of gene expression (23). Several of the proposed
models invoke the generation of chromatin loops that seg-
regate enhancer-sensitive and resistant promoters in
distinct domains (44,45). In the case described herein,
the model is further complicated by the short distance
existing between the cis-elements involved. A piece of in-
formation that could shed light into the mechanism is the
intriguing observation that the inclusion of the uG region
seems to abolish the enhancer blocking effect of uR in
EBA (Figure 4B, compare constructs 1R/1F with 3R/
3F). Although we cannot currently explain this behavior,
it would suggest that the EBA of uR can be modulated by
elements located in its proximity. In this regard, it has
been previously found that the EBA of the ‘gypsy’
element is affected by the number of copies of this
element. When two copies, instead of one, are located
between the enhancer and promoter, its blocking effect
is abolished (46). However, the enhancer blocking effect
is restored by the insertion of a third copy (47), depending
on the order and distance of the insulator elements,
indicating that complex protein–protein interactions are
responsible for these unexpected effects and underlying a
major role of insulators in whole nuclear genome organ-
ization (24,48). Thus, it is possible that the impairment of
the EBA of uR by uG can be reverted by other cis-
elements, present in the native genomic context, but not
included in this set of constructs. A further possibility is
that the HRE-containing block could enhance the tran-
scription from the minimal CMV promoter. If this is the
case, the enhancer blocking element within uR would be
located upstream of the HRE element in the construct 1R
and would be thus, unable to prevent its action upon the
minimal CMV promoter. Regardless of the speciﬁc mech-
anism by which uR exerts its effect, our data clearly dem-
onstrates that it contains an EBA.
Reprogramming of cellular metabolism, in particular
glucose metabolism, is central in the cellular adaptation
to hypoxia. The hypoxic induction of GYS1, encoding for
an isoform of glycogen synthase, is part of this
reprogramming (27). On the other hand, the existence of
an enhancer blocking element between the HRE and the
RUVBL2 promoter raises the question of why RUVBL2
expression has to be shielded from the HIF-mediated in-
duction. RUVBL2 gene encodes for Reptin, an AAA+
ATPase that forms part of chromatin remodeling
complexes. Interestingly, it has been recently shown that
hypoxia leads to reptin methylation and that, upon this
post-translational modiﬁcation, it is able to repress
HIF-mediated transcription (49). Thus, it is plausible
that RUVBL2 expression might not be induced by
hypoxia so as not to upset the balance between
methylated/unmethylated reptin that could lead to prema-
ture termination of HIF-mediated transcription. However,
this hypothesis does not provide an explanation for the
close proximity of these genes. The conservation of the
GYS1/RUVBL2 genomic arrangement from opossums to
humans suggests a selective pressure to maintain both
genes in close proximity. Previous studies have shown
that a substantial proportion of mammalian genes is
arranged in a divergent head-to-head structure and
controlled by bidirectional promoters (50), so that the
pair of genes tend to be co-expressed (50,51). The need
for co-regulation of the pair of genes under the control
of a bidirectional promoter could explain the selective
pressure that keeps them in close proximity. However, in
the case of GYS1/RUVBL2, co-regulation of both genes is
an unlikely reason for their close proximity as the exist-
ence of the insulator element would prevent the action of
ﬂanking cis-elements on the opposite promoter.
In summary, we have identiﬁed an insulator, acting as a
functional enhancer blocking element, that explains the
differential response of GYS1 and RUVBL2 genes to
hypoxia. To our knowledge, this is the ﬁrst report
describing a role for this type of genetic elements in
dictating the speciﬁcity of acutely induced transcription
factors in response to environmental, as opposed to devel-
opmental, signals. Importantly, the generalization of this
model adds to the arsenal of strategies, including chroma-
tin accessibility and combinatorial assembly of TFs, that
are employed by eukaryotes to ensure a highly speciﬁc
gene expression based on an otherwise promiscuous set
of cis-regulatory elements.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
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Abstract
The transcriptional response driven by Hypoxia-inducible factor (HIF) is central to the adaptation to oxygen restriction.
Despite recent characterization of genome-wide HIF DNA binding locations and hypoxia-regulated transcripts in different
cell types, the molecular bases of HIF target selection remain unresolved. Herein, we combined multi-level experimental
data and computational predictions to identify sequence motifs that may contribute to HIF target selectivity. We obtained
a core set of bona fide HIF binding regions by integrating multiple HIF1 DNA binding and hypoxia expression profiling
datasets. This core set exhibits evolutionarily conserved binding regions and is enriched in functional responses to hypoxia.
Computational prediction of enriched transcription factor binding sites identified sequence motifs corresponding to several
stress-responsive transcription factors, such as activator protein 1 (AP1), cAMP response element-binding (CREB), or CCAAT-
enhancer binding protein (CEBP). Experimental validations on HIF-regulated promoters suggest a functional role of the
identified motifs in modulating HIF-mediated transcription. Accordingly, transcriptional targets of these factors are over-
represented in a sorted list of hypoxia-regulated genes. Altogether, our results implicate cooperativity among stress-
responsive transcription factors in fine-tuning the HIF transcriptional response.
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Introduction
Oxygen is essential for the survival of all eukaryotic cells, and
metazoans are heavily dependent on this element to meet their
large metabolic demands. At the cellular level, 90% of oxygen is
consumed in oxidative phosphorylation. Consistent with a central
role of oxygen in aerobic metabolism, all metazoan cells respond
to an imbalance between demand and supply of oxygen (hypoxia)
by activating a gene expression program aimed at restoring oxygen
supply and reducing its consumption. The cellular response to
hypoxia is mainly controlled by the evolutionarily conserved
Hypoxia Inducible Factor (HIF) family of basic helix-loop-helix
transcription factors. HIFs are heterodimers of a beta subunit
(HIFb, also known as ARNT), and an alpha subunit (HIFa) [1].
While ARNT levels are not sensitive to oxygen, both HIFa
stability [2] and its transcriptional activity [3] are regulated by
oxygen-dependent hydroxylation [4–6]. Under oxygen restriction,
HIFa subunits escape proteasomal degradation, heterodimerize
with HIFb subunits and translocate to the cell nucleus, where they
bind the RCGTG consensus sequence (termed Hypoxia Response
Element, HRE) within regulatory regions of target genes, leading
to their transcriptional activation in hypoxia [7]. Mammals
present three isoforms of HIFa (HIF1a, HIF2a and HIF3a) that
differ in their tissue distribution, HIF1a being the more ubiquitous
and best characterized [8].
A large number of studies focusing on single genes have
identified individual HIF targets that, collectively, account for the
functional responses to hypoxia, mainly metabolic adaptation and
induction of angiogenesis [7]. More recently, works employing
HIF1a and HIF2a chromatin immunoprecipitation coupled to
genomic microarrays (ChIP-chip) or high-throughput sequencing
(ChIP-Seq) have addressed the genome-wide identification of HIF
binding locations [9–12], thereby improving the existing knowl-
edge on the HIF-modulated transcriptome and largely confirming
the RCGTG HIF binding consensus. Additionally, these studies
have provided important insights into the global properties of
HIF1 binding and transactivation. First, these works reported
a significant association between the presence of a HIF binding site
(HBS) and hypoxic induction of the neighboring genes. The same
trend was not found for genes repressed by hypoxia, suggesting
that hypoxia-mediated repression is largely indirect or HIF-
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independent [9,12,13]. Furthermore, they have clearly shown that
only a small subset of about a hundred of all RCGTG-containing
genes is robustly regulated by hypoxia. Hence, and in agreement
with work on other transcription factors [14], HIFs bind a small
proportion of potential binding sites, albeit the basis of their
binding and target selectivity are incompletely understood.
Understanding the mechanisms that explain HIFs transactiva-
tion selectivity is of paramount importance to expand our
knowledge on transcriptional regulation and to improve the
sensitivity and specificity of genome-wide efforts to characterize
the HIF transcriptional response. DNA accessibility of transcrip-
tion factor binding sites (TFBSs) can clearly contribute to binding
selectivity [15]. For HIFs, recent evidence includes enhanced
HIF1 and HIF2 binding to normoxic DNAse hypersensitivity sites
[12] and enrichment of HIF1 binding in the proximity of genes
with a ‘‘permissive’’ transcriptional state in normoxia, as
evidenced by significant basal expression [11]. Additionally,
DNA methylation has been also shown to modulate HIF1 binding,
as originally demonstrated for the 39 enhancer of the erythropoi-
etin gene [16,17]. A further mechanism that can impact target
selectivity is direct or indirect cooperativity between transcription
factors (TFs). Models of direct cooperativity have been mainly
derived from developmental enhancers, and include the strict
enhanceosome model [18], where cooperative occupancy occurs
through extensive protein-protein interactions between TFs or
common cofactors, and the more flexible billboard model [19],
which suggests that enhancers contain submodules that interact
independently or redundantly with promoters. Conversely, in-
direct cooperativity is based on the equilibrium competition
between nucleosomes and DNA-binding proteins, thereby not
requiring protein-protein interactions [20]. In the case of HIF-
mediated transcription, the binding of cooperating transcription
factors has been demonstrated for several target genes. In
particular, HIF-mediated expression of the erythropoietin gene
requires an adjacent HNF4 binding site [21], both GATA2 and
AP1 binding sites are necessary for epithelial induction of ET-1
under hypoxia [22], and PAI-1 induction by hypoxia has been
linked to cooperative promoter activation by CEBPa, HIF1a and
EGR-1 [23]. Other examples include cooperation with Smads
[24], Sp1 [25] or CREB [26]. Additionally, USFs have been
shown to complement HIF binding either at neighbouring (LDHA
promoter) or identical sites (BNIP3) [27], while collaboration with
ETS transcription factors has been proposed to play a role in
HIF2a target selectivity [28,29]. Recent genome-wide approaches
relying on experimental [9–11] and computational [13,30]
identification of HIF binding sites have reported overrepresented
transcription factor binding sites in the flanking sequences that
might be indicative of transcriptional cooperativity. However,
significant differences exist in the overrepresented TFBSs pre-
dicted in each study, and the functional significance of these
enriched motifs remains unclear.
Gene expression profiling indicates that the expression of
thousands of genes changes with hypoxia, with vast cell-type
differences in the specific genes being regulated [31–38]. HIF1a
ChIP-chip binding locations have been reported in cell lines of
diverse tissue origin, namely HepG2 hepatocarcinoma cells [9],
MCF-7 breast cancer cells [10] and U87 glioma cells [11],
showing differences in the binding sites identified in each
experiment. In previous studies we integrated microarray expres-
sion profiling experiments and HIF binding site predictions in
a core set of tissue-independent HIF target genes [13]. To further
investigate the selectivity of HIF1 binding, in this work we
conducted HIF1a ChIP-chip in cervical carcinoma HeLa cells and
observed largely non-overlapping binding locations with previous
studies. To explore the role of cooperativity in HIF target
selection, we integrated HIF1 alpha ChIP-chip binding locations
across cell-types with a meta-analysis of gene expression profiles of
cells exposed to hypoxia [13]. Computational prediction of
enriched transcription factor binding sites in this integrated set
suggested several stress-responsive transcription factors as potential
HIF1 collaborators. Experimental validation of these predictions
in cell-based reporter assays indicates that binding sites for stress-
responsive transcription factors other than HIFs, such as CEBPs,
contribute to cooperative hypoxic activation of individual targets.
Materials and Methods
Gene-expression Profiling Analysis
Gene profiling experiments of hypoxic cell cultures were
downloaded from the Gene Expression Omnibus database
(GEO, http://www.ncbi.nlm.nih.gov/geo/) [39]. The average
raw signal from biological replicates was used in the analysis.
When fifty percent of the replicates had null values the average
signal was set to null. All probes mapping to a particular locus
were considered independently. A gene (identified by a particular
probe) was recorded as having no basal expression when the signal
for the probe under normoxic conditions had a null value. A gene
(probe) was considered to be induced by hypoxia when the log-
ratio of the hypoxic over normoxic signal values exceeded by 2.6
standard deviations the average log-ratio of all the probes in the
array. Genes (probes) with a null normoxic value and not-null
hypoxic values were also considered as induced by hypoxia. The
presence and absence of conserved RCGTG motifs at each locus
was determined as described previously [13].
Cell Culture
HeLa cells were maintained in Dulbecco’s modified Eagle
medium supplemented with 100 units/ml penicillin, 100 mg/ml
streptomycin and 5% (v/v) fetal bovine serum. Cells were grown at
37uC and 5% CO2. Hypoxic treatments were carried out in sealed
chambers flushed with a 1%O2/5%CO2/94%N2 gas mixture
(Billups-Rothenberg, Inc.; CA, USA).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was performed as previously
described [40]. Briefly, 107 HeLa cells were subjected to hypoxia
(1% oxygen) for six hours or left untreated (normoxic conditions,
21% oxygen). Following treatments, cells were crosslinked with
1% formaldehyde for 12 min at 4uC. Cross-linking was stopped by
the addition of glycine (0.125 M final concentration). Cell lysis was
achieved by scraping in 1 ml of lysis buffer (1% SDS,
10 mM EDTA, 50 mM Tris/HCl, pH 8.1, and a protease in-
hibitor cocktail, Roche). Cell lysates were incubated on ice for
10 min and then sonicated to shear DNA to fragments between
200 and 1500 bp. Only experiments that showed homogeneous
sonication across all samples (from normoxia and hypoxia
treatments) were continued. 50 ml of each sample was stored
(input), while 100 ml were diluted in 1 ml of immunoprecipitation
buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl and
20 mM Tris/HCl, pH 8.1). Lysates were precleared with 200 mg
of a Salmon Sperm DNA/Protein A agarose 50% slurry (Upstate
Biotechnology, Lake Placid, NY, U.S.A.) for 1 h at 4uC; and then
immunoprecipitated twice, initially with whole rabbit serum for
6 h (IgG control) and then overnight at 4uC with a polyclonal anti-
HIF1 alpha antiserum (Abcam, ab2185). Immunocomplexes were
recovered by addition of 400 mg of Salmon Sperm DNA/Protein
A agarose 50% slurry, and then sequentially washed in Low Salt
Wash Buffer (0.1%SDS, 1%Triton X-100, 2 mM EDTA,
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20 mM Tris/HCl, pH 8.1, and 150 mM NaCl), High Salt Wash
Buffer (0.1% SDS, 1% Triton X-100,2 mM EDTA, 20 mM Tris/
HCl, pH 8.1, and 500 mM NaCl), LiCl buffer (0.25 M LiCl,1%
Nonidet P40, 1% deoxycholate, 1 mM EDTA and, 10 mM Tris/
HCl, pH 8.1), and twice in TE buffer (10 mM Tris, pH 8.0, and
1 mM EDTA). Elution of protein-bound DNA was performed
twice with 1% SDS 0.1 M NaHCO3. Eluates were pooled, and
crosslinking was reversed by the addition of 200 mM NaCl (final
concentration) and overnight incubation at 65uC. Protein and
RNA were removed by the addition of proteinase K (30 mg/
sample) and RNAse (200 mg/ml) for 2 hours at 42uC, and
immunoprecipitated DNA was purified by phenol-chloroform
extraction and ethanol precipitation. Successful ChIP was assayed
by standard PCR using two primer pairs, targeting the functional
EGLN3 HRE and a control region in the same locus [40].
Chromatin Immunoprecipitation on Microarray
The ChIP-chip method was carried out as previously described
[41]. First, purified DNA from chromatin immunoprecipitation
was amplified by ligation-mediated PCR. DNA ends were
extended by incubation with T4 DNA polymerase (New England
Biolabs), and blunted DNA was ligated to pre-annealed oligonu-
cleotide linkers (JW102 gcggtgacccgggagatctgaattc and JW103
gaattcagatc) using T4 DNA ligase (New England Biolabs), and
subsequently amplified by two rounds of PCR using JW102 as
primer, to yield 2–5 mg of amplified DNA. An aliquot of this
material was run in a microfluidics platform (Agilent 2100
Electrophoresis Bioanalyzer) to accurately measure size distribu-
tion of amplified material and discard gross amplification bias.
Additionally, quantitative PCR against both a Hypoxia-Response
Element (HRE) in the EGLN3 locus [40] and a control negative
region in the same locus was routinely performed to assess loss of
enrichment during amplification.
Amplified DNA from normoxic and hypoxic chromatin
immunoprecipitation samples was labelled with Cy3 and Cy5
fluorescent dyes, respectively, and hybridized to microarrays
following guidelines from the microarray manufacturer (Agilent
Mammalian ChIP-on-chip Protocol v.10). Hybridized microarray
slides were scanned in an Agilent DNA microarray scanner
(Agilent Technologies, CA, USA) at 5 mm resolution, and
acquired microarray images were quantified with GenePix 6.0
software (Molecular Devices, CA, USA). A total of six hybridiza-
tions were conducted, corresponding to four biological replicates.
The two technical replicates were dye-swap experiments, where
normoxic samples were labelled with Cy5 and hypoxic samples
with Cy3.
Analysis of ChIP-chip Data
A custom alternative promoter microarray was used for ChIP-
chip hybridizations [42]. Probes in the array cover 34000 known
or putative promoters representing about 7000 human genes, and
tile a region from 2200 to +200 of known or predicted
transcription start sites, with an average probe spacing of 80 bp.
Genomic coordinates of the probes in the array (hg17, May 2004)
were updated to the hg19 assembly using the alignment tool
Exonerate [43] with 97% sequence identity. Probes having non-
unique matches to this version of the Human Genome were
excluded from ChIP-chip analysis.
The R/Bioconductor packages ‘‘Ringo’’ and ‘‘limma’’ were
used to analyze ChIP-chip readouts [44,45]. Limma analysis was
performed after normalization of ChIP-chip data with the
variance-stabilizing method. A separate linear model was fitted
to each biological replicate, which comprised a single readout or
two in the case of dye-swap experiments, and these models were
averaged to obtain a single linear model that includes estimation of
moderated t-statistic p values. The Benjamini-Hochberg correc-
tion for multiple comparisons (False Discovery Rate) was applied
to these p values. Ringo analysis was performed essentially as
described [46], using the parameters indicated below. Raw data
were again normalized with the variance-stabilizing method. First,
for the calculation of the average smoothed signal across replicates,
we used: winHalfSize = 100 (based on probe density and spacing
in the array) and quant = 0.75. To obtain a threshold intensity
value for bound probes, a 0.99 quantile was used as upper bound
for the null distribution. For the identification of ChIP-enriched
regions on the smoothed signal, distCutOff = 200 (maximum
probe spacing within a single ChIP-enriched region) and
minProbesInRow=4 (minimum number of probes per region)
were used. Minor modifications to Ringo functions ‘‘cherByThres-
hold’’ and ‘‘findChersOnSmoothed’’ were made to take into
account probe-wise p values (as previously calculated by limma)
for ranking of ChIP-enriched regions. Specifically, ChIP-enriched
regions found by Ringo were required to harbour one or more
probes with an FDR-adjusted p value lower than 0.02 (2% false
discovery rate). Finally, ChIP-enriched regions in poorly covered
regions of the array (having less than 8 total probes, 4 inside the
region and 4 surrounding it) and those mapping to repetitive
regions were identified with in-house Perl scripts and taken out of
the analysis.
The microarray experiments described above have been
deposited in ArrayExpress under accession number E-MEXP-
3499.
Quantitative PCR
Purified DNA from chromatin immunoprecipitation samples
was used in quantitative PCR with SYBR green-based detection
(Applied Biosystems) following the manufacturer’s recommenda-
tions. Primers targeting candidate ChIP-enriched regions were
designed with Primer Express software v2.0 (Applied Biosystems)
and Primer3 (http://frodo.wi.mit.edu/primer3/). All measure-
ments were carried out in triplicate. Threshold cycle (Ct) values for
each sample were interpolated in a standard curve of input DNA
dilutions to obtain % of input absolute values. Enrichment of
HIF1 alpha binding to target loci was calculated as the ratio of the
amounts of target sequence (measured as % of input) detected in
hypoxic vs noxmoxic ChIP samples (% of input hypoxia/% of
input normoxia). For validation of ChIP-chip candidates, three
negative control regions (in the EGLN3, IRS4 and HIPEV1 loci,
[13]) were used to estimate an average background enrichment,
and a 90% confidence interval was applied on these values to set
a threshold for successful validation of candidate regions.
Obtaining a High-confidence Set of Core HIF Binding
Regions and a Background Set of Control Regions
Custom scripts written in Perl were used to indentify
evolutionarily conserved HIF binding sites (HBSs) within ChIP-
chip regions and to select HBSs that showed evolutionary
conservation. Conservation of the HIF binding consensus
RCGTG in four mammalian species, including mouse, was
required for the evolutionary conservation filter. HBSs were
further selected to map to genes robustly induced by hypoxia, as
indicated by the results of a meta-analysis of gene expression
profiling experiments in hypoxic cell cultures [13], using a p value
threshold of 0.02 (FDR). Finally, HBS coordinates were extended
into HIF binding regions (HBRs) that spanned surrounding non-
coding conserved sequences, as determined by .50% presence of
phastCons elements [47], and the corresponding multiple
sequence alignment of each HBR was retrieved. Multiple
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sequence alignments were downloaded from the UCSC Genome
Browser’s Table Browser [48].
To obtain a set of background (control) genomic regions,
custom perl scripts were used to exploit the microarray meta-
analysis results for the identification of genes harbouring conserved
RCGTG motifs but that are unlikely to be modulated by hypoxia.
To this end, gene loci that contained conserved RCGTG motifs in
their non-coding sequences were first selected. For these genes,
each of their probes was examined, and only genes for which all of
their associated probes exhibited a mean fold value within 0.25
standard deviations of the global mean in each of the 19 datasets
employed in the meta-analysis were considered as not induced by
hypoxia. The selected coordinates of conserved RCGTG motifs
mapping to these loci were extended as previously described for the
set of core HIF binding sites. Genomic regions from this collection
were further selected to match the frequency of genomic locations
(relative to the TSS) found in the core HBR set. Briefly, Perl scripts
were used to annotate core HBRs as promoter, 59UTR, intronic
or 39UTR genomic locations and to choose, from the whole
collection, a random sample according to the proportions of
genomic locations found in the core HBR set. Similarly as with the
set of core HIF binding regions, multiple sequence alignments
corresponding to the selected control regions were retrieved.
In silico TFBS Prediction
In silico transcription factor binding site predictions were carried
out employing custom scripts written in Perl. Position-weight
matrices (PWMs) collections were downloaded from the public
databases JASPAR (2010 release) and Transfac (7.0 version)
[49,50]. Raw frequency matrices were transformed into log-odd
matrices to take into account the background nucleotide
frequencies found in the whole collection of HIF binding regions
(core and background together), and the information content of
each matrix position was calculated as proposed by Stormo [51].
The formulae used for these calculations are detailed below.
PWM conversion:
The weight of base b in position i is calculated as:
Wb,i~log2
p(b,i)
p(b)
,
where p(b,i) is the corrected probability of base b in position i and
p(b) the background probability of base b.
The corrected probability is obtained from the raw matrix by
adding a pseudocount:
p(b,i)~
f (b,i)z 1
N
N
,
where f(b,i) are the counts of base b in position i and N the number
of sites used to construct the matrix.
Information content calculation:
Di~
X
b
p(b,i):log2
p(b,i)
p(b)
Subsequently, log-odd matrices were used to screen core HIF
binding regions and genomic-matched background regions for the
presence of putative TFBSs or other sequence motifs. Perl scripts
were employed to split each sequence into overlapping fragments
of length equal to that of the PWM under analysis. For each
fragment, a score value was calculated by summing up the log-odd
frequencies obtained by substitution of nucleotides found in the
fragment in the corresponding position of the PWM. The
contribution of each base to the score was weighted by the
information content of its position in the matrix, as detailed below.
Score calculation:
Sc~
X
i
Di:Wb,i,
where Di is the information content of position i and Wb,i the log-
odd weight of base b in position i.
Finally, the resulting score was normalized by subtraction of the
minimum score and division by the score range, and compared
with a threshold value. Fragments showing a score above the
threshold were considered as putative TFBSs, and the evolution-
ary conservation of nucleotides in each motif was evaluated for
matrix positions with information content over 60%. Putative
TFBSs showing evolutionary conservation in four mammalian
species (including mouse) and whose score was over the threshold
value were recorded as present (respresented as 1). Otherwise, they
were considered absent from the analyzed sequence (represented
as 0).
For each PWM, the three strategies proposed in MATCH [52]
were used for the calculation of threshold values. The minFN
strategy aims at minimizing false negative predictions (low
stringency), and was obtained by setting the threshold value that
detects 90% of cases in a randomly generated sample of sequences
in which the probability of nucleotides at each position is dictated
by the matrix frequencies. Conversely, the minFP threshold
focuses on minimizing false positives (high stringency), and its
calculation is based on the assumption that coding sequences in
the Genome are impoverished in functional TFBSs. We used the
threshold value that results in a single hit (on average) per
10000 bp when the matrix is used on all human coding sequences.
Finally, the minSum threshold was obtained by estimating the false
positive and false negative rate for all threshold values between
minFN and minFP, and then choosing the value that minimizes
the sum of both (medium stringency).
Statistical Analysis of Enriched TFBSs
Fisher’s exact test was used to identify PWMs showing
significant enrichment in the set of core HIF binding regions
versus the background collection. In particular, we considered
significant PWMs with a p value lower than 0.05. No correction
for multiple comparisons was applied to these p values.
Additionally, the Weka machine learning workbench [53] (3.6
version) was used to identify the most informative PWMs, that
were better able to distinguish core HIF binding regions from the
background set. To this end, the correlation-based feature
selection variable selection procedure was used. The algorithm
was run 10 times using stratified 10-fold cross-validation in each
iteration. Finally, the number of times that each variable had been
selected was recorded. This number ranges from zero (never
chosen) to a hundred (corresponding to every cross-validation fold
and every iteration).
Plasmid Construction
Human genomic DNA extracted from HeLa cells was used as
template for PCR amplification of the CA9 promoter region (hg19
coordinates chr9:35673508–35673956), which was subcloned into
the pGL3-Basic plasmid (Invitrogen). The Human GYS1 reporter
construct (hg19 chr19:49496421–49496978) has been previously
described [54]. The mouse LDHA promoter construct (mm9
chr7:54101027–54101258) and the derived HRE and CREB
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binding site mutations were a kind gift from Peter Ratcliffe [26].
The remaining HRE, predicted AP1 or CEBPB binding sites and
control mutations were generated by site-directed mutagenesis,
employing QuikChange Site-directed mutagenesis kit (Stratagene).
The introduced mutations are detailed in Table S1. The identity
of all constructs was verified by sequencing.
Reporter Assays
Reporter assays were performed using the human cervical-
carcinoma cell line HeLa. Cells were seeded on six-well plates
(2.5?105 cells/well) 6 h prior to transfection. Per well, a 4.5 mg
DNA mixture containing 1.5 mg of the indicated reporter
construct or empty plasmid and 0.25 mg of a plasmid encoding
for Renilla (sea pansy) luciferase under the control of a null
promoter (Promega, Madison, WI, U.S.A.) was used for trans-
fection using the calcium phosphate method. 16 h after trans-
fection, cells where washed, replated in 24-well plates, and
incubated in normoxia, in the presence of DMOG (dimethylox-
aloylglycine, 500 mM) or in hypoxia for an additional 16 hours.
After treatments, cells were lysed and the firefly and Renilla
luciferase activities of the lysate were determined using a dual-
luciferase system (Promega, Madison, WI, U.S.A.). The firefly
luciferase activity was normalized to that of Renilla luciferase.
Each experimental condition was assayed in duplicate. Hypoxia or
DMOG fold induction values for each experiment were analyzed
by repeated measures ANOVA with a Dunnet posthoc correction,
comparing values of the wild-type promoter construct to each of
the introduced mutations.
Gene-set Enrichment Analysis
Gene-set enrichment analysis (GSEA) was carried out as
previously described ([55] and http://www.broadinstitute.org/
gsea/index.jsp). We employed a ranked list of core hypoxia-
regulated genes derived from a meta-analysis of 16 hypoxia gene
expression experiments [13], where genes are sorted by their mean
hypoxic induction across cell lines/tissues represented in the meta-
analysis. We studied the distribution of transcription factor targets
in this list employing 3000 gene-sets from the GSEA molecular
signatures database, which includes experimentally derived lists of
targets for specific transcription factors. GSEA analysis provides
and enrichment score (ES) for each gene-set across the ranked list
of hipoxia-responsive genes. In order to compare several gene-sets,
enrichment scores are normalized to produce NES values
(normalized enrichment scores). Comparison with NES values
obtained from random gene-sets allows estimation of statistical
significance. We used an FDR-adjusted p-value of 0.05.
Results
1. Basal Gene Expression is Necessary but not Sufficient
for HIF Target Selection
Previous studies have proposed that chromatin accessibility and
basal gene expression mediate HIF target selectivity [11,12]. In
order to independently assess the contribution of this mechanism
to HIF target selection, we exploited publicly available genome
profiling experiments of hypoxic cell cultures [13] to look at the
association of basal expression and hypoxic induction. We
analyzed the basal expression of a list of well-characterized HIF
targets [7] and correlated it with their response to hypoxia. In
agreement with previous reports [11,12], we found that the
response to hypoxia, scored as the percentage of HIF-target genes
induced by the treatment, was significantly higher among genes
that were already expressed in the basal (normoxic) condition
(Figure 1A, p,0.01 Wilcoxon matched test). Moreover, when the
HIF target genes across all datasets were pooled and categorized
according to their basal expression and response to hypoxia, the
distribution was significantly different to that expected by chance
(Table S2, p,0.001 Chi-square test). These results further suggest
that chromatin accessibility contributes to HIF target selectivity by
modulating the availability of RCGTG motifs. However, given the
large number of genes with basal (normoxic) expression and the
widespread distribution of the RCGTG motifs, it is expected that
many RCGTG motifs would lie within open chromatin regions.
To look at the contribution of chromatin accessibility in more
detail, we next studied the response to hypoxia of all the genes with
detectable normoxic values represented in each array. To this end,
within the group of genes with basal gene expression, we identified
those harbouring conserved HIF-binding motifs in their non-
coding sequences (Figure 1B, HBS) and categorized them
according to their induction by hypoxia. For each microarray
dataset, the large majority of genes harbouring a conserved
RCGTG motif were not induced by hypoxia (Figure 1B, yellow
bar segments) in spite of proximity of the motif to genes with
significant normoxic expression. This observation strongly suggests
that although basal gene expression correlates with hypoxia
inducibility of a gene, additional mechanisms are needed to specify
HIF target selection.
2. Comparative Analysis of HIF1 Alpha Binding Locations
in Cell Lines of Diverse Tissue Origin
The binding of additional transcription factors in proximity of
HIFs constitutes a plausible mechanism that could contribute to
HIF target selection. In this regard, previous works have addressed
the identification of sequence motifs overrepresented in collections
of HIF binding regions obtained from ChIP-chip datasets or
combinations of computational predictions and gene expression
profiling experiments [9,10,30]. A recent work failed to identify
clearly overrepresented sequences [9], while the predictions
reported in two other studies showed very small overlap [10,30].
On the other hand, the wealth of HIF1 alpha binding and hypoxic
gene expression data obtained in different cell types provides
a unique opportunity to construct integrated sets of HIF1 binding
sites that may overcome the limitations of datasets based on a single
experiment. In order to study the role of cooperativity in HIF
target selectivity, we determined the genome-wide pattern of HIF1
alpha binding sites in cervical carcinoma HeLa cells and
compared our results to previously published HIF1 ChIP-chip
experiments in hepatocellular carcinoma HepG2 cells [9], breast
cancer MCF-7 cells [10] and U87 glioma cells [11], as detailed
below.
For the determination of HIF binding sites in HeLa cells, we
performed HIF1a chromatin immunoprecipitation in HeLa cells
exposed to normoxia or hypoxia (1% oxygen) for six hours.
Amplified samples from normoxic and hypoxic cells were
competitively hybridized to a proximal promoter microarray that
tiles a subset of human 7000 genes [42]. ChIP-chip data was
analyzed with the R/Bioconductor packages Ringo [44] and
limma [45] to identify hypoxic HIF1-bound genomic regions.
Stringent statistical thresholds (2% FDR) were applied to
normalized signals from four biological replicates (Figure 2A,
all). ChIP-enriched regions were required to harbour four or more
probes above background average signal (Figure 2A, blue
horizontal line) and one or more probes robustly induced by
hypoxia in a linear model of the four replicates (Figure 2B, red
dots, 2% FDR). This analysis produced a ranked list of 57 HIF1
binding regions (Table S3), spanning the coordinates of previously
characterized HIF binding sites [7] and including many potentially
novel HIF1 binding sites and HIF1 targets. Quantitative PCR
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validation of the ChIP-chip results in independent HIF1 alpha
chromatin immunoprecipiations confirmed hypoxic enrichment of
the majority of tested candidates (Figure 2C).
Next, we compared HIF1a ChIP-chip predictions in the four
cell lines by analyzing the overlap of reported binding locations
(Figure 2D). The majority (36 sequences) of HeLa HIF1a binding
locations did not overlap with ChIP-chip results obtained in other
cell types, although many were also found in at least one of the
previous reports. A similar trend was observed taking any of the
other studies as reference, suggesting that most HIF1 binding is
cell-type specific. To test the role of cooperativity in dictating
HIF1 target selection, we focused on HIF1a ChIP-chip binding
locations common to two or more studies as a bona-fide set of core
HIF1 binding regions. Analysis of evolutionary conservation in
these sequences, defined as RCGTG motifs within PhastCons
elements [47] and conserved in at least four mammalian species
including human and mouse, showed a strong enrichment of
conserved sequences in the core set of common HIF1 binding sites,
versus those found uniquely in a single ChIP-chip study (Table
S4). Since HBSs identified in more than one study are more likely
to correspond to functional sites, this analysis suggest that
evolutionary conservation of HIF binding motifs can be predictive
of functionality as has been shown for other TFBSs [56,57].
3. Binding Sites for Diverse Stress-responsive
Transcription Factors are Enriched in bona fide HIF
Binding Regions
We employed the previous set of core, bona fide HBSs to
computationally identify enriched TFBSs that could be indicative
of transcription factor cooperation. To focus on binding locations
for which there is evidence of transcriptional modulation of nearby
genes in hypoxia, we sought to combine the core set of HIF1
binding locations with HIF transactivation data. To this end, we
employed our previous microarray meta-analysis study [13] of 16
gene expression profiling experiments comparing normoxic and
hypoxic cell cultures. This integrated gene-expression dataset was
used to select, from the binding dataset, HIF1 binding locations
that mapped close to genes showing robust hypoxic induction
(p,0.02, false discovery rate) (Figure 3A, right). Lastly, and in
order to reduce the number of spurious predictions in in silico
sequence analyses, we focused on HIF binding sites whose
sequence showed evolutionary conservation in mammalian species
(Figure 3A). These selection criteria produced an integrated set of
core HIF binding sites (Table S5). A gene annotation enrichment
analysis of the sites in this integrated set revealed enriched
annotation terms clearly associated with functional responses to
hypoxia, such as glycolysis, 2-oxoglutarate dioxygenase activity
and glycogen metabolism [7,58] (Table S6), strongly suggesting
that it faithfully represents bona fide HIF binding locations.
We next sought to identify putative TFBSs enriched in the vicinity
of the selected core HIF binding sites (Figure 3B). For this purpose,
Figure 1. Basal gene expression is not sufficient for HIF transactivation. (A) A list of well-characterized HIF target genes (from ref. 7) present
in individual gene expression profiling (microarray) datasets (see B for GEO IDs) were categorized according to their basal (normoxic) expression level
into two groups: Null, no detectable basal expression; Significant, detectable basal expression. In addition, for each microarray experiment, HIF-target
genes were further classified into those whose expression was significantly induced by hypoxia (ratio hypoxia/normoxia greater than 2.6Sd above the
mean) and non-responsive genes. The graph represents the percentage of HIF target genes in each category that were induced by hypoxia. Each pair
of joined dots represents the data from a single microarray experiment. Box and whisker plots represent the distribution of values in each category.
**: p,0.01 (Wilkoxon matched test) (B) For each of the indicated microarray datasets (GEO identifiers in horizontal axis), we identified all the genes
showing a significant basal (normoxic) expression. Then, we classified them according to their response to hypoxia (‘‘Induced’’ and ‘‘notInduced’’, see
A) and the presence of conserved RCGTG motifs in their regulatory regions (‘‘HBS’’ and ‘‘NoHBS’’, respectively). The graph depicts cumulative
percentages (vertical axis) of genes in each of the four combinations of the two categories: no conserved HIF binding motifs and no hypoxic
induction (blue, NoHBS_notInduced), no conserved HIF binding motifs but hypoxic induction (green, NoHBS_Induced), conserved HIF binding motifs
but no hypoxic induction (yellow, HBS_notInduced) and conserved HIF binding sites and hypoxic induction (red, HBS_Induced).
doi:10.1371/journal.pone.0045708.g001
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we obtained the sequences flanking each HBS (Table S5). The
length of flanking non-coding sequences was based on evolutionary
conservation, as indicated by genomic annotation of PhastCons
elements [47]. Statistical assessment of sequence motif enrichment
in this set of sequences requires comparison with a background set,
the election of this set greatly influencing the results of the analysis
[59].We constructed a set of sequences resembling those in the set of
core HIF binding regions by screening the non-coding Human
Genome for evolutionarily conserved HIF binding consensus
sequences, and extended these motifs to span the flanking conserved
sequence (Figure 3B and Figure S1). From this set, we selected
regions that are unlikely to be transcriptionally modulated by
hypoxia, as judged by no differential expression in any of the 16
hypoxia experiments included in our previously reported genome
profiling meta-analysis [13]. Finally, a subset from these sequences
was chosen that matched the genomic locations and base
composition found in the core set (Figure S1). We thereby obtained
a custom set of circa 3500 background sequences containing
a RCGTG HIF binding consensus.
The sequences in the core HIF binding regions and background
sets were screened for TFBSs employing the mammalian position-
weight matrixes from the public Transfac 7.0 and Jaspar (2010
Figure 2. Comparative analysis of HIF1A ChIP-chip data in cell lines of different tissue origin. (A) Visualization of HIF1A ChIP-chip
readouts for the GAPDH promoter region in HeLa cells. The plot represents normalized intensities (log fold change hypoxia/normoxia, vertical axis)
along the hg19 genomic coordinate (horizontal axis). Vertical black bars (top of the graph) mark the center position of array probes. The signal of four
independent biological replicates is indicated in different colors (BR1 to 4). The smoothed black line corresponds to the averaged signal across
replicates. The horizontal blue line indicates the intensity threshold for bound probes. (B) Volcano plot of HeLa ChIP-chip data (linear model across
the four biological replicates). Spots in the plot correspond to individual probes in the array. Probes significantly enriched in hypoxic samples
(p,0.02, FDR) are highlighted as red spots. (C) Quantitative PCR validation of HeLa ChIP-chip candidates. The official Gene Symbol corresponding to
each region is indicated in the horizontal axis. Four control regions (one positive and three negative) were used as reference to estimate the
successful validation of the indicated ChIP-chip candidates (candidate ranks in parenthesis). Bars represent the average fold enrichment in hypoxic
versus normoxic ChIP samples (vertical axis), as obtained in three independent experiments. Error bars represent the standard deviation. The
horizontal black line indicates the threshold for successful validation (90% confidence interval). (D) 4-way Venn diagram indicating the overlap of
HIF1A bound regions as reported by ChIP-chip studies in hepatoma (HepG2 cells, ref. 9), mammary gland (MCF-7 cells, ref. 10), glioma (U87 cells, ref.
11) and cervix (HeLa cells, this study) origin.
doi:10.1371/journal.pone.0045708.g002
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release) databases and custom scripts based on the MATCH
algorithm [52], recording the presence or absence of a total of 605
sequences motifs in each sequence by using three different
stringencies (Table 1). In order to reduce spurious hits, we only
considered as positive hits those motifs that were conserved in
mammalian species. Fisher’s exact test was applied to these
datasets to identify motif predictions enriched in the set of core
HIF binding regions. Enriched motifs were consistently found
across different stringencies and database sets. In addition to HIF
PWMs, we found a significant enrichment for PWMs associated to
CREB1, FOS/AP1 and NFY (Table 1).
As an independent assessment of enriched motifs that is less
dependent on the composition of the core set, we compared the
results of the previous analysis with a variable selection approach
implemented in the Weka machine learning software [53].
Correlation-based feature selection was applied to the complete
set of high-stringency predictions to detect non-redundant variables
(PWMs) able to distinguish between the core and background sets.
As expected, a number of the top-ranked PWMs, such as those for
HIF1, AP1/ATF3 or NFY were coincident with the Fisher’s exact
test predictions (Table 2). However, additional enrichedmotifs were
found (such as CEBPB or NFAT), probably reflecting an increased
predictive power after stratified cross-validation.
We next asked whether the TFs associated to the enriched
TFBSs may share any common characteristics. Gene annotation
enrichment analysis (Table S7) of these enriched transcription
factors pointed at stimulus-responsive transcription factors as
significantly enriched in core HIF binding regions, and indeed
most of the identified DNA-binding proteins have been reported
to function as transcription factors of stress responses [60],
including hypoxia-responsive TFs [61]. On the whole, our results
suggest that binding sequences of several additional TFs other
than HIFs, and in particular diverse stress-responsive TFs, are
enriched in bona fide HIF binding regions.
4. Functional Impact of Transcription Factor Binding Sites
Proximal to Hypoxia Response Elements
In order to address the functional relevance of the enriched
TFBSs identified in silico, we next set out to validate some of these
predictions experimentally. To this end, we selected hits for
Figure 3. Integrative strategy for prediction of cooperativity in HIF binding regions. (A) HIF1 binding locations common to at least two
out of four different ChIP-chip studies in HeLa, HepG2, MCF-7 and U87 cells (left), mammalian sequence conservation of the HIF binding regions
(center) and regions close to genes robustly induced in hypoxia in a meta-analysis of 16 gene expression experiments (right) were integrated into
a set of bona-fide core HIF binding regions (B) Stepwise diagram for prediction and validation of TFBSs enriched in core HIF binding regions:
collection of a set of core HIF binding regions and a background set of control sequences (left), in silico prediction of transcription factor binding sites
present or absent in the sequences of core and background sets (center), statistical analyses of enriched TFBSs in sequences from the core set (right,
top) and experimental validation of these predictions (right, bottom).
doi:10.1371/journal.pone.0045708.g003
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enriched TFBSs focusing on: 1) HREs located close to the TSSs of
genes, to be able to study these promoter regions in in cellulo
reporter assays, and 2) TFBS predictions located close to the
Hypoxia Response Element (HRE). According to these criteria, we
evaluated a CREB binding site prediction in the LDHA promoter
(Figure 4A), a CEBPB binding site identified in silico in the GYS1
promoter (Figure 4B), and a predicted AP1 site in the CA9
promoter (Figure 4C). The selected promoters were cloned
upstream of a firefly luciferase gene, either in their wild-type
version or harbouring mutations in the predicted TFBSs. We then
compared the effect of these mutations with that of the hypoxia
response element (HRE). Finally, and in order to evaluate non-
specific effects of the introduced changes, we also generated
control mutations in these promoters by altering randomly-
selected DNA motifs in the vicinity of the HRE (Figure 4). These
control mutations lay in non-conserved (LDHA and GYS1
CONTROL 2) as well as conserved (CA9 and GYS1 CONTROL
1) genomic regions.
We next measured the luciferase activity of these constructs in
normoxia, hypoxia (1% oxygen) and upon treatment with the
prolyl hydroxylase inhibitor DMOG (500 mM). As expected,
mutation of the HRE in all the studied promoters completely
abrogated induction by either hypoxia or DMOG treatment
(Figure 4). Importantly, mutation of the predicted CREB site in
the proximity of the HRE within the LDHA promoter led to
a partial reduction in the inducibility of the construct, while
introduction of a random mutation had a negligible effect in the
response of the promoter to either hypoxia or DMOG. Similarly,
mutation of the CEBPB binding site proximal to the GYS1 HRE
led to a partial abrogation of the hypoxic induction when
compared to mutation of the HRE core (Figure 4B). This
reduction was not consistently recapitulated when two distinct
control mutations were introduced in the promoter (Figure 4B,
Control 1 and Control 2), strongly suggesting that it is a specific
effect. Importantly, similar results were obtained upon DMOG
treatment (Figure 4B). Finally, in contrast to the two previous
cases, directed mutagenesis of the AP1 site proximal to the CA9
HRE led to slightly increased inducibility of the construct by either
hypoxia or DMOG (Figure 4C), reaching statistical significance
only for the latter. This effect was distinct from that of a control
mutation or the expected abrogation of the induction produced by
mutation of the HRE.
Collectively, these results indicate that at least some of the
TFBSs computationally predicted as enriched in a core set of bona
Table 1. Enriched TFBSs in core HIF binding regions (Fisher’s exact test).
PWM Collection Stringency Overrepresented PWM Hits Transcription factor P value
JASPAR CORE 2010 minFN (low) MA0033.1_FOXL1 53 FOXL1 0,001
MA0259.1_HIF1A::ARNT 54 HIF1 0,0076
minFP (high) MA0018.2_CREB1 7 CREB1 0,0203
MA0060.1_NFYA 9 NFYA 0,0234
MA0259.1_HIF1A::ARNT 44 HIF1 6E215
minSum (intermediate) MA0032.1_FOXC1 36 FOXC1 0,0065
MA0060.1_NFYA 14 NFYA 0,0218
MA0099.1_Fos 20 FOS 0,0305
MA0259.1_HIF1A::ARNT 52 HIF1 3E206
JASPAR PHYLOFACTS 2010 minFN (low) PF0014_TGACGTCA 4 FOS/AP1 0,0377
PF0032_TGASTMAGC 3 NF-E2 0,0268
minFP (high) PF0014_TGACGTCA 4 FOS/AP1 0,0445
PF0032_TGASTMAGC 3 NF-E2 0,0308
minSum (intermediate) PF0014_TGACGTCA 4 FOS/AP1 0,0383
PF0032_TGASTMAGC 3 NF-E2 0,0272
TRANSFAC 7.0 minFN (low) M00055_V$NMYC_01 34 NMYC 0,0174
M00244_V$NGFIC_01 5 NGFIC 0,0425
M00246_V$EGR2_01 5 EGR2 0,0499
M00251_V$XBP1_01 19 XBP1 0,02
minFP (high) M00185_V$NFY_Q6 6 NFY 0,0284
M00188_V$AP1_Q4 7 AP1 0,0096
minSum (intermediate) M00040_V$CREBP1_01 6 CREBP1 0,0465
M00185_V$NFY_Q6 14 NFY 0,0244
M00244_V$NGFIC_01 5 NGFIC 0,0437
M00287_V$NFY_01 14 NFY 0,0248
M00394_V$MSX1_01 16 MSX1 0,0229
Enriched sequence motifs in core HIF binding regions, as indicated by statistical analysis (Fisher’s exact test, p,0.05 with no correction for multiple comparisons). For
each overrepresented sequence motif/PWM, the table indicates the following: the database collection (PWM collection), the stringency used in in silico TFBS
identification (Stringency), the number of hits obtained in the set of core HBRs (Hits), the transcription factor (Tr. Factor) associated to the PWM and the p value of the
enrichment (p value). Robust predictions across different stringencies and PWM datasets are highlighted in bold.
doi:10.1371/journal.pone.0045708.t001
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fide HIF binding regions play a functional role in the transactiva-
tion by hypoxia or DMOG treatment of HIF-responsive
promoters. Moreover, our data also suggests that diverse stress-
responsive transcription factors, probably through modulation of
basal transcription or recruitment of common cofactors, contrib-
ute to the specification of HIF target selectivity.
5. Transcriptional Targets of Stress-responsive
Transcription Factors are Enriched Among HIF Target
Genes
The results in the previous section were restricted to a limited
set of validated promoters. However, if the involved transcription
factors are of general relevance to HIF mediated transcription,
some of their targets would be expected to be common with HIFs.
To judge the potential generality of the involvement of CEBPs,
CREB and AP1 in modulation induction of HIF transcriptional
targets, we employed a gene-set enrichment analysis (GSEA) [55]
as an unbiased way to explore the distribution of other
transcription factor targets among hypoxia inducible genes. For
this analysis, we employed a list of over 11000 genes sorted
according to their response to hypoxia, and derived from our
previous meta-analysis of gene expression profiles [13]. This sorted
list was then queried against the curated collection (C2) of the
GSEA molecular signatures database (http://www.broadinstitute.
org/gsea/index.jsp). This collection comprises over 3000 gene sets
from various sources including experimentally derived lists of
targets for specific transcription factors. Thus, this analysis
identifies sets of functionally related genes, such as those co-
regulated in response to specific genetic and chemical perturba-
tions, that are significantly enriched in the top positions of a list of
genes induced by hypoxia.
As expected, GSEA analysis revealed a statistically significant
enrichment of well-characterized HIF targets in this sorted list
(Figure 5A, black circles). Moreover, enrichment of CEBPA/B
targets was also significant for three different gene-sets (Figure 5A,
purple circles, and Figure 5B). These gene sets derive from
independent expression profiling experiments performed in cells
overexpressing different members of the CEBP family [62–64]. In
addition, the analysis also revealed enrichment for two gene sets
containing targets regulated by the ATF/CREB family (Figure 5A,
orange circles), albeit the FDR-adjusted p-values did not reach
statistical significance (0.106 and 0.229 respectively). Finally,
enrichment of AP1 targets was not statistically significant
(Figure 5A, green circle). Altogether, these results suggest, at least
for the case of CEBPs (Figure 5B), that transcription factor
collaboration can be a general mechanism contributing to HIF
target selectivity.
Discussion
The complete elucidation of the molecular principles governing
the translation of genomic information to gene regulation remains
a central question in biology. In particular, understanding the
mechanisms dictating target selection by HIF transcription factors
is of fundamental importance to truly dissect the genes directly
modulated by HIFs, and therefore to completely characterize the
transcriptional response to hypoxia that these factors orchestrate,
and its interactions with other transcriptional pathways. Several
mechanisms have been proposed to contribute to selective DNA
binding and gene regulation by transcription factors with largely
generic DNA binding domains [65], among them the co-binding
of several transcription factor molecules [14,66,67]. In order to
dissect these mechanisms, high-quality collections of binding sites
are an obvious pre-requisite. The recent development of high-
throughput chromatin immunoprecipitation experiments [41,68]
has spurred knowledge on the genome-wide DNA binding
locations of transcription factors, and these techniques hence
constitute an essential tool to explore mechanisms of transcrip-
tional regulation on a global scale [69–71]. In this work, we
employed an integrative approach to identify additional transcrip-
tion factors that could contribute to HIFs binding and target
selectivity. This strategy was based on computational prediction of
enriched sequence motifs in a set of core HIF binding regions
constructed through selection of HIF1 alpha binding locations
derived from genome-wide chromatin immunoprecipitation ex-
periments in HeLa (this study), HepG2 [9], MCF-7 [10] and U87
cells [11]. During preparation of this manuscript, a fourth study
employing ChIP-Seq in MCF-7 cells was published [12], pro-
viding high-resolution data on genome-wide HIF binding locations
independently of gene architecture.
Chromatin accessibility has been shown to play an important
role in dictating transcription factor binding [72–74]. In this
regard, integration of HIF1 alpha binding locations in U87 and
HepG2 cells with gene expression data in the same cell types
revealed a preference for HIF1 binding to map to transcriptionally
active genes in normoxia [11], therefore suggesting that chromatin
accessibility, as indirectly evidenced by basal transcriptional
activity, determines HIF1 binding. As an independent approach
to test this hypothesis, we looked at the correlation of normoxic
gene expression and induction of known HIF targets in publicly
available microarray datasets of hypoxic cell cultures [13]. In
agreement, we found a statistically significant association between
basal expression and hypoxia inducibility of known targets
(Figure 1A and Table S2). Furthermore, comparison of HIF1a
and HIF2a binding locations in MCF-7 cells with DNAse
Table 2. Enriched TFBSs in core HIF binding regions (variable
selection).
Overrepresented PWM Number chosen Transcription factor
MA0259.1 100 HIF1
PF0146 86 unknown (RRCCGTTA)
PF0032 82 NFE-2
M00222 80 Hand1:E47
M00188 77 AP1
PF0096 67 unknown (YGCANTGCR)
PF0014 58 ATF3
M00109 57 CEBPB
M00185 45 NFY
M00246 36 EGR2
M00244 20 NGFIC
MA0154.1 15 EBF1
PF0009 13 ATF3
M00302 11 NFAT
M00002 10 E47
The Table indicates sequence motifs/PWMs identified as discriminative of core
HBRs employing correlation-based feature selection in 10 iterations of 10-fold
stratified cross-validation. The results are ranked according to the total number
of folds (up to a hundred) in which the variable was chosen by the algorithm
(Number chosen). The associated transcription factor, were known, is indicated
along with the PWM (Tr. factor). Predictions coincident with Fisher’s exact test
(Table 1) are highlighted in bold.
doi:10.1371/journal.pone.0045708.t002
Cooperativity in HIF Binding Regions
PLOS ONE | www.plosone.org 10 September 2012 | Volume 7 | Issue 9 | e45708
Figure 4. Effect of stress-responsive transcription factor binding sites in the proximity of hypoxia-response elements on hypoxic
induction of HIF-responsive promoters. HeLa cells were transfected with reporter plasmids containing promoter regions of mouse LDHA (A),
human GYS1 (B) and human CA9 (C) in their wild-type form or harbouring the indicated mutations. Diagrams to the left of each graph indicate the
location of the different mutations in the employed promoter constructs (grey blocks, highlighted with red border). Effects on reporter induction by
hypoxia and the hypoxia mimetic DMOG are summarized in the central columns: -, no hypoxic/DMOG induction; +, ++, +++: increasing strength of
hypoxic/DMOG induction. Graphs represent the fold induction over normoxia of the wild-type promoter (WT) upon hypoxia or DMOG treatment,
compared to that of promoter versions harbouring mutations in the hypoxia response element (HRE), in CREB (A), CEBPB (B), or AP1 (C) binding sites
proximal to the HRE, or in control genomic regions (CONTROL). Bars represent average values in four to six independent experiments, and error bars
the standard deviation. Statistical significance of observed activity compared to the wild-type promoters are indicated: n.s.: not significant, *: p,0.05,
**: p,0.01 (repeated measures ANOVA with Dunnet post-hoc correction).
doi:10.1371/journal.pone.0045708.g004
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hypersentitivity data in the same cell type [12] also revealed
a significant association of HIF binding with normoxic DNAse
hypersensitive sites, again pointing at an important role of open
chromatin regions in dicating HIF binding. However, when
conserved RCGTG HIF binding consensus motifs are identified in
non-coding regions of genes showing basal expression, a majority
of these are not induced by hypoxia (Figure 3B). Therefore,
although chromatin accessibility clearly favors HIF1 binding,
additional mechanisms are likely needed to fully specify HIF target
selectivity.
DNA methylation of a HIF binding site was originally shown to
block HIF1a binding to the 39 erythropoietin enhancer [16], and
indeed erythropoietin expression appears to be restricted to cell
types in which the hypoxia response element is unmethylated.
Altered HIF binding due to methylation changes in HREs has
been further validated in additional target genes, such as BNIP3
[75] or HIF1A [76], and is often associated with cancer
progression. However, a global view on the effects of DNA
methylation in HIF binding selectivity is lacking, and may be
challenging to analyze in view of recent evidence arguing for
dynamic DNA methylation in hypoxia [77].
Additional transcription factors binding in the proximity of
a HIF1 binding site could impact either HIF1 binding or
transcriptional modulation of the target gene. In agreement with
this possibility, a recent study addressing the functional validation
of common genetic variants at a renal cancer susceptibility locus
[78] found HIF2 binding to be dependent on a polymorphism
falling outside the RCGTG HIF binding consensus, strongly
suggesting that sequences outside the HIF binding site can be
functionally important in determining HIF binding. We tested this
hypothesis by computational prediction of transcription factor
binding sites enriched in a core set of bona fide HIF binding regions
(Figure 3B). These were obtained through integration of HIF1a
ChIP-chip data with a gene expression meta-analysis of hypoxic
cell cultures [13] (Figure 3A), thereby combining multiple HIF
DNA binding and hypoxic gene expression datasets. Our
approach has the advantage of using an integrated set of sequences
that could overcome the limitations of analyses based on a single
dataset [10,30], where a proportion of binding sites could
potentially correspond to false positives or non-functional sites.
In addition to HIF matrices, we observed additional sequence
motifs that were enriched in core HIF binding regions (Tables 1
and 2) and that could potentially impact HIF binding and
transactivation selectivity. Of note, the transcriptional activity of
several of these proteins, such as AP-1, CREB, EGR-2 or CEBPB
is known to be induced by hypoxia [61]. Nevertheless, and in
agreement with previous predictions of enriched TFBSs in the
vicinity of experimentally [10] or computationally [30] identified
HIF binding sites, the statistical significance of these predictions is
relatively low and, even on an integrated dataset, no single
collaborating TF stands out. In fact, HIF PWMs are the most
enriched in core HIF binding regions. Since sequences in the
background set used for comparison also contain RCGTG motifs
(Figure S1), this enrichment likely arises from the well known
preference for A versus G in the first position of the HIF binding
consensus. These results collectively suggest that several additional
transcription factors could influence HIF transcriptional activity.
Importantly, we noted that most of the enriched TFBSs
corresponded to stress-responsive transcription factors. Varied
stress-responsive TFs have been shown to coordinately regulate
the same genes [23,79], and indeed several transcription factors
are activated by the same stresses in mammalian cells [61,80,81].
Figure 5. Transcriptional targets of stress-responsive transcription factors are enriched among core hypoxia-responsive genes. (A)
Gene-set enrichment analysis on a set of 11673 genes sorted by their response to hypoxia according to a meta-analysis of hypoxia gene expression
experiments (ref. 13). The graph depicts the normalized enrichment score of 3174 gene sets from the curated collection (C2) of the GSEA molecular
signatures database v3.0, that includes sets of transcription factor target genes. Solid circles highlight gene-sets derived from studies on HIF1 (black,
ELVIDGE_HYPOXIA_UP and SEMENZA_HIF1_TARGETS), CEBPA/B (purple, GERY_CEBP_TARGETS, HALMOS_CEBPA_TARGETS_UP and TAVOR_CEBPA_-
TARGETS_UP), CREB1/ATF5 (orange, GHO_ATF5_TARGETS_DN and MCCLUNG_CREB1_TARGETS_UP) and AP1 (green, OZANNE_AP1_TARGETS_UP)
transcriptional targets. The vertical blue line corresponds to an FDR-adjusted p-value of 0.05. (B) GSEA analysis of hypoxia-responsive genes (see A)
against the GERY_CEBPA_TARGETS (M12338, derived from the GEO dataset GSE2188) gene-set. Hypoxic response is rank-ordered in the horizontal
axis (Rank in ordered dataset). Black bars indicate the position of individual targets in the CEBPA gene-set. The graph on top (green curve) represents
enrichment scores of CEBPA targets across hypoxia responsive genes, indicating positive correlation between the two. The gradient color bar
indicates positive (red) and negative (blue) correlation boundaries.
doi:10.1371/journal.pone.0045708.g005
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However, it is unclear whether this cooperation among stress-
responsive pathways translates at the genomic level. In order to
evaluate the functional significance of the TFBSs enriched in core
HIF binding regions, we carried out an experimental validation by
disrupting selected sequences in bona fide HIF-responsive promo-
ters (Figure 4). Importantly, no experimental confirmation had
been attempted on previously reported predictions [10,30], and
therefore the biological significance of those findings remained
unclear. In spite of being limited to three selected promoters, our
results clearly indicate that, compared to control mutations,
alteration of binding sequences of transcription factors enriched in
HIF binding regions, and different from HIFs themselves, have
a specific effect on the transcriptional activation of HIF-responsive
promoters. In particular, we found negative effects on hypoxic
induction of LDHA and GYS1 promoters upon disruption of CREB
and CEBPB binding sites proximal to the HRE, whereas mutation
of an AP1 site proximal to the CA9 HRE led to a slightly
augmented hypoxic induction of the promoter. In agreement with
our results, mutation of the same CREB binding site was been
previously shown to alter LDHA hypoxic induction [26]. In-
terestingly, USF binding to a palindrome CACGTG HRE in the
LDHA promoter was suggested to complement HIF binding [27].
However, our results do not allow us to corroborate these findings,
as mutation of this HRE was not evaluated in our experiments
(Materials and Methods and Table S1). Furthermore, hypoxic CA9
expression has been linked to cooperation between AP1 family
member ATF4 and HIF1a [82]. In this study, ATF4 over-
expression led to an augmented CA9 induction in hypoxia, with
reduced hypoxic expression of CA9 being observed upon ATF4
knock-down. Chromatin immunoprecipitation experiments
mapped ATF4 binding to the 21400/21000 region of the CA9
promoter, which falls outside of the promoter region employed in
our experiments. Nevertheless, the apparent paradox with our
results argues for careful interpretation of the role of AP1 in the
HIF transcriptional response. In fact, both positive and negative
effects of AP1 have been reported on hypoxic gene expression [81]
and, given the number of AP1 family members, these probably
arise from compositional differences in AP1 complexes.
Importantly, the effects observed upon mutation of CREB,
CEBPB or AP1 binding sites (Figure 4) were always moderate
when compared to mutation of the HIF binding consensus
RCGTG, suggesting that rather than being an absolute re-
quirement for hypoxic induction, the integrity of these neighboring
TFBSs fine-tunes the HIF-mediated transcriptional response.
Thus, it is possible that multiple independent factors contribute,
in an additive fashion, to HIF-mediated transcription. This model
could also explain why we found a relatively large number of
enriched TFBSs in HIF binding regions, but all of them sharing
a modest statistical significance. On the whole, these observations
indicate that several of the enriched TFBSs identified in our
approach are of functional relevance for HIF-mediated transcrip-
tion. Nevertheless, it should be noted that other TFs for which
collaboration with HIFs has been previously suggested [61] are not
recovered as enriched in our approach. An inherent assumption in
our method is that such TFBSs will be enriched in bona fide HIF
binding regions (Figure 3), which may not hold true if cooperation
is specific to a small number of target genes. Furthermore, the
employed HIF binding data in this study is for the HIF1a subunit
only, whereas transcription factor cooperativity may well apply to
other HIF subunits. In fact, several reports have implicated the
ETS family of transcription factors in target selection by HIF2a
[28,29].
We observed very similar tendencies when transcriptional
activation of reporter constructs was elicited by DMOG or
hypoxia treatment (Figure 4), additionally suggesting that, at least
in our experimental conditions, the contribution of these factors
could occur mainly in basal conditions, as it is unlikely that
hypoxia and DMOG treatment induce completely overlapping
cellular responses. Several recent reports [11,12] have suggested
that chromatin accessibility determines HIF1 binding, although
this mechanism may not fully explain HIFs binding and target
selectivity (Figure 1). Our results indicate that an additional layer
of specificity comes from proximal co-binding of other transcrip-
tion factors and HIFs to open chromatin regions, thereby
facilitating or restricting HIF-mediated transcription. Elucidation
of the underlying molecular mechanisms falls outside the scope of
our work, although it is tempting to speculate that transcription
factors binding in proximity of HIFs may be involved in
recruitment of co-activator or co-repressor proteins. Of note,
a recent mammalian two-hybrid survey of protein-protein
interactions for human and mouse TFs [83] reported a physical
association between HIF1A and AP-1 family member JUN, as well
as the previously known interaction between CEBPB and p300
[84]. p300/CBP is a master co-activator of HIF-mediated
transcription whose recruitment can also be mediated by CREB
[85]. In this regard, evidence from a synthetic transactivation
screen on the EGLN1 promoter [86] pointed to ETV4 as an
additional p300-dependent coactivator of HIF-mediated tran-
scription. Moreover, HIF1 is known to interact with Jab1/CSN5
[87,88], a protein originally identified as a transcriptional co-
activator for AP1 [89]. Future investigations on protein compo-
sition of HIF-bound enhancers should be pivotal in supporting this
model.
The associations between HIFs and AP1, CREB and CEBPs
analyzed in our reporter results could be general across many HIF
targets or be restricted to individual targets. To judge the
generality of these results, we conducted a gene-set enrichment
analysis (GSEA) of transcription factor targets in a sorted list of
genes regulated by hypoxia [13]. The results of this analysis
showed a significant enrichment of CEBP targets among hypoxia-
inducible genes (Figure 5), suggesting that at least for this family of
transcription factors, the functional association with HIFs could be
relatively general. Of note, recent works have reported a direct
protein-protein interaction between HIF1a and CEBPa [90,91],
and have implicated CEBPa activity in regulation of the HIF
target genes galectin-1 [92] and PAI-1 [23]. Hypoxic induction of
both galectin-1 and PAI-1 was found to be synergistically dependent
on both HIF1a and CEBPa activity and their co-binding to the
promoter region. Our results further suggest that this functional
association may be general across a wider collection of HIF
targets.
In conclusion, the data presented herein demonstrates that
integration of high-throughput chromatin immunoprecipitation
and gene expression data is a successful approach to select high-
quality core HIF binding regions, and provides experimental proof
of principle for the biological relevance of enriched transcription
factor binding sites other than the HIF binding consensus in HIF-
mediated transcription. Specifically, our results suggest that diverse
stress-responsive transcription factors, in particular CEBPs,
contribute to fine-tuning of the HIF-mediated transcriptional
response.
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